Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
GRCh37/hg19 Xp21.1(chrX:35441680-35453280)x1			not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000616867	X	35441680 - 35453280			616867	608203		
GRCh37/hg19 10q21.3(chr10:67336685-67344145)x1			not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000613017	10	67336685 - 67344145			613017	604353		
GRCh37/hg19 10q21.1(chr10:54929003-54944056)x0			not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000612981	10	54929003 - 54944056			612981	604317		
GRCh37/hg19 20q13.13(chr20:47096920-47103289)x0			not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000604606	20	47096920 - 47103289			604606	595942		
GRCh37/hg19 2q32.1(chr2:184848859-184855568)x0			not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000604122	2	184848859 - 184855568			604122	595458		
GRCh37/hg19 14q24.3(chr14:78295342-78296579)x0	ADCK1		not provided	Benign(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000614428	14	78295342 - 78296579			614428	605764		
GRCh37/hg19 3p14.2(chr3:62711374-62728523)x1	CADPS		not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000605829	3	62711374 - 62728523			605829	597165		
NC_000017.10:g.(?_29422322)_(29701178_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001073833	17	29422322 - 29701178			1073833	1057875		
NC_000017.10:g.(?_29588709)_(29701193_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001072220	17	29588709 - 29701193			1072220	1057894		
NC_000017.10:g.(?_29587625)_(29669475_?)del	EVI2A|NF1|OMG|EVI2B		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV001072219	17	29587625 - 29669475			1072219	1057893		
NC_000017.10:g.(?_29422322)_(29665163_?)del	EVI2A|OMG|EVI2B|NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001072079	17	29422322 - 29665163			1072079	1057874		
NC_000017.10:g.(?_29422055)_(29701173_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001071967	17	29422055 - 29701173			1071967	1057870		
NC_000017.10:g.(?_29527428)_(29657848_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001070266	17	29527428 - 29657848			1070266	1057881		
NC_000017.10:g.(?_29587381)_(29662055_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	VCV001070147	17	29587381 - 29662055			1070147	1057892		
NC_000017.10:g.(?_29586040)_(29701173_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001070146	17	29586040 - 29701173			1070146	1057891		
NC_000017.10:g.(?_29559081)_(29701173_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001070145	17	29559081 - 29701173			1070145	1057888		
GRCh37/hg19 17q11.2(chr17:29393104-30427403)x1	EVI2A|MIR193A|EVI2B|RAB11FIP4|LRRC37B|NF1|OMG|SUZ12|COPRS|UTP6		See cases	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000929369	17	29393104 - 30427403			929369	917693		
NC_000017.11:g.(?_31093927)_(31378677_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000833518	17	29420945 - 29705695			833518	820994		
NC_000017.11:g.(?_31206230)_(31374165_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000833286	17	29533248 - 29701183			833286	821016		
NC_000017.11:g.(?_31203089)_(31352424_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832518	17	29530107 - 29679442			832518	821015		
NC_000017.11:g.(?_31095030)_(31374155_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000832492	17	29422048 - 29701173			832492	820998		
NC_000017.11:g.(?_31218985)_(31374175_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000832408	17	29546003 - 29701193			832408	821018		
NC_000017.11:g.(?_31095304)_(31374161_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000832212	17	29422322 - 29701179	17	31095304 - 31374161	832212	530627		
NC_000017.11:g.(?_31225075)_(31360723_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000831517	17	29552093 - 29687741			831517	821020		
GRCh37/hg19 17q11.2(chr17:28999903-30409337)x1	EVI2A|EVI2B|NF1|OMG|SUZ12|CRLF3|COPRS|ADAP2|UTP6|TEFM|ATAD5|RNF135|RAB11FIP4|LRRC37B|MIR193A		not provided	Pathogenic(Last reviewed: Sep 6, 2018)	no assertion criteria provided	VCV000685655	17	28999903 - 30409337			685655	673247		
NC_000017.11:g.(?_31248974)_(31374165_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000660684	17	29575992 - 29701183	17	31248974 - 31374165	660684	653093		
NC_000017.11:g.(?_31218995)_(31374165_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000651252	17	29546013 - 29701183	17	31218995 - 31374165	651252	652632		
NC_000017.11:g.(?_31155963)_(31374175_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281170|LOC108281180|LOC108281181|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000647950	17	29482981 - 29701193	17	31155963 - 31374175	647950	652626		
NC_000017.11:g.(?_31169881)_(31374165_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281181|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000643145	17	29496899 - 29701183	17	31169881 - 31374165	643145	653347		
NC_000017.11:g.(?_31095300)_(31374165_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000583583	17	29422318 - 29701183	17	31095300 - 31374165	583583	570663		
NC_000017.11:g.(?_31169871)_(31343155_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281181		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000583535	17	29496889 - 29670173	17	31169871 - 31343155	583535	574253		
GRCh37/hg19 17q11.2(chr17:29033882-30326958)	EVI2A|EVI2B|NF1|OMG|SUZ12|CRLF3|COPRS|ADAP2|UTP6|TEFM|ATAD5|RNF135|RAB11FIP4|MIR193A		Neurofibromatosis type 6	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523264	17	29033882 - 30326958			523264	514180		
GRCh37/hg19 17q11.2(chr17:29033882-30326958)	EVI2A|EVI2B|NF1|OMG|SUZ12|CRLF3|COPRS|ADAP2|UTP6|TEFM|ATAD5|RNF135|RAB11FIP4|MIR193A		Neurofibromatosis type 6	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523263	17	29033882 - 30326958			523263	514179		
NM_001042492.2(NF1):c.(?_-50)_(*68_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000506282	17	29422278 - 29701241	17	31095260 - 31374223	506282	497266		
NC_000017.11:g.(?_31179106)_(31357039_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281181|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000457505	17	29506124 - 29684057	17	31179106 - 31357039	457505	467084		
NC_000017.11:g.(?_31155977)_(31374161_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281170|LOC108281180|LOC108281181|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000457502	17	29482995 - 29701179	17	31155977 - 31374161	457502	467083		
NC_000017.10:g.(?_29422308)_(29701193_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000457496	17	29422308 - 29701193			457496	466986		
NC_000017.11:g.(?_31261711)_(31340645_?)del	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000417327	17	29588729 - 29667663	17	31261711 - 31340645	417327	401479		
NM_000267.3(NF1):c.-383_*3522del	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000237507	17	29421945 - 29704695	17	31094927 - 31377677	237507	242577		
NM_000267.3(NF1):c.4773-22561_6311del	EVI2B|EVI2A|NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217085	17	29630277 - 29663879	17	31303259 - 31336861	217085	213719		
NM_000267.3(NF1):c.4662-397_4773-14262del	EVI2B|NF1|OMG		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217082	17	29591850 - 29638576	17	31264832 - 31311558	217082	213718		
NC_000015.10:g.(?_38253166)_(39021201_?)del	FAM98B|LINC02694|RASGRP1|SPRED1		Legius syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000583432	15	38545367 - 39313402	15	38253166 - 39021201	583432	566864		
NC_000022.10:g.(?_29083885)_(30337586_?)del	GAS2L1|EMID1|HSCB|RFPL1S|ZNRF3|AP1B1|EWSR1|NEFH|CCDC117|CABP7|NF2|RFPL1|XBP1|NIPSNAP1|THOC5|MTMR3|CHEK2|C22orf31|RHBDD3|UQCR10|ZMAT5|KREMEN1|ASCC2|RASL10A		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001076222	22	29083885 - 30337586			1076222	1058131		
GRCh37/hg19 Xp21.3(chrX:29266900-29278905)x0	IL1RAPL1		not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000616814	X	29266900 - 29278905			616814	608150		
GRCh37/hg19 1q25.2(chr1:180228968-180230081)x0	LHX4		not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000600126	1	180228968 - 180230081			600126	591462		
NM_001042492.3(NF1):c.61-5189_205-1285del	LOC108281170|NF1|LOC108281169		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217032	17	29477812 - 29484743	17	31150794 - 31157725	217032	213678		
NM_001042492.3(NF1):c.7458-600_7615+735del	LOC108281182|NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217102	17	29678649 - 29680141	17	31351631 - 31353123	217102	213735		
NM_001042492.3(NF1):c.4_5delinsTT (p.Ala2Phe)	LOC111811965|NF1	A2F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480205	17	29422331 - 29422332	17	31095313 - 31095314	480205	477975	rs1555594471	NC_000017.11:31095312:GC:TT
NM_001042492.3(NF1):c.15del (p.Arg5fs)	LOC111811965|NF1	R5fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000369956	17	29422341	17	31095323	369956	354178	rs1057516197	NC_000017.11:31095322:GG:G
GRCh38/hg38 Xp22.31(chrX:7021831-8129470)x0	LOC113875037|MIR4767|MIR651|PNPLA4|PUDP|STS|VCX		See cases	Pathogenic(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000146227	X	6939872 - 8097511	X	7021831 - 8129470	146227	155978		
NM_001042492.3(NF1):c.1498_1500del (p.Ile500del)	NF1	I500del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319474	17	29541574 - 29541576	17	31214556 - 31214558	1319474	1309727		NC_000017.11:31214555:ATT:
NM_001042492.3(NF1):c.1602_1603del (p.Gln535fs)	NF1	Q535fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319473	17	29546096 - 29546097	17	31219078 - 31219079	1319473	1309726		NC_000017.11:31219077:CTC:C
NM_001042492.3(NF1):c.4973_4974del (p.Phe1658fs)	NF1	F1637fs, F1658fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319470	17	29652974 - 29652975	17	31325956 - 31325957	1319470	1309723		NC_000017.11:31325955:TTT:T
NM_001042492.3(NF1):c.5409del (p.Ile1803fs)	NF1	I1782fs, I1803fs	Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: Feb 18, 2021)	criteria provided, single submitter	VCV001285535	17	29654656	17	31327638	1285535	1275378		NC_000017.11:31327637:TT:T
NM_001042492.3(NF1):c.3351_3355del (p.Cys1117_Glu1119delinsTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001285423	17	29559752 - 29559756	17	31232734 - 31232738	1285423	1275266		NC_000017.11:31232733:TGCAGTG:TG
NM_001042492.3(NF1):c.1882del (p.Tyr628fs)	NF1	Y628fs	Neurofibromatosis, type 1|Caf√©-au-lait macules with pulmonary stenosis	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001213688	17	29552144	17	31225126	1213688	1203681		NC_000017.11:31225125:TTTTTT:TTTTT
NM_001042492.3(NF1):c.4597del (p.Arg1533fs)	NF1	R1512fs, R1533fs	Neurofibromatosis-Noonan syndrome	Pathogenic	no assertion criteria provided	VCV001184516	17	29588747	17	31261729	1184516	1174357		NC_000017.11:31261728:AA:A
NM_001042492.3(NF1):c.1527+14del	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001169079	17	29541611	17	31214593	1169079	1157928		NC_000017.11:31214592:TTTTTTT:TTTTTT
NM_001042492.3(NF1):c.1062+8_1062+13del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001156176	17	29527619 - 29527624	17	31200601 - 31200606	1156176	1146954		NC_000017.11:31200600:ATGCTTAT:AT
NM_001042492.3(NF1):c.4836-14_4836-6del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV001148964	17	29652824 - 29652832	17	31325806 - 31325814	1148964	1146989		NC_000017.11:31325805:GTCATTTTC:
NM_001042492.3(NF1):c.3197+9del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001146888	17	29557946	17	31230928	1146888	1146974		NC_000017.11:31230927:AAAAAAA:AAAAAA
NM_001042492.3(NF1):c.6921+10_6921+11del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001138523	17	29665832 - 29665833	17	31338814 - 31338815	1138523	1126114		NC_000017.11:31338813:TGT:T
NM_001042492.3(NF1):c.7063-6_7063-3del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV001109293	17	29670020 - 29670023	17	31343002 - 31343005	1109293	1104691		NC_000017.11:31343001:TTAAT:T
NM_001042492.3(NF1):c.4725-7del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV001101795	17	29592240	17	31265222	1101795	1104669		NC_000017.11:31265221:C:
NM_001042492.3(NF1):c.1528-7del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV001096733	17	29546015	17	31218997	1096733	1082842		NC_000017.11:31218996:CC:C
NM_001042492.3(NF1):c.6147+5_6147+7del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001092791	17	29663495 - 29663497	17	31336477 - 31336479	1092791	1082891		NC_000017.11:31336476:ATCA:A
NM_001042492.3(NF1):c.7189+8del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001084687	17	29670156	17	31343138	1084687	1082901		NC_000017.11:31343137:AAAAAA:AAAAA
NM_001042492.3(NF1):c.1002del (p.Asn335fs)	NF1	N335fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001076699	17	29527553	17	31200535	1076699	1063908		NC_000017.11:31200534:C:
NM_001042492.3(NF1):c.375del (p.Glu126fs)	NF1	E126fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001076572	17	29490290	17	31163272	1076572	1063894		NC_000017.11:31163271:T:
NM_001042492.3(NF1):c.1179del (p.Phe394fs)	NF1	F394fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001076566	17	29528171	17	31201153	1076566	1063914		NC_000017.11:31201152:C:
NM_001042492.3(NF1):c.7446_7457+6del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001076517	17	29677325 - 29677342	17	31350307 - 31350324	1076517	1064114		NC_000017.11:31350306:CCCTTCCTATAGGTAAGT:
NM_001042492.3(NF1):c.3538_3544del (p.Met1180fs)	NF1	M1180fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001076422	17	29560061 - 29560067	17	31233043 - 31233049	1076422	1063991		NC_000017.11:31233042:ATGGAAG:
NC_000017.10:g.(?_29585391_29760973del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001076221					1076221	1057890		
NC_000017.10:g.(?_29559786_29644315del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV001076220					1076220	1057889		
NC_000017.10:g.(?_29556370_29563755del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001076219					1076219	1057887		
NC_000017.10:g.(?_29547895_29556446del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001076218					1076218	1057885		
NC_000017.10:g.(?_29541567_29580544del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV001076217					1076217	1057884		
NC_000017.10:g.(?_29386946_29560072del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 12, 2020)	criteria provided, single submitter	VCV001076216					1076216	1057867		
NM_001042492.3(NF1):c.1339del (p.Leu447fs)	NF1	L447fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 15, 2020)	criteria provided, single submitter	VCV001076194	17	29533336	17	31206318	1076194	1063919		NC_000017.11:31206317:C:
NM_001042492.3(NF1):c.5268+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001076120	17	29653271	17	31326253	1076120	1064053		NC_000017.11:31326252:G:
NM_001042492.3(NF1):c.974del (p.Val325fs)	NF1	V325fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001076089	17	29527525	17	31200507	1076089	1063907		NC_000017.11:31200506:T:
NC_000017.10:g.(?_29482991)_(29577082_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001076038	17	29482991 - 29577082			1076038	1057877		
NC_000017.10:g.(?_29548419)_(29557002_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2020)	criteria provided, single submitter	VCV001076037	17	29548419 - 29557002			1076037	1057886		
NC_000017.10:g.(?_29541459)_(29624377_?)del	NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001076036	17	29541459 - 29624377			1076036	1057883		
NM_001042492.3(NF1):c.2944del (p.His982fs)	NF1	H982fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001075972	17	29556946	17	31229928	1075972	1063971		NC_000017.11:31229927:C:
NM_001042492.3(NF1):c.3600_3609del (p.Leu1201fs)	NF1	L1201fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001075971	17	29560122 - 29560131	17	31233104 - 31233113	1075971	1063994		NC_000017.11:31233103:TATTGGCTGAT:T
NM_001042492.3(NF1):c.3733_3740del (p.Val1244_Thr1245insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001075889	17	29562650 - 29562657	17	31235632 - 31235639	1075889	1064001		NC_000017.11:31235631:GTTACTCTGTT:GTT
NM_001042492.3(NF1):c.3970del (p.Thr1324fs)	NF1	T1324fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001075868	17	29563035	17	31236017	1075868	1064010		NC_000017.11:31236016:A:
NM_001042492.3(NF1):c.3938_3941del (p.Asp1313fs)	NF1	D1313fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001075773	17	29563001 - 29563004	17	31235983 - 31235986	1075773	1064007		NC_000017.11:31235982:TGATTG:TG
NM_001042492.3(NF1):c.1707del (p.Trp571fs)	NF1	W571fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001075592	17	29548933	17	31221915	1075592	1063931		NC_000017.11:31221914:A:
NM_001042492.3(NF1):c.1660del (p.Gln554fs)	NF1	Q554fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001075490	17	29548886	17	31221868	1075490	1063928		NC_000017.11:31221867:C:
NM_001042492.3(NF1):c.4955del (p.Asn1652fs)	NF1	N1631fs, N1652fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001075451	17	29652956	17	31325938	1075451	1064039		NC_000017.11:31325937:AA:A
NM_001042492.3(NF1):c.1023_1024del (p.Ile342fs)	NF1	I342fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001075316	17	29527574 - 29527575	17	31200556 - 31200557	1075316	1063909		NC_000017.11:31200555:CA:
NM_001042492.3(NF1):c.3032_3033del (p.Ile1011fs)	NF1	I1011fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001075031	17	29557318 - 29557319	17	31230300 - 31230301	1075031	1063976		NC_000017.11:31230299:ATA:A
NM_001042492.3(NF1):c.5736_5737delinsAT (p.Ser1912_Lys1913delinsArgTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001074730	17	29657440 - 29657441	17	31330422 - 31330423	1074730	1064061		NC_000017.11:31330421:TA:AT
NM_001042492.3(NF1):c.6136del (p.Val2046fs)	NF1	V2025fs, V2046fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001074642	17	29663479	17	31336461	1074642	1064070		NC_000017.11:31336460:GG:G
NM_001042492.3(NF1):c.1102del (p.Ser368fs)	NF1	S368fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001074627	17	29528094	17	31201076	1074627	1063912		NC_000017.11:31201075:A:
NM_001042492.3(NF1):c.6512del (p.Lys2171fs)	NF1	K2150fs, K2171fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001074498	17	29664469	17	31337451	1074498	1064079		NC_000017.11:31337450:AA:A
NM_001042492.3(NF1):c.1054del (p.Asp352fs)	NF1	D352fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001074403	17	29527605	17	31200587	1074403	1063910		NC_000017.11:31200586:G:
NM_001042492.3(NF1):c.6592del (p.Ala2198fs)	NF1	A2177fs, A2198fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001074365	17	29664550	17	31337532	1074365	1064080		NC_000017.11:31337531:G:
NM_001042492.3(NF1):c.3551del (p.Thr1184fs)	NF1	T1184fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001074329	17	29560074	17	31233056	1074329	1063993		NC_000017.11:31233055:C:
NM_001042492.3(NF1):c.2158del (p.Arg720fs)	NF1	R720fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001074282	17	29553608	17	31226590	1074282	1063945		NC_000017.11:31226589:CC:C
NM_001042492.3(NF1):c.1341_1342del (p.Leu447_His448insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001074228	17	29533338 - 29533339	17	31206320 - 31206321	1074228	1063920		NC_000017.11:31206319:TC:
NM_001042492.3(NF1):c.7979del (p.Leu2660fs)	NF1	L2639fs, L2660fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001074177	17	29685504	17	31358486	1074177	1064131		NC_000017.11:31358485:TTT:TT
NC_000017.10:g.(?_29685177)_(29686053_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001074108	17	29685177 - 29686053			1074108	1057901		
NC_000017.10:g.(?_29676126)_(29677346_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, single submitter	VCV001074107	17	29676126 - 29677346			1074107	1057899		
NC_000017.10:g.(?_29490198)_(29497021_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV001074106	17	29490198 - 29497021			1074106	1057879		
NC_000017.10:g.(?_29490184)_(29592377_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001074105	17	29490184 - 29592377			1074105	1057878		
NM_001042492.3(NF1):c.3094del (p.Cys1032fs)	NF1	C1032fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001074080	17	29557378	17	31230360	1074080	1063978		NC_000017.11:31230359:TTTT:TTT
NM_001042492.3(NF1):c.7895del (p.Asp2632fs)	NF1	D2611fs, D2632fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001074063	17	29684312	17	31357294	1074063	1064128		NC_000017.11:31357293:A:
NM_001042492.3(NF1):c.7226del (p.Thr2409fs)	NF1	T2388fs, T2409fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001074047	17	29676174	17	31349156	1074047	1064103		NC_000017.11:31349155:C:
NM_001042492.3(NF1):c.4510del (p.Val1504fs)	NF1	V1483fs, V1504fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001074033	17	29587466	17	31260448	1074033	1064025		NC_000017.11:31260447:G:
NM_001042492.3(NF1):c.6060_6147+57del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001074021	17	29663404 - 29663548	17	31336386 - 31336530	1074021	1064068		
NM_001042492.3(NF1):c.1373del (p.Pro458fs)	NF1	P458fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001074019	17	29533368	17	31206350	1074019	1063921		NC_000017.11:31206349:CCC:CC
NM_001042492.3(NF1):c.5119_5126del (p.Val1707fs)	NF1	V1686fs, V1707fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 26, 2018)	criteria provided, single submitter	VCV001073992	17	29653120 - 29653127	17	31326102 - 31326109	1073992	1064046		NC_000017.11:31326101:TGTTTTCAT:T
NC_000017.10:g.(?_29677191)_(29677346_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001073836	17	29677191 - 29677346			1073836	1057900		
NC_000017.10:g.(?_29482981)_(29483164_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001073835	17	29482981 - 29483164			1073835	1057876		
NC_000017.10:g.(?_29528423)_(29528509_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV001073834	17	29528423 - 29528509			1073834	1057882		
NM_001042492.3(NF1):c.5262_5268del (p.Ile1755fs)	NF1	I1734fs, I1755fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001073801	17	29653264 - 29653270	17	31326246 - 31326252	1073801	1064051		NC_000017.11:31326245:TATTAAA:
NM_001042492.3(NF1):c.4410del (p.Ser1470fs)	NF1	S1449fs, S1470fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001073727	17	29586127	17	31259109	1073727	1064022		NC_000017.11:31259108:C:
NM_001042492.3(NF1):c.5035del (p.Ile1679fs)	NF1	I1658fs, I1679fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001073726	17	29653037	17	31326019	1073726	1064042		NC_000017.11:31326018:A:
NM_001042492.3(NF1):c.3381del (p.Gly1128fs)	NF1	G1128fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV001073701	17	29559784	17	31232766	1073701	1063988		NC_000017.11:31232765:A:
NM_001042492.3(NF1):c.6249del (p.Tyr2084fs)	NF1	Y2063fs, Y2084fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001073578	17	29663754	17	31336736	1073578	1064076		NC_000017.11:31336735:C:
NM_001042492.3(NF1):c.2721del (p.Val909fs)	NF1	V909fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001073541	17	29556354	17	31229336	1073541	1063963		NC_000017.11:31229335:G:
NM_001042492.3(NF1):c.7190-6_7190-2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001073526	17	29676132 - 29676136	17	31349114 - 31349118	1073526	1064102		NC_000017.11:31349113:TTGTA:
NM_001042492.3(NF1):c.6973del (p.Asp2326fs)	NF1	D2305fs, D2326fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001073459	17	29667574	17	31340556	1073459	1064092		NC_000017.11:31340555:C:
NM_001042492.3(NF1):c.1526_1527+2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001073458	17	29541601 - 29541604	17	31214583 - 31214586	1073458	1063926		NC_000017.11:31214582:TGTGT:T
NM_001042492.3(NF1):c.2229del (p.Val744fs)	NF1	V744fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001073399	17	29553680	17	31226662	1073399	1063947		NC_000017.11:31226661:T:
NM_001042492.3(NF1):c.3791_3792del (p.Glu1264fs)	NF1	E1264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001073396	17	29562711 - 29562712	17	31235693 - 31235694	1073396	1064002		NC_000017.11:31235692:AA:
NM_001042492.3(NF1):c.4695del (p.Ser1566fs)	NF1	S1545fs, S1566fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001073380	17	29588845	17	31261827	1073380	1064027		NC_000017.11:31261826:CC:C
NM_001042492.3(NF1):c.239_242del (p.Tyr80fs)	NF1	Y80fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001073379	17	29486061 - 29486064	17	31159043 - 31159046	1073379	1063889		NC_000017.11:31159042:TATCT:T
NM_001042492.3(NF1):c.2450del (p.Met817fs)	NF1	M817fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001073167	17	29556083	17	31229065	1073167	1063959		NC_000017.11:31229064:T:
NM_001042492.3(NF1):c.661del (p.Trp221fs)	NF1	W221fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001073115	17	29508731	17	31181713	1073115	1063898		NC_000017.11:31181712:TTTT:TTT
NM_001042492.3(NF1):c.2724del (p.Val909fs)	NF1	V909fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001072944	17	29556355	17	31229337	1072944	1063964		NC_000017.11:31229336:AAA:AA
NM_001042492.3(NF1):c.2756del (p.Asp919fs)	NF1	D919fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001072756	17	29556389	17	31229371	1072756	1063966		NC_000017.11:31229370:A:
NM_001042492.3(NF1):c.6909del (p.Leu2304fs)	NF1	L2283fs, L2304fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV001072662	17	29665811	17	31338793	1072662	1064090		NC_000017.11:31338792:A:
NM_001042492.3(NF1):c.818del (p.Leu273fs)	NF1	L273fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001072655	17	29509613	17	31182595	1072655	1063902		NC_000017.11:31182594:T:
NM_001042492.3(NF1):c.9del (p.His4fs)	NF1|LOC111811965	H4fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001072626	17	29422336	17	31095318	1072626	1063882		NC_000017.11:31095317:G:
NM_001042492.3(NF1):c.1143_1144del (p.Ser382fs)	NF1	S382fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001072623	17	29528134 - 29528135	17	31201116 - 31201117	1072623	1063913		NC_000017.11:31201115:TTT:T
NM_001042492.3(NF1):c.5267_5268del (p.Lys1756fs)	NF1	K1735fs, K1756fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001072614	17	29653268 - 29653269	17	31326250 - 31326251	1072614	1064052		NC_000017.11:31326249:AAA:A
NM_001042492.3(NF1):c.3309_3312del (p.Phe1103fs)	NF1	F1103fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001072572	17	29559200 - 29559203	17	31232182 - 31232185	1072572	1063986		NC_000017.11:31232181:TTTCTT:TT
NM_001042492.3(NF1):c.7369_7370del (p.Lys2456_His2457insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001072498	17	29677247 - 29677248	17	31350229 - 31350230	1072498	1064108		NC_000017.11:31350228:ACA:A
NM_001042492.3(NF1):c.4720del (p.Thr1574fs)	NF1	T1553fs, T1574fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001072496	17	29588871	17	31261853	1072496	1064028		NC_000017.11:31261852:A:
NM_001042492.3(NF1):c.3455_3458del (p.Leu1152fs)	NF1	L1152fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001072353	17	29559855 - 29559858	17	31232837 - 31232840	1072353	1063989		NC_000017.11:31232836:ACTTACT:ACT
NM_001042492.3(NF1):c.7793del (p.Val2598fs)	NF1	V2577fs, V2598fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001072325	17	29684032	17	31357014	1072325	1064124		NC_000017.11:31357013:T:
NM_001042492.3(NF1):c.1807_1811del (p.Ile603fs)	NF1	I603fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001072308	17	29550547 - 29550551	17	31223529 - 31223533	1072308	1063936		NC_000017.11:31223528:ATATT:
NM_001042492.3(NF1):c.5690del (p.Gly1897fs)	NF1	G1876fs, G1897fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001072272	17	29657393	17	31330375	1072272	1064059		NC_000017.11:31330374:GG:G
NC_000017.10:g.(?_29654511)_(29667669_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV001072224	17	29654511 - 29667669			1072224	1057898		
NC_000017.10:g.(?_29652828)_(29677346_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001072223	17	29652828 - 29677346			1072223	1057897		
NC_000017.10:g.(?_29652818)_(29670173_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001072222	17	29652818 - 29670173			1072222	1057896		
NC_000017.10:g.(?_29592237)_(29653280_?)del	NF1|OMG|EVI2A|EVI2B		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001072221	17	29592237 - 29653280			1072221	1057895		
NM_001042492.3(NF1):c.375_376del (p.Glu126fs)	NF1	E126fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001072197	17	29490289 - 29490290	17	31163271 - 31163272	1072197	1063893		NC_000017.11:31163270:GTG:G
NM_001042492.3(NF1):c.7610del (p.Leu2537fs)	NF1	L2516fs, L2537fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001072172	17	29679426	17	31352408	1072172	1064116		NC_000017.11:31352407:TT:T
NC_000017.10:g.(?_29422308)_(29497035_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001072080	17	29422308 - 29497035			1072080	1057871		
NC_000017.10:g.(?_29422314)_(29548957_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, single submitter	VCV001072077	17	29422314 - 29548957			1072077	1057872		
NC_000017.10:g.(?_29422055)_(29541613_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001072076	17	29422055 - 29541613			1072076	1057869		
NM_001042492.3(NF1):c.5158del (p.Glu1720fs)	NF1	E1699fs, E1720fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001072070	17	29653160	17	31326142	1072070	1064047		NC_000017.11:31326141:G:
NM_001042492.3(NF1):c.4856del (p.Asn1619fs)	NF1	N1598fs, N1619fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV001071980	17	29652857	17	31325839	1071980	1064035		NC_000017.11:31325838:AA:A
NC_000017.10:g.(?_29420318_29701183del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV001071966					1071966	1057868		
NM_001042492.3(NF1):c.4373_4430+20delinsGCAACTGAGTAAGTGGCAAGAAAATTACCTGCATCAAAGTTGCTTTTCACAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001071952	17	29586090 - 29586167	17	31259072 - 31259149	1071952	1064021		
NM_001042492.3(NF1):c.2856del (p.Leu952fs)	NF1	L952fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001071917	17	29556858	17	31229840	1071917	1063967		NC_000017.11:31229839:A:
NM_001042492.3(NF1):c.6747del (p.Val2250fs)	NF1	V2229fs, V2250fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001071916	17	29665084	17	31338066	1071916	1064088		NC_000017.11:31338065:TT:T
NM_001042492.3(NF1):c.5497_5498del (p.Leu1833fs)	NF1	L1812fs, L1833fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001071848	17	29654745 - 29654746	17	31327727 - 31327728	1071848	1064056		NC_000017.11:31327726:CT:
NM_001042492.3(NF1):c.7764del (p.Gln2588fs)	NF1	Q2567fs, Q2588fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001071681	17	29684002	17	31356984	1071681	1064123		NC_000017.11:31356983:AA:A
NM_001042492.3(NF1):c.1742del (p.Ile581fs)	NF1	I581fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001071643	17	29550482	17	31223464	1071643	1063934		NC_000017.11:31223463:T:
NM_001042492.3(NF1):c.3073del (p.Arg1025fs)	NF1	R1025fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001071611	17	29557359	17	31230341	1071611	1063977		NC_000017.11:31230340:AA:A
NM_001042492.3(NF1):c.937del (p.Ser313fs)	NF1	S313fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001071315	17	29527487	17	31200469	1071315	1063905		NC_000017.11:31200468:AA:A
NM_001042492.3(NF1):c.7442del (p.Gly2481fs)	NF1	G2460fs, G2481fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001071255	17	29677320	17	31350302	1071255	1064113		NC_000017.11:31350301:GG:G
NM_001042492.3(NF1):c.1498_1499del (p.Ile500fs)	NF1	I500fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001071151	17	29541574 - 29541575	17	31214556 - 31214557	1071151	1063925		NC_000017.11:31214555:AT:
NM_001042492.3(NF1):c.4968del (p.Asp1657fs)	NF1	D1636fs, D1657fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001070988	17	29652970	17	31325952	1070988	1064040		NC_000017.11:31325951:A:
NM_001042492.3(NF1):c.6251_6257del (p.Arg2083_Tyr2084insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001070927	17	29663753 - 29663759	17	31336735 - 31336741	1070927	1064075		NC_000017.11:31336734:GCTACATGCT:GCT
NM_001042492.3(NF1):c.3968del (p.Pro1323fs)	NF1	P1323fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, single submitter	VCV001070804	17	29563032	17	31236014	1070804	1064009		NC_000017.11:31236013:CC:C
NM_001042492.3(NF1):c.4478_4485del (p.Asn1493fs)	NF1	N1472fs, N1493fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001070798	17	29587434 - 29587441	17	31260416 - 31260423	1070798	1064023		NC_000017.11:31260415:ATCATAGT:
NM_001042492.3(NF1):c.2935del (p.Ser979fs)	NF1	S979fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001070604	17	29556937	17	31229919	1070604	1063970		NC_000017.11:31229918:A:
NM_001042492.3(NF1):c.6477del (p.Lys2160fs)	NF1	K2139fs, K2160fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001070593	17	29664433	17	31337415	1070593	1064078		NC_000017.11:31337414:CCC:CC
NM_001042492.3(NF1):c.827del (p.Leu276fs)	NF1	L276fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001070584	17	29509621	17	31182603	1070584	1063903		NC_000017.11:31182602:TT:T
NM_001042492.3(NF1):c.3326del (p.Leu1109fs)	NF1	L1109fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001070556	17	29559728	17	31232710	1070556	1063987		NC_000017.11:31232709:TT:T
NM_001042492.3(NF1):c.1661_1662del (p.Gln554fs)	NF1	Q554fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001070470	17	29548887 - 29548888	17	31221869 - 31221870	1070470	1063929		NC_000017.11:31221868:AG:
NM_001042492.3(NF1):c.172del (p.Leu58fs)	NF1	L58fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001070451	17	29483111	17	31156093	1070451	1063886		NC_000017.11:31156092:CC:C
NM_001042492.3(NF1):c.4208_4220del (p.Gly1403fs)	NF1	G1382fs, G1403fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001070331	17	29585395 - 29585407	17	31258377 - 31258389	1070331	1064017		NC_000017.11:31258376:GGTGCAGTAGGAAG:G
NC_000017.10:g.(?_29508430)_(29592367_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001070265	17	29508430 - 29592367			1070265	1057880		
NM_001042492.3(NF1):c.4824del (p.Tyr1607_Tyr1608insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001069825	17	29592346	17	31265328	1069825	1064031		NC_000017.11:31265327:T:
NM_001042492.3(NF1):c.7424del (p.Thr2475fs)	NF1	T2454fs, T2475fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001069810	17	29677303	17	31350285	1069810	1064111		NC_000017.11:31350284:C:
NM_001042492.3(NF1):c.7948_7958del (p.Phe2650fs)	NF1	F2629fs, F2650fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001069796	17	29684365 - 29684375	17	31357347 - 31357357	1069796	1064130		NC_000017.11:31357346:TTTCCCAAAGT:
NM_001042492.3(NF1):c.2964del (p.Ile988fs)	NF1	I988fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001069753	17	29556965	17	31229947	1069753	1063972		NC_000017.11:31229946:TT:T
NM_001042492.3(NF1):c.6051del (p.Ser2018fs)	NF1	S1997fs, S2018fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001069752	17	29663394	17	31336376	1069752	1064067		NC_000017.11:31336375:CC:C
NM_001042492.3(NF1):c.3800del (p.Leu1267fs)	NF1	L1267fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001069721	17	29562719	17	31235701	1069721	1064003		NC_000017.11:31235700:TT:T
NM_001042492.3(NF1):c.1235del (p.Asn412fs)	NF1	N412fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001069547	17	29528476	17	31201458	1069547	1063915		NC_000017.11:31201457:AAA:AA
NM_001042492.3(NF1):c.1908del (p.Ser637fs)	NF1	S637fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV001069510	17	29552175	17	31225157	1069510	1063938		NC_000017.11:31225156:T:
NM_001042492.3(NF1):c.3940del (p.Trp1314fs)	NF1	W1314fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001069442	17	29563004	17	31235986	1069442	1064008		NC_000017.11:31235985:TT:T
NM_001042492.3(NF1):c.7173_7174del (p.Gly2392fs)	NF1	G2371fs, G2392fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001069302	17	29670137 - 29670138	17	31343119 - 31343120	1069302	1064100		NC_000017.11:31343118:TG:
NM_001042492.3(NF1):c.6593del (p.Ala2198fs)	NF1	A2177fs, A2198fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001069240	17	29664551	17	31337533	1069240	1064081		NC_000017.11:31337532:C:
NM_001042492.3(NF1):c.3148del (p.Met1050fs)	NF1	M1050fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001069230	17	29557894	17	31230876	1069230	1063982		NC_000017.11:31230875:A:
NM_001042492.3(NF1):c.5246_5247del (p.Lys1749fs)	NF1	K1728fs, K1749fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001069148	17	29653247 - 29653248	17	31326229 - 31326230	1069148	1064050		NC_000017.11:31326228:AAA:A
NM_001042492.3(NF1):c.2111del (p.Leu704fs)	NF1	L704fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV001069088	17	29553562	17	31226544	1069088	1063942		NC_000017.11:31226543:T:
NM_001042492.3(NF1):c.3141del (p.Trp1048fs)	NF1	W1048fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001068972	17	29557887	17	31230869	1068972	1063981		NC_000017.11:31230868:C:
NM_001042492.3(NF1):c.6204_6211del (p.Leu2069fs)	NF1	L2048fs, L2069fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001068971	17	29663707 - 29663714	17	31336689 - 31336696	1068971	1064073		NC_000017.11:31336688:ACTTTAGAAC:AC
NM_001042492.3(NF1):c.3528_3544del (p.Arg1176fs)	NF1	R1176fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001068701	17	29560048 - 29560064	17	31233030 - 31233046	1068701	1063990		NC_000017.11:31233029:AAGAGCTACATTTATGGAAG:AAG
NM_001042492.3(NF1):c.2276_2277del (p.Val759fs)	NF1	V759fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001068562	17	29554259 - 29554260	17	31227241 - 31227242	1068562	1063948		NC_000017.11:31227240:GTG:G
NM_001042492.3(NF1):c.6del (p.Ala3fs)	NF1|LOC111811965	A3fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001068537	17	29422332	17	31095314	1068537	1063881		NC_000017.11:31095313:CC:C
NM_001042492.3(NF1):c.2294del (p.Arg765fs)	NF1	R765fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001068536	17	29554278	17	31227260	1068536	1063949		NC_000017.11:31227259:G:
NM_001042492.3(NF1):c.2986_2987del (p.Val996fs)	NF1	V996fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001068504	17	29556988 - 29556989	17	31229970 - 31229971	1068504	1063973		NC_000017.11:31229969:GT:
NC_000017.10:g.(?_29490395_29491750del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV001067838					1067838	1054615		
NC_000017.10:g.(?_29575992)_(29587543_?)del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001067837	17	29575992 - 29587543			1067837	1054618		
NM_001042492.3(NF1):c.4110+1del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001067617	17	29576137	17	31249119	1067617	1056396		NC_000017.11:31249118:GG:G
NM_001042492.3(NF1):c.5812+1del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV001067386	17	29657517	17	31330499	1067386	1056402		NC_000017.11:31330498:G:
NM_001042492.3(NF1):c.1393-5_1398del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 25, 2020)	criteria provided, single submitter	VCV001067362	17	29541462 - 29541472	17	31214444 - 31214454	1067362	1056390		NC_000017.11:31214443:TTTTTAGAGTCTT:TT
NM_001042492.3(NF1):c.59_60+4del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001066935	17	29422386 - 29422391	17	31095368 - 31095373	1066935	1056385		NC_000017.11:31095367:AGGTAA:
NC_000017.10:g.(?_29558432_29559785del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV001066496					1066496	1054617		
NC_000017.10:g.(?_29557300_29559486del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001066495					1066495	1054616		
NM_001042492.3(NF1):c.4725-15_4725-3del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001066350	17	29592232 - 29592244	17	31265214 - 31265226	1066350	1056399		NC_000017.11:31265213:TTATTTTTCTTTT:
NM_001042492.3(NF1):c.3639_3640del (p.Met1214fs)	NF1	M1214fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, single submitter	VCV001064550	17	29560162 - 29560163	17	31233144 - 31233145	1064550	1052791		NC_000017.11:31233143:AA:
NM_001042492.3(NF1):c.4247_4248delinsTC (p.Pro1416Leu)	NF1	P1395L, P1416L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001051739	17	29585435 - 29585436	17	31258417 - 31258418	1051739	1050151		NC_000017.11:31258416:CT:TC
NM_001042492.3(NF1):c.2868_2873del (p.Asn957_Thr958del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001051408	17	29556866 - 29556871	17	31229848 - 31229853	1051408	1050140		NC_000017.11:31229847:ATACCAATAC:ATAC
NM_001042492.3(NF1):c.6004del (p.Gln2002fs)	NF1	Q1981fs, Q2002fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048754	17	29662047	17	31335029	1048754	1036822		NC_000017.11:31335028:C:
NM_001042492.3(NF1):c.7814del (p.Leu2605fs)	NF1	L2584fs, L2605fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048753	17	29684052	17	31357034	1048753	1036840		NC_000017.11:31357033:TT:T
NM_001042492.3(NF1):c.1101del (p.Ser368fs)	NF1	S368fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048752	17	29528093	17	31201075	1048752	1036771		NC_000017.11:31201074:C:
NM_001042492.3(NF1):c.4235_4240del (p.Arg1412_Phe1413del)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048751	17	29585422 - 29585427	17	31258404 - 31258409	1048751	1036802		NC_000017.11:31258403:AGATTTA:A
NM_001042492.3(NF1):c.5473_5506del (p.Ile1825fs)	NF1	I1804fs, I1825fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048746	17	29654720 - 29654753	17	31327702 - 31327735	1048746	1036819		NC_000017.11:31327701:CATTCATATCCGGACCCGCTGGGAACTGTCACAGC:C
NM_001042492.3(NF1):c.2082del (p.Leu695fs)	NF1	L695fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048745	17	29553531	17	31226513	1048745	1036779		NC_000017.11:31226512:TTT:TT
NM_001042492.3(NF1):c.3789del (p.Glu1264fs)	NF1	E1264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048742	17	29562707	17	31235689	1048742	1036800		NC_000017.11:31235688:AAA:AA
NM_001042492.3(NF1):c.288_288+2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048741	17	29486111 - 29486113	17	31159093 - 31159095	1048741	1036760		NC_000017.11:31159092:GGT:
NM_001042492.3(NF1):c.2729del (p.Gly910fs)	NF1	G910fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048739	17	29556360	17	31229342	1048739	1036782		NC_000017.11:31229341:GGG:GG
NM_001042492.3(NF1):c.7376del (p.Lys2459fs)	NF1	K2438fs, K2459fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048738	17	29677253	17	31350235	1048738	1036836		NC_000017.11:31350234:AAA:AA
NM_001042492.3(NF1):c.4313del (p.Gly1438fs)	NF1	G1417fs, G1438fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048737	17	29585498	17	31258480	1048737	1036803		NC_000017.11:31258479:GGGG:GGG
NM_001042492.3(NF1):c.3595del (p.Thr1199fs)	NF1	T1199fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048734	17	29560116	17	31233098	1048734	1036796		NC_000017.11:31233097:AAA:AA
NM_001042492.3(NF1):c.6591del (p.Phe2197fs)	NF1	F2176fs, F2197fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001048733	17	29664546	17	31337528	1048733	1036828		NC_000017.11:31337527:TTTT:TTT
NM_001042492.3(NF1):c.4608_4611delinsC (p.Asp1537del)	NF1	D1516del, D1537del	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048730	17	29588759 - 29588762	17	31261741 - 31261744	1048730	1036810		NC_000017.11:31261740:TGAT:C
NM_001042492.3(NF1):c.2409_2409+4delinsC	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048724	17	29554624 - 29554628	17	31227606 - 31227610	1048724	1036781		NC_000017.11:31227605:GGTAA:C
NM_001042492.3(NF1):c.5390del (p.Asn1797fs)	NF1	N1776fs, N1797fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048722	17	29654637	17	31327619	1048722	1036817		NC_000017.11:31327618:AA:A
NM_001042492.3(NF1):c.2957del (p.Ala986fs)	NF1	A986fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048713	17	29556959	17	31229941	1048713	1036786		NC_000017.11:31229940:C:
NM_001042492.3(NF1):c.693del (p.Phe231fs)	NF1	F231fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048704	17	29508764	17	31181746	1048704	1036769		NC_000017.11:31181745:TTT:TT
NM_001042492.3(NF1):c.3778del (p.Met1260fs)	NF1	M1260fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048703	17	29562698	17	31235680	1048703	1036799		NC_000017.11:31235679:A:
NM_001042492.3(NF1):c.7048del (p.Ile2350fs)	NF1	I2329fs, I2350fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048702	17	29667649	17	31340631	1048702	1036833		NC_000017.11:31340630:A:
NM_001042492.3(NF1):c.1358del (p.Gly453fs)	NF1	G453fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048701	17	29533354	17	31206336	1048701	1036772		NC_000017.11:31206335:GG:G
NM_001042492.3(NF1):c.6732del (p.Gln2245fs)	NF1	Q2224fs, Q2245fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048700	17	29665070	17	31338052	1048700	1036830		NC_000017.11:31338051:G:
NM_001042492.3(NF1):c.3104del (p.Met1035fs)	NF1	M1035fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048696	17	29557391	17	31230373	1048696	1036788		NC_000017.11:31230372:T:
NM_001042492.3(NF1):c.2847_2850+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048694	17	29556477 - 29556481	17	31229459 - 31229463	1048694	1036784		NC_000017.11:31229458:AGGACAGG:AGG
NM_001042492.3(NF1):c.3556del (p.Ile1186fs)	NF1	I1186fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048693	17	29560075	17	31233057	1048693	1036794		NC_000017.11:31233056:AAAAA:AAAA
NM_001042492.3(NF1):c.160del (p.Val54fs)	NF1	V54fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048691	17	29483099	17	31156081	1048691	1036759		NC_000017.11:31156080:GG:G
NM_001042492.3(NF1):c.3641_3645del (p.Met1214fs)	NF1	M1214fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048688	17	29560164 - 29560168	17	31233146 - 31233150	1048688	1036798		NC_000017.11:31233145:TGATG:
NM_001042492.3(NF1):c.4327del (p.Ser1443fs)	NF1	S1422fs, S1443fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048686	17	29585515	17	31258497	1048686	1036804		NC_000017.11:31258496:T:
NM_001042492.3(NF1):c.1920del (p.Ser641fs)	NF1	S641fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048683	17	29552186	17	31225168	1048683	1036776		NC_000017.11:31225167:CC:C
NM_001042492.3(NF1):c.3063_3065del (p.Met1023del)	NF1	M1023del	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048681	17	29557349 - 29557351	17	31230331 - 31230333	1048681	1036787		NC_000017.11:31230330:TAAT:T
NM_001042492.3(NF1):c.6488del (p.Leu2163fs)	NF1	L2142fs, L2163fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048676	17	29664445	17	31337427	1048676	1036826		NC_000017.11:31337426:TT:T
NM_001042492.3(NF1):c.7739-3_7743delCAGAAACT	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048674	17	29683975 - 29683982	17	31356957 - 31356964	1048674	1036838		NC_000017.11:31356956:CAGAAACTCAGA:CAGA
NM_001042492.3(NF1):c.7171del (p.Val2391fs)	NF1	V2370fs, V2391fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048673	17	29670134	17	31343116	1048673	1036835		NC_000017.11:31343115:GG:G
NM_001042492.3(NF1):c.579_581del (p.Leu194del)	NF1	L194del	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048672	17	29497006 - 29497008	17	31169988 - 31169990	1048672	1036766		NC_000017.11:31169987:CTCCT:CT
NM_001042492.3(NF1):c.3363_3365del (p.Glu1121del)	NF1	E1121del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001043508	17	29559764 - 29559766	17	31232746 - 31232748	1043508	1033171		NC_000017.11:31232745:GAAGA:GA
NM_001042492.3(NF1):c.3173_3174delinsCA (p.Asp1058Ala)	NF1	D1058A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001038352	17	29557919 - 29557920	17	31230901 - 31230902	1038352	1033169		NC_000017.11:31230900:AT:CA
NM_001042492.3(NF1):c.7845_7847del (p.Ile2615_Gln2616delinsMet)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001017808	17	29684084 - 29684086	17	31357066 - 31357068	1017808	1012700		NC_000017.11:31357065:CCA:
NM_001042492.3(NF1):c.3452_3457del (p.Asn1151_Leu1153delinsIle)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001017591	17	29559855 - 29559860	17	31232837 - 31232842	1017591	1012668		NC_000017.11:31232836:ACTTAC:
NM_001042492.3(NF1):c.238del (p.Tyr80fs)	NF1	Y80fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV001012198	17	29486061	17	31159043	1012198	999964		NC_000017.11:31159042:T:
NM_001042492.3(NF1):c.6620_6622del (p.Glu2207del)	NF1	E2186del, E2207del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001008265	17	29664576 - 29664578	17	31337558 - 31337560	1008265	997469		NC_000017.11:31337557:AGAAG:AG
NM_001042492.3(NF1):c.1930_1935del (p.Ser644_Met645del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001007592	17	29552194 - 29552199	17	31225176 - 31225181	1007592	997416		NC_000017.11:31225175:ATGTCCATG:ATG
NM_001042492.3(NF1):c.2851-23_2851-7del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001003831	17	29556829 - 29556845	17	31229811 - 31229827	1003831	997425		NC_000017.11:31229810:TTAATGTATTTGTTCTTT:T
NM_001042492.3(NF1):c.6886_6903del (p.Ile2296_Leu2301del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001003143	17	29665786 - 29665803	17	31338768 - 31338785	1003143	997474		NC_000017.11:31338767:TAATAGCACTAACCAAATTA:TA
NM_001042492.3(NF1):c.3198-4del	NF1		not provided|Neurofibromatosis, type 1	Benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996534	17	29559062	17	31232044	996534	984144		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.6955_6969del (p.Ala2319_Leu2323del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996531	17	29667556 - 29667570	17	31340538 - 31340552	996531	984227		NC_000017.11:31340537:GCTGTGGCTGTGCTG:
NM_001042492.3(NF1):c.4489del (p.Ser1497fs)	NF1	S1476fs, S1497fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996524	17	29587443	17	31260425	996524	984172		NC_000017.11:31260424:TTT:TT
NM_001042492.3(NF1):c.4885del (p.Leu1628_Leu1629insTer)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996522	17	29652887	17	31325869	996522	984183		NC_000017.11:31325868:C:
NM_001042492.3(NF1):c.3009_3018del (p.Asn1004fs)	NF1	N1004fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996520	17	29557296 - 29557305	17	31230278 - 31230287	996520	984134		NC_000017.11:31230277:GAATATGGTC:
NM_001042492.3(NF1):c.1254del (p.Thr419fs)	NF1	T419fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996518	17	29528497	17	31201479	996518	984105		NC_000017.11:31201478:C:
NM_001042492.3(NF1):c.2835del (p.Phe945fs)	NF1	F945fs	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996517	17	29556463	17	31229445	996517	984127		NC_000017.11:31229444:TTTTTT:TTTTT
NM_001042492.3(NF1):c.4367del (p.Thr1456fs)	NF1	T1435fs, T1456fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996516	17	29586084	17	31259066	996516	984170		NC_000017.11:31259065:C:
NM_001042492.3(NF1):c.8142del (p.Phe2714fs)	NF1	F2693fs, F2714fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996515	17	29686013	17	31358995	996515	984248		NC_000017.11:31358994:TTT:TT
NM_001042492.3(NF1):c.6221del (p.Met2074fs)	NF1	M2053fs, M2074fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996514	17	29663726	17	31336708	996514	984214		NC_000017.11:31336707:T:
NM_001042492.3(NF1):c.1440del (p.Lys480fs)	NF1	K480fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996511	17	29541512	17	31214494	996511	984108		NC_000017.11:31214493:AAAAA:AAAA
NM_001042492.3(NF1):c.4944del (p.Pro1650fs)	NF1	P1629fs, P1650fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996505	17	29652945	17	31325927	996505	984185		NC_000017.11:31325926:CC:C
NM_001042492.3(NF1):c.5255_5256del (p.Lys1752fs)	NF1	K1731fs, K1752fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996504	17	29653256 - 29653257	17	31326238 - 31326239	996504	984188		NC_000017.11:31326237:AAA:A
NM_001042492.3(NF1):c.6949del (p.Trp2317fs)	NF1	W2296fs, W2317fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996503	17	29667547	17	31340529	996503	984225		NC_000017.11:31340528:TTTT:TTT
NM_001042492.3(NF1):c.5016del (p.Asp1672fs)	NF1	D1651fs, D1672fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996502	17	29653018	17	31326000	996502	984186		NC_000017.11:31325999:C:
NM_001042492.3(NF1):c.3198-10_3198-4del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996498	17	29559062 - 29559068	17	31232044 - 31232050	996498	984141		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.978_980del (p.Leu327del)	NF1	L327del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996497	17	29527529 - 29527531	17	31200511 - 31200513	996497	984097		NC_000017.11:31200510:ACT:
NM_001042492.3(NF1):c.3198-7_3198-4del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996496	17	29559062 - 29559065	17	31232044 - 31232047	996496	984143		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.2072delinsGGGC (p.Leu691delinsArgAla)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996494	17	29553523	17	31226505	996494	984118		NC_000017.11:31226504:T:GGGC
NM_001042492.3(NF1):c.3818del (p.Thr1273fs)	NF1	T1273fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996487	17	29562738	17	31235720	996487	984156		NC_000017.11:31235719:C:
NM_001042492.3(NF1):c.3362_3365del (p.Glu1121fs)	NF1	E1121fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996483	17	29559765 - 29559768	17	31232747 - 31232750	996483	984150		NC_000017.11:31232746:AAGA:
NM_001042492.3(NF1):c.3007_3020del (p.Gly1003fs)	NF1	G1003fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996482	17	29557294 - 29557307	17	31230276 - 31230289	996482	984133		NC_000017.11:31230275:GGGAATATGGTCCA:
NM_001042492.3(NF1):c.7860del (p.Thr2621fs)	NF1	T2600fs, T2621fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996480	17	29684098	17	31357080	996480	984246		NC_000017.11:31357079:TT:T
NM_001042492.3(NF1):c.6668delinsTT (p.Cys2223fs)	NF1	C2202fs, C2223fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996479	17	29664862	17	31337844	996479	984219		NC_000017.11:31337843:G:TT
NM_001042492.3(NF1):c.4770_4771delinsT (p.Leu1590fs)	NF1	L1569fs, L1590fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996477	17	29592292 - 29592293	17	31265274 - 31265275	996477	984179		NC_000017.11:31265273:AA:T
NM_001042492.3(NF1):c.1896_1912del (p.Cys632fs)	NF1	C632fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996476	17	29552161 - 29552177	17	31225143 - 31225159	996476	984113		NC_000017.11:31225142:TGTGATATTCCTTCTAGTG:TG
NM_001042492.3(NF1):c.2705del (p.Met902fs)	NF1	M902fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996472	17	29556338	17	31229320	996472	984126		NC_000017.11:31229319:T:
NM_001042492.3(NF1):c.3965del (p.Asp1322fs)	NF1	D1322fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996471	17	29563030	17	31236012	996471	984159		NC_000017.11:31236011:A:
NM_001042492.3(NF1):c.3564_3585del (p.Gln1188fs)	NF1	Q1188fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996470	17	29560085 - 29560106	17	31233067 - 31233088	996470	984153		NC_000017.11:31233066:CAACAAGGCACAGAATTTGACACA:CA
NM_001042492.3(NF1):c.3198-11_3198-4del	NF1		Neurofibromatosis, type 1|not provided	Benign/Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996465	17	29559062 - 29559069	17	31232044 - 31232051	996465	984140		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.7374_7377del (p.Arg2458fs)	NF1	R2437fs, R2458fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996463	17	29677251 - 29677254	17	31350233 - 31350236	996463	984236		NC_000017.11:31350232:AGAAAG:AG
NM_001042492.3(NF1):c.7452del (p.Tyr2485fs)	NF1	Y2464fs, Y2485fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996462	17	29677330	17	31350312	996462	984237		NC_000017.11:31350311:CC:C
NM_001042492.3(NF1):c.3196del (p.Arg1066fs)	NF1	R1066fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996447	17	29557941	17	31230923	996447	984139		NC_000017.11:31230922:AA:A
NM_001042492.3(NF1):c.7062+2del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996446	17	29667665	17	31340647	996446	984230		NC_000017.11:31340646:T:
NM_001042492.3(NF1):c.1931_1934del (p.Ser644fs)	NF1	S644fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996445	17	29552197 - 29552200	17	31225179 - 31225182	996445	984115		NC_000017.11:31225178:TCCAT:T
NM_001042492.3(NF1):c.1738del (p.Tyr580fs)	NF1	Y580fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996444	17	29550473	17	31223455	996444	984112		NC_000017.11:31223454:TTTTTT:TTTTT
NM_001042492.3(NF1):c.4619_4622delinsAA (p.Ala1540fs)	NF1	A1519fs, A1540fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996443	17	29588770 - 29588773	17	31261752 - 31261755	996443	984175		NC_000017.11:31261751:CAAC:AA
NM_001042492.3(NF1):c.2326-4_2326-1del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996442	17	29554537 - 29554540	17	31227519 - 31227522	996442	984120		NC_000017.11:31227518:TTAG:
NM_001042492.3(NF1):c.7544del (p.Ser2515fs)	NF1	S2494fs, S2515fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996436	17	29679361	17	31352343	996436	984241		NC_000017.11:31352342:G:
NM_001042492.3(NF1):c.5619del (p.Tyr1874fs)	NF1	Y1853fs, Y1874fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996435	17	29657322	17	31330304	996435	984200		NC_000017.11:31330303:CC:C
NM_001042492.3(NF1):c.1414del (p.Lys471_Val472insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996431	17	29541490	17	31214472	996431	984107		NC_000017.11:31214471:G:
NM_001042492.3(NF1):c.3186del (p.Lys1062fs)	NF1	K1062fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996427	17	29557929	17	31230911	996427	984138		NC_000017.11:31230910:AAAA:AAA
NM_001042492.3(NF1):c.4639_4640del (p.Gly1547fs)	NF1	G1526fs, G1547fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996425	17	29588789 - 29588790	17	31261771 - 31261772	996425	984176		NC_000017.11:31261770:GGG:G
NM_001042492.3(NF1):c.2546del (p.Gly849fs)	NF1	G849fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996424	17	29556175	17	31229157	996424	984124		NC_000017.11:31229156:GGGGG:GGGG
NM_001042492.3(NF1):c.6721_6722del (p.Asn2241fs)	NF1	N2220fs, N2241fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996423	17	29665059 - 29665060	17	31338041 - 31338042	996423	984222		NC_000017.11:31338040:AA:
NM_001042492.3(NF1):c.5819_5834del (p.Glu1940fs)	NF1	E1919fs, E1940fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996422	17	29661859 - 29661874	17	31334841 - 31334856	996422	984207		NC_000017.11:31334840:TTGAATTGAAACACCTTTG:TTG
NM_001042492.3(NF1):c.6533del (p.Phe2178fs)	NF1	F2157fs, F2178fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996421	17	29664490	17	31337472	996421	984218		NC_000017.11:31337471:TT:T
NM_001042492.3(NF1):c.7842_7845del (p.Lys2614fs)	NF1	K2593fs, K2614fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996420	17	29684081 - 29684084	17	31357063 - 31357066	996420	984245		NC_000017.11:31357062:GATC:
NM_001042492.3(NF1):c.2339del (p.Thr780fs)	NF1	T780fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996417	17	29554554	17	31227536	996417	984121		NC_000017.11:31227535:C:
NM_001042492.3(NF1):c.3198-8_3198-4del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996415	17	29559062 - 29559066	17	31232044 - 31232048	996415	984142		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.4835+3_4835+10delinsT	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996410	17	29592360 - 29592367	17	31265342 - 31265349	996410	984181		NC_000017.11:31265341:AAGAAATA:T
NM_001042492.3(NF1):c.4018del (p.Leu1340fs)	NF1	L1340fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996406	17	29576044	17	31249026	996406	984162		NC_000017.11:31249025:CC:C
NM_001042492.3(NF1):c.2940del (p.Glu981fs)	NF1	E981fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996405	17	29556942	17	31229924	996405	984130		NC_000017.11:31229923:T:
NM_001042492.3(NF1):c.5374del (p.Cys1792fs)	NF1	C1771fs, C1792fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996402	17	29654622	17	31327604	996402	984194		NC_000017.11:31327603:T:
NM_001042492.3(NF1):c.2894_2900del (p.Ile965fs)	NF1	I965fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996400	17	29556896 - 29556902	17	31229878 - 31229884	996400	984129		NC_000017.11:31229877:TAGCTAT:
NM_001042492.3(NF1):c.1129_1136del (p.Ile377fs)	NF1	I377fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996399	17	29528119 - 29528126	17	31201101 - 31201108	996399	984101		NC_000017.11:31201100:TGATTGACTG:TG
NM_001042492.3(NF1):c.5329del (p.Val1777fs)	NF1	V1756fs, V1777fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996398	17	29654577	17	31327559	996398	984193		NC_000017.11:31327558:G:
NM_001042492.3(NF1):c.7615+1del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996397	17	29679432	17	31352414	996397	984243		NC_000017.11:31352413:GG:G
NM_001042492.3(NF1):c.5387del (p.Glu1796fs)	NF1	E1775fs, E1796fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996396	17	29654635	17	31327617	996396	984195		NC_000017.11:31327616:A:
NM_001042492.3(NF1):c.6994_6995delinsATTT (p.Ser2332fs)	NF1	S2311fs, S2332fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996393	17	29667595 - 29667596	17	31340577 - 31340578	996393	984229		NC_000017.11:31340576:TC:ATTT
NM_001042492.3(NF1):c.4208del (p.Gly1403fs)	NF1	G1382fs, G1403fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996391	17	29585395	17	31258377	996391	984168		NC_000017.11:31258376:GG:G
NM_001042492.3(NF1):c.1986del (p.Asn664fs)	NF1	N664fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996390	17	29552250	17	31225232	996390	984116		NC_000017.11:31225231:AAAA:AAA
NM_001042492.3(NF1):c.7456_7457+7del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996388	17	29677335 - 29677343	17	31350317 - 31350325	996388	984238		NC_000017.11:31350316:AGGTAAGTG:
NM_001042492.3(NF1):c.573del (p.Lys191fs)	NF1	K191fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996387	17	29496999	17	31169981	996387	984091		NC_000017.11:31169980:AAAA:AAA
NM_001042492.3(NF1):c.2447del (p.Arg816fs)	NF1	R816fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996385	17	29556080	17	31229062	996385	984123		NC_000017.11:31229061:G:
NM_001042492.3(NF1):c.1372_1373delinsG (p.Pro458fs)	NF1	P458fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996383	17	29533369 - 29533370	17	31206351 - 31206352	996383	984106		NC_000017.11:31206350:CC:G
NM_001042492.3(NF1):c.4038del (p.Phe1347fs)	NF1	F1347fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996379	17	29576065	17	31249047	996379	984163		NC_000017.11:31249046:C:
NM_001042492.3(NF1):c.1062+2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996378	17	29527615	17	31200597	996378	984100		NC_000017.11:31200596:T:
NM_001042492.3(NF1):c.7110del (p.Cys2371fs)	NF1	C2350fs, C2371fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996377	17	29670074	17	31343056	996377	984233		NC_000017.11:31343055:C:
NM_001042492.3(NF1):c.6948_6949del (p.Phe2316fs)	NF1	F2295fs, F2316fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996376	17	29667547 - 29667548	17	31340529 - 31340530	996376	984224		NC_000017.11:31340528:TTTT:TT
NM_001042492.3(NF1):c.3347_3350del (p.Asp1116fs)	NF1	D1116fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996375	17	29559748 - 29559751	17	31232730 - 31232733	996375	984149		NC_000017.11:31232729:TGACTG:TG
NM_001042492.3(NF1):c.1021_1022del (p.Val341fs)	NF1	V341fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996374	17	29527571 - 29527572	17	31200553 - 31200554	996374	984099		NC_000017.11:31200552:TGT:T
NM_001042492.3(NF1):c.5308del (p.Thr1770fs)	NF1	T1749fs, T1770fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996373	17	29654555	17	31327537	996373	984191		NC_000017.11:31327536:AA:A
NM_001042492.3(NF1):c.162del (p.Val54_Ile55insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996371	17	29483101	17	31156083	996371	984085		NC_000017.11:31156082:TT:T
NM_001042492.3(NF1):c.4388del (p.Pro1463fs)	NF1	P1442fs, P1463fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000995900	17	29586104	17	31259086	995900	983606		NC_000017.11:31259085:CC:C
NM_001042492.3(NF1):c.5872del (p.Arg1958fs)	NF1	R1937fs, R1958fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2020)	no assertion criteria provided	VCV000992410	17	29661915	17	31334897	992410	980380		NC_000017.11:31334896:C:
NM_001042492.3(NF1):c.4720_4724del (p.Thr1574fs)	NF1	T1553fs, T1574fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 30, 2020)	criteria provided, single submitter	VCV000987799	17	29588870 - 29588874	17	31261852 - 31261856	987799	975833		NC_000017.11:31261851:GACTAG:G
NM_001042492.3(NF1):c.3778_3781del (p.Met1260fs)	NF1	M1260fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000986734	17	29562698 - 29562701	17	31235680 - 31235683	986734	974885		NC_000017.11:31235679:ATGT:
NM_001042492.3(NF1):c.5837del (p.Leu1946fs)	NF1	L1925fs, L1946fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000984422	17	29661878	17	31334860	984422	972491		NC_000017.11:31334859:TTT:TT
NM_001042492.3(NF1):c.61-11_61-2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV000981529	17	29482990 - 29482999	17	31155972 - 31155981	981529	969613		NC_000017.11:31155971:TTTTTTTTCA:
NM_001042492.3(NF1):c.7175del (p.Gly2392fs)	NF1	G2371fs, G2392fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000978051	17	29670138	17	31343120	978051	966177		NC_000017.11:31343119:GG:G
NM_001042492.3(NF1):c.1413del (p.Lys471_Val472insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000976085	17	29541485	17	31214467	976085	964471		NC_000017.11:31214466:AAAAA:AAAA
NM_001042492.3(NF1):c.2823del (p.Ser942fs)	NF1	S942fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000975864	17	29556456	17	31229438	975864	964472		NC_000017.11:31229437:C:
NM_001042492.3(NF1):c.2948del (p.Leu983fs)	NF1	L983fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000975857	17	29556950	17	31229932	975857	964473		NC_000017.11:31229931:T:
NM_001042492.3(NF1):c.6081_6083delinsGG (p.Ala2028fs)	NF1	A2028fs, A2007fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000971989	17	29663425 - 29663427	17	31336407 - 31336409	971989	958065		NC_000017.11:31336406:AGC:GG
NM_001042492.3(NF1):c.7421del (p.Asp2474fs)	NF1	D2453fs, D2474fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000971721	17	29677300	17	31350282	971721	958075		NC_000017.11:31350281:A:
NM_001042492.3(NF1):c.1296delinsATA (p.Cys434fs)	NF1	C434fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000971041	17	29533293	17	31206275	971041	958028		NC_000017.11:31206274:G:ATA
NM_001042492.3(NF1):c.6139del (p.Ser2047fs)	NF1	S2026fs, S2047fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000969515	17	29663481	17	31336463	969515	958066		NC_000017.11:31336462:TTT:TT
NM_001042492.3(NF1):c.1251_1260+25del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000969133	17	29528491 - 29528525	17	31201473 - 31201507	969133	960877		NC_000017.11:31201472:AATCATCACCAATGTAAGTCCAAAAGGTATTGCTAAAT:AAT
NM_001042492.3(NF1):c.6609_6610del (p.Glu2203fs)	NF1	E2203fs, E2182fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000969122	17	29664566 - 29664567	17	31337548 - 31337549	969122	958068		NC_000017.11:31337547:AAA:A
NM_001042492.3(NF1):c.3443del (p.Ala1148fs)	NF1	A1148fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000968352	17	29559846	17	31232828	968352	958048		NC_000017.11:31232827:C:
NM_001042492.3(NF1):c.8002_8003del (p.Leu2668fs)	NF1	L2647fs, L2668fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000967234	17	29685529 - 29685530	17	31358511 - 31358512	967234	958080		NC_000017.11:31358510:CT:
NM_001042492.3(NF1):c.1859_1861del (p.Ser620_Ser621delinsThr)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000967141	17	29552126 - 29552128	17	31225108 - 31225110	967141	958035		NC_000017.11:31225107:GTT:
NM_001042492.3(NF1):c.1663_1666del (p.Leu555fs)	NF1	L555fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000966994	17	29548887 - 29548890	17	31221869 - 31221872	966994	958031		NC_000017.11:31221868:AGTTAG:AG
NM_001042492.3(NF1):c.1728_1729del (p.Gln576fs)	NF1	Q576fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000966892	17	29550467 - 29550468	17	31223449 - 31223450	966892	958033		NC_000017.11:31223448:AAA:A
NM_001042492.3(NF1):c.5199_5230delinsTGCT (p.Leu1733fs)	NF1	L1733fs, L1712fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000965757	17	29653201 - 29653232	17	31326183 - 31326214	965757	958060		NC_000017.11:31326182:AGAAGAGGACCTGAAGGTATTCCACAATGCTC:TGCT
NM_001042492.3(NF1):c.1830_1833del (p.Leu612fs)	NF1	L612fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000965680	17	29550568 - 29550571	17	31223550 - 31223553	965680	958034		NC_000017.11:31223549:TTTCTT:TT
NM_001042492.3(NF1):c.7458_7462delinsTCT (p.Arg2486fs)	NF1	R2465fs, R2486fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000965641	17	29679275 - 29679279	17	31352257 - 31352261	965641	958077		NC_000017.11:31352256:GACAC:TCT
NM_001042492.3(NF1):c.205-11_205-6delinsGGAAAA	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000965529	17	29486017 - 29486022	17	31158999 - 31159004	965529	960875		NC_000017.11:31158998:TTTTCT:GGAAAA
NM_001042492.3(NF1):c.1261_1268delinsCCC (p.Ser421fs)	NF1	S421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000965468	17	29533258 - 29533265	17	31206240 - 31206247	965468	958026		NC_000017.11:31206239:TCCGCATT:CCC
NM_001042492.3(NF1):c.6823_6827delinsTGG (p.Leu2275fs)	NF1	L2254fs, L2275fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000965365	17	29665725 - 29665729	17	31338707 - 31338711	965365	958069		NC_000017.11:31338706:CTTGA:TGG
NM_001042492.3(NF1):c.1606_1607del (p.Ser536fs)	NF1	S536fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000965281	17	29546101 - 29546102	17	31219083 - 31219084	965281	958030		NC_000017.11:31219082:TC:
NM_001042492.3(NF1):c.3818_3819delinsGA (p.Thr1273Arg)	NF1	T1273R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000964241	17	29562738 - 29562739	17	31235720 - 31235721	964241	949803		NC_000017.11:31235719:CT:GA
NM_001042492.3(NF1):c.1888del (p.Gly629_Val630insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000964171	17	29552152	17	31225134	964171	949778		NC_000017.11:31225133:GGGG:GGG
NM_001042492.3(NF1):c.838del (p.Glu279_Ile280insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000963736	17	29509631	17	31182613	963736	949763		NC_000017.11:31182612:AAA:AA
NM_001042492.3(NF1):c.1393-3_1393-2del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000962039	17	29541466 - 29541467	17	31214448 - 31214449	962039	960199		NC_000017.11:31214447:TA:
NM_001042492.3(NF1):c.3794_3796del (p.Val1265del)	NF1	V1265del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000961224	17	29562712 - 29562714	17	31235694 - 31235696	961224	949802		NC_000017.11:31235693:AGTAG:AG
NM_001042492.3(NF1):c.1394del (p.Ser465fs)	NF1	S465fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000960954	17	29541470	17	31214452	960954	949773		NC_000017.11:31214451:G:
NM_001042492.3(NF1):c.3964del (p.Asp1322fs)	NF1	D1322fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000960557	17	29563028	17	31236010	960557	949806		NC_000017.11:31236009:GG:G
NM_001042492.3(NF1):c.7268del (p.His2423fs)	NF1	H2423fs, H2402fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000959672	17	29676216	17	31349198	959672	949859		NC_000017.11:31349197:A:
NM_001042492.3(NF1):c.6840del (p.Gly2281fs)	NF1	G2260fs, G2281fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000959202	17	29665739	17	31338721	959202	949851		NC_000017.11:31338720:AAAA:AAA
NM_001042492.3(NF1):c.6356_6360del (p.Arg2119fs)	NF1	R2119fs, R2098fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000958619	17	29663861 - 29663865	17	31336843 - 31336847	958619	949843		NC_000017.11:31336842:GAGCT:
NM_001042492.3(NF1):c.1671del (p.Ser557fs)	NF1	S557fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000958581	17	29548897	17	31221879	958581	949775		NC_000017.11:31221878:C:
NM_001042492.3(NF1):c.2485_2494del (p.Ser829fs)	NF1	S829fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000957885	17	29556117 - 29556126	17	31229099 - 31229108	957885	949787		NC_000017.11:31229098:GTCTGACACAG:G
NM_001042492.3(NF1):c.7628del (p.Ser2543fs)	NF1	S2543fs, S2522fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000957276	17	29683490	17	31356472	957276	949864		NC_000017.11:31356471:G:
NM_001042492.3(NF1):c.253_261del (p.Ile85_Leu87del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000956891	17	29486073 - 29486081	17	31159055 - 31159063	956891	949756		NC_000017.11:31159054:TTGATTATATTG:TTG
NM_001042492.3(NF1):c.7278del (p.Cys2426fs)	NF1	C2405fs, C2426fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000956335	17	29676226	17	31349208	956335	949860		NC_000017.11:31349207:T:
NM_001042492.3(NF1):c.8203del (p.Asp2736fs)	NF1	D2715fs, D2736fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000955834	17	29687547	17	31360529	955834	949870		NC_000017.11:31360528:C:
NM_001042492.3(NF1):c.7968_7970+2del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000955817	17	29684382 - 29684386	17	31357364 - 31357368	955817	960211		NC_000017.11:31357363:TGTTGTGT:TGT
NM_001042492.3(NF1):c.1110del (p.Ala371fs)	NF1	A371fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000955471	17	29528102	17	31201084	955471	949767		NC_000017.11:31201083:T:
NM_001042492.3(NF1):c.7839del (p.Lys2614fs)	NF1	K2593fs, K2614fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000955221	17	29684078	17	31357060	955221	949867		NC_000017.11:31357059:G:
NM_001042492.3(NF1):c.1646del (p.Leu549fs)	NF1	L549fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000955166	17	29548872	17	31221854	955166	949774		NC_000017.11:31221853:T:
NM_001042492.3(NF1):c.6832del (p.Cys2278fs)	NF1	C2257fs, C2278fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000954564	17	29665733	17	31338715	954564	949850		NC_000017.11:31338714:TT:T
NM_001042492.3(NF1):c.479+1_479+1356del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000954369	17	29490395 - 29491750	17	31163377 - 31164732	954369	960195		
NM_001042492.3(NF1):c.5609_5609+1delinsAA	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000953772	17	29654857 - 29654858	17	31327839 - 31327840	953772	960208		NC_000017.11:31327838:GG:AA
NM_001042492.3(NF1):c.3826del (p.Arg1276fs)	NF1	R1276fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000953184	17	29562745	17	31235727	953184	949805		NC_000017.11:31235726:CC:C
NM_001042492.3(NF1):c.6425del (p.Ser2142fs)	NF1	S2121fs, S2142fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000952633	17	29663930	17	31336912	952633	928193		NC_000017.11:31336911:G:
NM_001042492.3(NF1):c.3853del (p.Ile1284_Met1285insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000952205	17	29562772	17	31235754	952205	928155		NC_000017.11:31235753:AA:A
NM_001042492.3(NF1):c.2991-8_3000del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000952097	17	29557268 - 29557285	17	31230250 - 31230267	952097	941170		NC_000017.11:31230249:GTCTATATAGGTATGTTCGT:GT
NM_001042492.3(NF1):c.702_708del (p.Tyr235fs)	NF1	Y235fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000952081	17	29508775 - 29508781	17	31181757 - 31181763	952081	928100		NC_000017.11:31181756:GTACCAG:
NM_001042492.3(NF1):c.1691_1692del (p.Asp564fs)	NF1	D564fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000951619	17	29548917 - 29548918	17	31221899 - 31221900	951619	928114		NC_000017.11:31221898:AT:
NM_001042492.3(NF1):c.1854_1857del (p.Asp618fs)	NF1	D618fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000951548	17	29552118 - 29552121	17	31225100 - 31225103	951548	928115		NC_000017.11:31225099:AGATAGA:AGA
NM_001042492.3(NF1):c.5075del (p.Tyr1692fs)	NF1	Y1692fs, Y1671fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000951057	17	29653077	17	31326059	951057	928170		NC_000017.11:31326058:A:
NM_001042492.3(NF1):c.1036del (p.Val346fs)	NF1	V346fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000950709	17	29527587	17	31200569	950709	928108		NC_000017.11:31200568:G:
NM_001042492.3(NF1):c.7314_7317del (p.Ala2437_Tyr2438insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000950075	17	29676260 - 29676263	17	31349242 - 31349245	950075	928208		NC_000017.11:31349241:TACTTA:TA
NM_001042492.3(NF1):c.6686_6688del (p.Trp2229_Thr2230delinsSer)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000949971	17	29664880 - 29664882	17	31337862 - 31337864	949971	928195		NC_000017.11:31337861:GGA:
NM_001042492.3(NF1):c.6507_6921+170del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000948966	17	29664463 - 29665991	17	31337445 - 31338973	948966	941157		
NM_001042492.3(NF1):c.6361del (p.Ser2121fs)	NF1	S2100fs, S2121fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000948875	17	29663865	17	31336847	948875	928191		NC_000017.11:31336846:TT:T
NM_001042492.3(NF1):c.847_854del (p.Asp283fs)	NF1	D283fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000948854	17	29509642 - 29509649	17	31182624 - 31182631	948854	928103		NC_000017.11:31182623:GATATATC:
NM_001042492.3(NF1):c.2209del (p.Thr737fs)	NF1	T737fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000948318	17	29553660	17	31226642	948318	928124		NC_000017.11:31226641:A:
NM_001042492.3(NF1):c.5709del (p.Asn1903fs)	NF1	N1903fs, N1882fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000948094	17	29657413	17	31330395	948094	928181		NC_000017.11:31330394:C:
NM_001042492.3(NF1):c.2419del (p.Ser807fs)	NF1	S807fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000947640	17	29556050	17	31229032	947640	928129		NC_000017.11:31229031:AAA:AA
NM_001042492.3(NF1):c.3777_3778del (p.Met1260fs)	NF1	M1260fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000947461	17	29562696 - 29562697	17	31235678 - 31235679	947461	928153		NC_000017.11:31235677:ACA:A
NM_001042492.3(NF1):c.4974del (p.Leu1659fs)	NF1	L1638fs, L1659fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000946762	17	29652974	17	31325956	946762	928168		NC_000017.11:31325955:TTT:TT
NM_001042492.3(NF1):c.878del (p.Asn293fs)	NF1	N293fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000944420	17	29509672	17	31182654	944420	928105		NC_000017.11:31182653:AA:A
NM_001042492.3(NF1):c.6148-4_6148-2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2019)	criteria provided, single submitter	VCV000943910	17	29663649 - 29663651	17	31336631 - 31336633	943910	940402		NC_000017.11:31336630:ACA:
NM_001042492.3(NF1):c.2034_2035delinsAG (p.Ile679Val)	NF1	I679V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000943898	17	29553485 - 29553486	17	31226467 - 31226468	943898	937780		NC_000017.11:31226466:GA:AG
NM_000267.3(NF1):c.4516del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000943771	17	29588728	17	31261710	943771	940399		NC_000017.11:31261709:GGG:GG
NM_001042492.3(NF1):c.3392_3401del (p.Lys1131fs)	NF1	K1131fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000942950	17	29559795 - 29559804	17	31232777 - 31232786	942950	937806		NC_000017.11:31232776:AACGTGGCAT:
NM_001042492.3(NF1):c.6719_6723del (p.Tyr2240fs)	NF1	Y2219fs, Y2240fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000942027	17	29665054 - 29665058	17	31338036 - 31338040	942027	937864		NC_000017.11:31338035:AATATAAT:AAT
NM_001042492.3(NF1):c.2891_2892delinsAG (p.Thr964Lys)	NF1	T964K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000940258	17	29556893 - 29556894	17	31229875 - 31229876	940258	937794		NC_000017.11:31229874:CC:AG
NM_001042492.3(NF1):c.6147_6147+4del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000939693	17	29663489 - 29663493	17	31336471 - 31336475	939693	940401		NC_000017.11:31336470:AAGGTAA:AA
NM_001042492.3(NF1):c.5092_5095del (p.Thr1698fs)	NF1	T1677fs, T1698fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000939018	17	29653091 - 29653094	17	31326073 - 31326076	939018	937845		NC_000017.11:31326072:CTGACTG:CTG
NM_001042492.3(NF1):c.6845del (p.Pro2282fs)	NF1	P2261fs, P2282fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000938606	17	29665746	17	31338728	938606	937866		NC_000017.11:31338727:CC:C
NM_001042492.3(NF1):c.5733_5734delinsAC (p.Ser1912Arg)	NF1	S1912R, S1891R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000937079	17	29657437 - 29657438	17	31330419 - 31330420	937079	937853		NC_000017.11:31330418:TA:AC
NM_001042492.3(NF1):c.2883del (p.Glu962fs)	NF1	E962fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000936883	17	29556885	17	31229867	936883	937793		NC_000017.11:31229866:A:
NM_001042492.3(NF1):c.7281del (p.Asp2427fs)	NF1	D2427fs, D2406fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000936484	17	29676229	17	31349211	936484	937873		NC_000017.11:31349210:C:
NM_001042492.3(NF1):c.2131del (p.Arg711fs)	NF1	R711fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000936437	17	29553581	17	31226563	936437	937781		NC_000017.11:31226562:CC:C
NM_001042492.3(NF1):c.7290del (p.Glu2430_Val2431insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000935565	17	29676237	17	31349219	935565	937874		NC_000017.11:31349218:AA:A
NM_001042492.3(NF1):c.6580del (p.Arg2194fs)	NF1	R2173fs, R2194fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000935469	17	29664538	17	31337520	935469	937861		NC_000017.11:31337519:A:
NM_001042492.3(NF1):c.4778del (p.Phe1593fs)	NF1	F1572fs, F1593fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000935040	17	29592297	17	31265279	935040	937837		NC_000017.11:31265278:TTTT:TTT
NM_001042492.3(NF1):c.1995del (p.Ser666fs)	NF1	S666fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000934362	17	29552261	17	31225243	934362	937779		NC_000017.11:31225242:CC:C
NM_001042492.3(NF1):c.461_462del (p.Val153_Phe154insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000934275	17	29490375 - 29490376	17	31163357 - 31163358	934275	937764		NC_000017.11:31163356:TTT:T
NM_001042492.3(NF1):c.6658del (p.Ile2220fs)	NF1	I2220fs, I2199fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000933911	17	29664852	17	31337834	933911	937862		NC_000017.11:31337833:A:
NM_001042492.3(NF1):c.7209del (p.Ala2404fs)	NF1	A2404fs, A2383fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000933752	17	29676157	17	31349139	933752	937871		NC_000017.11:31349138:T:
NM_001042492.3(NF1):c.2398del (p.Glu800fs)	NF1	E800fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000933451	17	29554612	17	31227594	933451	937787		NC_000017.11:31227593:GG:G
NM_001042492.3(NF1):c.4252del (p.Ile1418fs)	NF1	I1397fs, I1418fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000931537	17	29585440	17	31258422	931537	919721		NC_000017.11:31258421:A:
NM_001042492.3(NF1):c.5129del (p.Asp1710fs)	NF1	D1689fs, D1710fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000928593	17	29653131	17	31326113	928593	917231		NC_000017.11:31326112:A:
NM_001042492.3(NF1):c.6407_6408del (p.Cys2136fs)	NF1	C2136fs, C2115fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000864428	17	29663911 - 29663912	17	31336893 - 31336894	864428	845100		NC_000017.11:31336892:TGT:T
NM_001042492.3(NF1):c.3015_3315-230del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000863944	17	29557300 - 29559486	17	31230282 - 31232468	863944	852153		
NM_001042492.3(NF1):c.3900_3902del (p.Leu1301del)	NF1	L1301del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000863428	17	29562963 - 29562965	17	31235945 - 31235947	863428	845008		NC_000017.11:31235944:CTCCT:CT
NM_001042492.3(NF1):c.952_953del (p.Glu318fs)	NF1	E318fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000863185	17	29527502 - 29527503	17	31200484 - 31200485	863185	844880		NC_000017.11:31200483:AGA:A
NM_001042492.3(NF1):c.2810del (p.Lys936_Leu937insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000862987	17	29556442	17	31229424	862987	844958		NC_000017.11:31229423:TT:T
NM_001042492.3(NF1):c.3926del (p.Ile1309fs)	NF1	I1309fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000862782	17	29562991	17	31235973	862782	845010		NC_000017.11:31235972:T:
NM_001042492.3(NF1):c.7725_7726del (p.Asp2576fs)	NF1	D2576fs, D2555fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000862093	17	29683587 - 29683588	17	31356569 - 31356570	862093	845180		NC_000017.11:31356568:TG:
NM_001042492.3(NF1):c.393_394delinsCC (p.Ala132Pro)	NF1	A132P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000861399	17	29490308 - 29490309	17	31163290 - 31163291	861399	844857		NC_000017.11:31163289:AG:CC
NM_001042492.3(NF1):c.6590_6591del (p.Phe2197fs)	NF1	F2197fs, F2176fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000861239	17	29664546 - 29664547	17	31337528 - 31337529	861239	845115		NC_000017.11:31337527:TTTT:TT
NM_001042492.3(NF1):c.2679del (p.Lys893fs)	NF1	K893fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000859970	17	29556310	17	31229292	859970	844952		NC_000017.11:31229291:AAA:AA
NM_001042492.3(NF1):c.2276del (p.Val759fs)	NF1	V759fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000859969	17	29554260	17	31227242	859969	844939		NC_000017.11:31227241:T:
NM_001042492.3(NF1):c.5172_5173del (p.Lys1725fs)	NF1	K1725fs, K1704fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000859473	17	29653173 - 29653174	17	31326155 - 31326156	859473	845058		NC_000017.11:31326154:AGA:A
NM_001042492.3(NF1):c.903_913del (p.Asp301fs)	NF1	D301fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000859342	17	29527453 - 29527463	17	31200435 - 31200445	859342	844878		NC_000017.11:31200434:ACAGTCTACGAA:A
NM_001042492.3(NF1):c.7495_7496delinsCT (p.Gly2499Leu)	NF1	G2478L, G2499L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000858928	17	29679312 - 29679313	17	31352294 - 31352295	858928	845166		NC_000017.11:31352293:GG:CT
NM_001042492.3(NF1):c.5314_5339del (p.Lys1771_Val1772insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000858878	17	29654559 - 29654584	17	31327541 - 31327566	858878	845061		NC_000017.11:31327540:AAAGTCCTAGGGCAATCAGTCTTTCTAAA:AAA
NM_001042492.3(NF1):c.7114_7133del (p.Lys2372fs)	NF1	K2351fs, K2372fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000858867	17	29670078 - 29670097	17	31343060 - 31343079	858867	845136		NC_000017.11:31343059:AAGCAAATGGATCATTTTGT:
NM_001042492.3(NF1):c.8295_8296del (p.Leu2766fs)	NF1	L2766fs, L2745fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000858470	17	29687638 - 29687639	17	31360620 - 31360621	858470	845197		NC_000017.11:31360619:CAC:C
NM_001042492.3(NF1):c.7608del (p.Lys2536fs)	NF1	K2536fs, K2515fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000858274	17	29679425	17	31352407	858274	845174		NC_000017.11:31352406:G:
NM_001042492.3(NF1):c.1477_1481del (p.Leu493fs)	NF1	L493fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000857230	17	29541549 - 29541553	17	31214531 - 31214535	857230	844900		NC_000017.11:31214530:TCTTCTCTT:TCTT
NM_001042492.3(NF1):c.7271_7272del (p.Arg2424fs)	NF1	R2424fs, R2403fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV000856570	17	29676218 - 29676219	17	31349200 - 31349201	856570	845153		NC_000017.11:31349199:AGA:A
NM_001042492.3(NF1):c.1555del (p.Gln519fs)	NF1	Q519fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000856397	17	29546048	17	31219030	856397	844904		NC_000017.11:31219029:CCC:CC
NM_001042492.3(NF1):c.5328_5329delinsTA (p.Val1777Ile)	NF1	V1777I, V1756I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000856337	17	29654576 - 29654577	17	31327558 - 31327559	856337	845062		NC_000017.11:31327557:AG:TA
NM_001042492.3(NF1):c.3051del (p.Gln1017fs)	NF1	Q1017fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000856218	17	29557337	17	31230319	856218	844972		NC_000017.11:31230318:AA:A
NM_001042492.3(NF1):c.7531_7532del (p.Val2511fs)	NF1	V2490fs, V2511fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000856137	17	29679347 - 29679348	17	31352329 - 31352330	856137	845168		NC_000017.11:31352328:TGT:T
NM_001042492.3(NF1):c.1522del (p.Leu508fs)	NF1	L508fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000855655	17	29541598	17	31214580	855655	844903		NC_000017.11:31214579:C:
NM_001042492.3(NF1):c.2396_2409+4del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000855540	17	29554609 - 29554626	17	31227591 - 31227608	855540	852865		NC_000017.11:31227590:AATGGAAGATGGCCAGGTAA:AA
NM_001042492.3(NF1):c.3243del (p.Gly1082fs)	NF1	G1082fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000855008	17	29559136	17	31232118	855008	844982		NC_000017.11:31232117:T:
NM_001042492.3(NF1):c.4340_4341delinsCA (p.Gln1447Pro)	NF1	Q1447P, Q1426P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000854788	17	29586057 - 29586058	17	31259039 - 31259040	854788	845035		NC_000017.11:31259038:AG:CA
NM_001042492.3(NF1):c.1153del (p.Arg385fs)	NF1	R385fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000854268	17	29528145	17	31201127	854268	844889		NC_000017.11:31201126:C:
NM_001042492.3(NF1):c.5049_5059del (p.Asn1683fs)	NF1	N1662fs, N1683fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000853045	17	29653050 - 29653060	17	31326032 - 31326042	853045	845055		NC_000017.11:31326031:ACTCCTGGGTCA:A
NM_001042492.3(NF1):c.1062_1062+6del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000852800	17	29527612 - 29527618	17	31200594 - 31200600	852800	852167		NC_000017.11:31200593:AGGTAACA:A
NM_001042492.3(NF1):c.4065del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000852526	17	29576092	17	31249074	852526	845020		NC_000017.11:31249073:A:
NM_001042492.3(NF1):c.349del (p.Ile117fs)	NF1	I117fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000851792	17	29490262	17	31163244	851792	844854		NC_000017.11:31163243:AAA:AA
NM_001042492.3(NF1):c.7325del (p.Leu2442fs)	NF1	L2442fs, L2421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000851770	17	29677202	17	31350184	851770	845156		NC_000017.11:31350183:TTT:TT
NM_001042492.3(NF1):c.6802del (p.Ile2268fs)	NF1	I2268fs, I2247fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000851106	17	29665139	17	31338121	851106	845121		NC_000017.11:31338120:AA:A
NM_001042492.3(NF1):c.6939del (p.Ala2314fs)	NF1	A2314fs, A2293fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000850595	17	29667538	17	31340520	850595	845127		NC_000017.11:31340519:AAA:AA
NM_001042492.3(NF1):c.2765del (p.Gly922fs)	NF1	G922fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000850578	17	29556396	17	31229378	850578	844957		NC_000017.11:31229377:GGG:GG
NM_001042492.3(NF1):c.7262del (p.Asn2421fs)	NF1	N2421fs, N2400fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000849953	17	29676209	17	31349191	849953	845151		NC_000017.11:31349190:AA:A
NM_001042492.3(NF1):c.2271_2272del (p.Arg758fs)	NF1	R758fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000849296	17	29554253 - 29554254	17	31227235 - 31227236	849296	844937		NC_000017.11:31227234:AAAA:AA
NM_001042492.3(NF1):c.8074del (p.Glu2692fs)	NF1	E2692fs, E2671fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000849177	17	29685601	17	31358583	849177	845191		NC_000017.11:31358582:G:
NM_001042492.3(NF1):c.5662del (p.Ile1888fs)	NF1	I1888fs, I1867fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000848857	17	29657362	17	31330344	848857	845079		NC_000017.11:31330343:AAAAA:AAAA
NM_001042492.3(NF1):c.3869del (p.Lys1290fs)	NF1	K1290fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000848632	17	29562788	17	31235770	848632	845005		NC_000017.11:31235769:AA:A
NM_001042492.3(NF1):c.7262_7266del (p.Asn2421fs)	NF1	N2400fs, N2421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000848332	17	29676209 - 29676213	17	31349191 - 31349195	848332	845152		NC_000017.11:31349190:AACAAA:A
NM_001042492.3(NF1):c.3884_3887del (p.Thr1295fs)	NF1	T1295fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000848117	17	29562946 - 29562949	17	31235928 - 31235931	848117	845006		NC_000017.11:31235927:CTACCTA:CTA
NM_001042492.3(NF1):c.4068del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000847979	17	29576094	17	31249076	847979	845021		NC_000017.11:31249075:AA:A
NM_001042492.3(NF1):c.2049_2083del (p.Gln684fs)	NF1	Q684fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000847553	17	29553499 - 29553533	17	31226481 - 31226515	847553	844930		NC_000017.11:31226480:CCCAGACCAAACTAGAAGTGGCCCTGTACATGTTTC:C
NM_001042492.3(NF1):c.4042del (p.His1348fs)	NF1	H1348fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000847279	17	29576068	17	31249050	847279	845019		NC_000017.11:31249049:CC:C
NM_001042492.3(NF1):c.1868del (p.His623fs)	NF1	H623fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000846196	17	29552135	17	31225117	846196	844920		NC_000017.11:31225116:A:
NM_001042492.3(NF1):c.1849_1850delinsTA (p.Ala617Ter)	NF1	A617*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846124	17	29552116 - 29552117	17	31225098 - 31225099	846124	844919		NC_000017.11:31225097:GC:TA
NM_001042492.3(NF1):c.6096del (p.Asp2033fs)	NF1	D2012fs, D2033fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000845972	17	29663440	17	31336422	845972	845092		NC_000017.11:31336421:A:
NM_001042492.3(NF1):c.4888del (p.Thr1630fs)	NF1	T1630fs, T1609fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000845544	17	29652890	17	31325872	845544	845050		NC_000017.11:31325871:A:
NM_001042492.3(NF1):c.1955_1956del (p.Arg652fs)	NF1	R652fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 13, 2019)	criteria provided, single submitter	VCV000845519	17	29552222 - 29552223	17	31225204 - 31225205	845519	844925		NC_000017.11:31225203:GT:
NM_001042492.3(NF1):c.4436del (p.Phe1479fs)	NF1	F1458fs, F1479fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000845258	17	29587388	17	31260370	845258	845041		NC_000017.11:31260369:TTTTT:TTTT
NM_000267.3:c.1491_4110+4407del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000845037					845037	852690		
NM_001042492.3(NF1):c.3058del (p.Glu1020fs)	NF1	E1020fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000844702	17	29557345	17	31230327	844702	844973		NC_000017.11:31230326:G:
NM_001042492.3(NF1):c.4298del (p.Pro1433fs)	NF1	P1433fs, P1412fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000843416	17	29585485	17	31258467	843416	845033		NC_000017.11:31258466:CC:C
NM_001042492.3(NF1):c.8422_8427del (p.Cys2808_Asn2809del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000842941	17	29701073 - 29701078	17	31374055 - 31374060	842941	845201		NC_000017.11:31374054:ACTGTAAC:AC
NM_001042492.3(NF1):c.3331del (p.Phe1110_Met1111insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2019)	criteria provided, single submitter	VCV000842681	17	29559734	17	31232716	842681	844987		NC_000017.11:31232715:A:
NM_001042492.3(NF1):c.1884del (p.Phe627_Tyr628insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000842649	17	29552151	17	31225133	842649	844921		NC_000017.11:31225132:C:
NM_001042492.3(NF1):c.4590del (p.Val1531fs)	NF1	V1510fs, V1531fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV000842480	17	29588741	17	31261723	842480	845045		NC_000017.11:31261722:T:
NM_001042492.3(NF1):c.3276del (p.Val1093fs)	NF1	V1093fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000841871	17	29559169	17	31232151	841871	844985		NC_000017.11:31232150:T:
NM_001042492.3(NF1):c.3215_3216del (p.Ser1072fs)	NF1	S1072fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000841847	17	29559108 - 29559109	17	31232090 - 31232091	841847	844981		NC_000017.11:31232089:GC:
NM_001042492.3(NF1):c.4239del (p.Phe1413fs)	NF1	F1392fs, F1413fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000841064	17	29585425	17	31258407	841064	845029		NC_000017.11:31258406:TTT:TT
NM_001042492.3(NF1):c.403del (p.Arg135fs)	NF1	R135fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000840878	17	29490318	17	31163300	840878	844858		NC_000017.11:31163299:C:
NM_001042492.3(NF1):c.5384_5410del (p.Asp1795_Ile1803del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000840667	17	29654631 - 29654657	17	31327613 - 31327639	840667	845063		NC_000017.11:31327612:GATGAGAACCAGTTCACCTTAACCATTG:G
NM_001042492.3(NF1):c.4110+5_4110+8del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000840478	17	29576141 - 29576144	17	31249123 - 31249126	840478	852714		NC_000017.11:31249122:TGCTT:T
NM_001042492.3(NF1):c.4034del (p.Lys1345fs)	NF1	K1345fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000840335	17	29576058	17	31249040	840335	845018		NC_000017.11:31249039:AAAA:AAA
NM_001042492.3(NF1):c.2199del (p.Asn734fs)	NF1	N734fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000840160	17	29553648	17	31226630	840160	844935		NC_000017.11:31226629:CCC:CC
NM_001042492.3(NF1):c.2481_2491del (p.Leu828fs)	NF1	L828fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000839727	17	29556113 - 29556123	17	31229095 - 31229105	839727	844945		NC_000017.11:31229094:ATTTGTCTGACA:A
NM_001042492.3(NF1):c.2276_2280del (p.Val759fs)	NF1	V759fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000839187	17	29554259 - 29554263	17	31227241 - 31227245	839187	844938		NC_000017.11:31227240:GTGATG:G
NM_001042492.3(NF1):c.3447_3448delinsTG (p.Met1149_Ser1150delinsIleAla)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000838458	17	29559850 - 29559851	17	31232832 - 31232833	838458	844991		NC_000017.11:31232831:GT:TG
NM_001042492.3(NF1):c.8030del (p.Leu2677fs)	NF1	L2677fs, L2656fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000838455	17	29685555	17	31358537	838455	845188		NC_000017.11:31358536:TTT:TT
NM_001042492.3(NF1):c.2064del (p.Val689fs)	NF1	V689fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000838146	17	29553514	17	31226496	838146	844931		NC_000017.11:31226495:AA:A
NM_001042492.3(NF1):c.3262_3263del (p.Glu1088fs)	NF1	E1088fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000837482	17	29559155 - 29559156	17	31232137 - 31232138	837482	844984		NC_000017.11:31232136:GA:
NM_001042492.3(NF1):c.2842del (p.Gln948fs)	NF1	Q948fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000837151	17	29556473	17	31229455	837151	844962		NC_000017.11:31229454:CCC:CC
NM_001042492.3(NF1):c.1753_1759del (p.Leu585fs)	NF1	L585fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000836939	17	29550492 - 29550498	17	31223474 - 31223480	836939	844914		NC_000017.11:31223473:ATTAACTA:A
NM_001042492.3(NF1):c.2728_2729del (p.Gly910fs)	NF1	G910fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000836581	17	29556360 - 29556361	17	31229342 - 31229343	836581	844956		NC_000017.11:31229341:GGG:G
NM_001042492.3(NF1):c.5629_5630del (p.Leu1877fs)	NF1	L1856fs, L1877fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000835556	17	29657332 - 29657333	17	31330314 - 31330315	835556	845075		NC_000017.11:31330313:TCT:T
NM_001042492.3(NF1):c.3207_3208delinsTT (p.Gln1070Ter)	NF1	Q1070*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000835546	17	29559100 - 29559101	17	31232082 - 31232083	835546	844980		NC_000017.11:31232081:CC:TT
NM_001042492.3(NF1):c.3810_3820del (p.Met1271fs)	NF1	M1271fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000835230	17	29562722 - 29562732	17	31235704 - 31235714	835230	845002		NC_000017.11:31235703:GCAGACTCCATGCAGACTC:GCAGACTC
NM_001042492.3(NF1):c.1192del (p.Leu398fs)	NF1	L398fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000835175	17	29528434	17	31201416	835175	844890		NC_000017.11:31201415:CC:C
NM_001042492.3(NF1):c.5013del (p.Ala1670_Tyr1671insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000834483	17	29653015	17	31325997	834483	845054		NC_000017.11:31325996:C:
NM_001042492.3(NF1):c.2824del (p.Ser942fs)	NF1	S942fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000834401	17	29556457	17	31229439	834401	844960		NC_000017.11:31229438:A:
NM_001042492.3(NF1):c.4865del (p.Leu1622fs)	NF1	L1622fs, L1601fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000834344	17	29652865	17	31325847	834344	845049		NC_000017.11:31325846:TTT:TT
NC_000017.11:g.(?_31336323)_(31340655_?)del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000833510	17	29663341 - 29667673			833510	821029		
NC_000017.11:g.(?_31342999)_(31374165_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000833495	17	29670017 - 29701183			833495	821031		
NC_000017.11:g.(?_31155973)_(31156136_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000833279	17	29482991 - 29483154			833279	821003		
NC_000017.11:g.(?_31218985)_(31222471_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000833276	17	29546003 - 29549489			833276	821017		
NC_000017.11:g.(?_31232063)_(31236281_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000833234	17	29559081 - 29563299			833234	821021		
NC_000017.11:g.(?_31169881)_(31183454_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000833181	17	29496899 - 29510472			833181	821008		
NC_000017.11:g.(?_31181402)_(31253278_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000833000	17	29508420 - 29580296			833000	821012		
NC_000017.11:g.(?_31374003)_(31374155_?)del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832994	17	29701021 - 29701173			832994	821033		
NC_000017.11:g.(?_31160230)_(31163386_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000832872	17	29487248 - 29490404			832872	821007		
NC_000017.11:g.(?_31181402)_(31182685_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000832814	17	29508420 - 29509703			832814	821011		
NC_000017.11:g.(?_31352247)_(31352424_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000832737	17	29679265 - 29679442			832737	821032		
NC_000017.11:g.(?_31200402)_(31206391_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000832511	17	29527420 - 29533409			832511	821014		
NC_000017.11:g.(?_31225075)_(31236281_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000831764	17	29552093 - 29563299			831764	821019		
NC_000017.11:g.(?_31095030)_(31170007_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000831619	17	29422048 - 29497025			831619	820997		
NC_000017.11:g.(?_31095030)_(31095379_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000831526	17	29422048 - 29422397			831526	820995		
NC_000017.11:g.(?_31095290)_(31183409_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000831422	17	29422308 - 29510427			831422	821001		
NC_000017.11:g.(?_31095290)_(31095389_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000831072	17	29422308 - 29422407			831072	821000		
NC_000017.11:g.(?_31342999)_(31360713_?)del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000830957	17	29670017 - 29687731			830957	821030		
NC_000017.11:g.(?_31248974)_(31265349_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000830849	17	29575992 - 29592367			830849	821024		
NC_000017.11:g.(?_31181408)_(31183454_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830815	17	29508426 - 29510472			830815	821013		
NC_000017.11:g.(?_31327479)_(31327859_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000830566	17	29654497 - 29654877			830566	821026		
NC_000017.11:g.(?_31248964)_(31265359_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000830506	17	29575982 - 29592377			830506	821022		
NC_000017.11:g.(?_31336313)_(31340665_?)del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000830440	17	29663331 - 29667683			830440	821027		
NM_001042492.3(NF1):c.7847_7850del (p.Gln2616fs)	NF1	Q2595fs, Q2616fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000827764	17	29684085 - 29684088	17	31357067 - 31357070	827764	815962	rs1597866554	NC_000017.11:31357066:CAGGC:C
NM_001042492.3(NF1):c.6503del (p.Ser2168fs)	NF1	S2168fs, S2147fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826407	17	29664461	17	31337443	826407	813423	rs1597843782	NC_000017.11:31337442:G:
NM_001042492.3(NF1):c.6007-2_6007del	NF1		Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000826069	17	29663349 - 29663351	17	31336331 - 31336333	826069	815659	rs1597842196	NC_000017.11:31336330:AGA:
NM_001042492.3(NF1):c.3604del (p.Ala1202fs)	NF1	A1202fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000823979	17	29560126	17	31233108	823979	813257	rs1597720036	NC_000017.11:31233107:GG:G
NM_001042492.3(NF1):c.1955del (p.Arg652fs)	NF1	R652fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820408	17	29552222	17	31225204	820408	813171	rs1597710690	NC_000017.11:31225203:G:
NM_001042492.3(NF1):c.1121_1122del (p.Asp374fs)	NF1	D374fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818359	17	29528113 - 29528114	17	31201095 - 31201096	818359	813126	rs1597682030	NC_000017.11:31201094:AT:
NM_001042492.3(NF1):c.5980_5983del (p.Ala1994fs)	NF1	A1973fs, A1994fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818198	17	29662020 - 29662023	17	31335002 - 31335005	818198	806401	rs1597840291	NC_000017.11:31335001:CAAGCAA:CAA
NM_001042492.3(NF1):c.5130del (p.Cys1711fs)	NF1	C1711fs, C1690fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818194	17	29653132	17	31326114	818194	806397	rs1597830078	NC_000017.11:31326113:C:
NM_001042492.3(NF1):c.5046delinsGGTTAC (p.Cys1682fs)	NF1	C1661fs, C1682fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818193	17	29653048	17	31326030	818193	806396	rs1597829913	NC_000017.11:31326029:T:GGTTAC
NM_001042492.3(NF1):c.4756_4772del (p.Ala1586fs)	NF1	A1586fs, A1565fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818192	17	29592275 - 29592291	17	31265257 - 31265273	818192	806395	rs1597753208	NC_000017.11:31265256:AAGGCTTTGAAAACGTTAAG:AAG
NM_001042492.3(NF1):c.2947del (p.His982_Leu983insTer)	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818190	17	29556949	17	31229931	818190	806393	rs1597716380	NC_000017.11:31229930:C:
NM_001042492.3(NF1):c.7898del (p.Glu2633fs)	NF1	E2612fs, E2633fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818188	17	29684315	17	31357297	818188	806403	rs1597866854	NC_000017.11:31357296:A:
NM_001042492.3(NF1):c.6819+2_6826del	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818187	17	29665158 - 29665727	17	31338140 - 31338709	818187	806404	rs1597845213	
NM_001042492.3(NF1):c.643del (p.Ser215fs)	NF1	S215fs	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818180	17	29508496	17	31181478	818180	806387	rs1597658192	NC_000017.11:31181477:A:
NM_001042492.3(NF1):c.5901del (p.Lys1967fs)	NF1	K1967fs, K1946fs	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000817915	17	29661942	17	31334924	817915	805942	rs1597840123	NC_000017.11:31334923:AAA:AA
NM_001042492.3(NF1):c.1785_1786del (p.Glu595fs)	NF1	E595fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817846	17	29550524 - 29550525	17	31223506 - 31223507	817846	805938	rs1567845900	NC_000017.11:31223505:AAA:A
NM_001042492.3(NF1):c.67del (p.Pro22_Ile23insTer)	NF1		not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000817575	17	29483006	17	31155988	817575	805932	rs1597625799	NC_000017.11:31155987:AA:A
NM_001042492.3(NF1):c.5806_5812del (p.Lys1936fs)	NF1	K1915fs, K1936fs	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817404	17	29657510 - 29657516	17	31330492 - 31330498	817404	805941	rs1597834959	NC_000017.11:31330491:AAATCTA:
NM_001042492.3(NF1):c.339del (p.Leu113fs)	NF1	L113fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817346	17	29490254	17	31163236	817346	805933	rs1597635745	NC_000017.11:31163235:G:
NM_001042492.3(NF1):c.2207del (p.Asn736fs)	NF1	N736fs	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817311	17	29553657	17	31226639	817311	805939	rs1597712699	NC_000017.11:31226638:AA:A
NM_001042492.3(NF1):c.1711del (p.Trp571fs)	NF1	W571fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817039	17	29548934	17	31221916	817039	805937	rs1597706737	NC_000017.11:31221915:TTTT:TTT
NM_001042492.3(NF1):c.6428-3del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816770	17	29664383	17	31337365	816770	804968	rs1597843640	NC_000017.11:31337364:C:
NM_001042492.3(NF1):c.4578-3del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816767	17	29588726	17	31261708	816767	804961	rs1597748663	NC_000017.11:31261707:T:
NM_001042492.3(NF1):c.2991-11del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816760	17	29557267	17	31230249	816760	804950	rs1597716765	NC_000017.11:31230248:T:
NM_001042492.3(NF1):c.7870-24_7870-19delinsTTTTAG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816749	17	29684263 - 29684268	17	31357245 - 31357250	816749	804978	rs1597866743	NC_000017.11:31357244:GTTTAC:TTTTAG
NM_001042492.3(NF1):c.5813-12_5813-9del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816748	17	29661843 - 29661846	17	31334825 - 31334828	816748	804963	rs1597839926	NC_000017.11:31334824:TATTT:T
NM_001042492.3(NF1):c.4578-20_4578-18del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816747	17	29588709 - 29588711	17	31261691 - 31261693	816747	804959	rs1597748617	NC_000017.11:31261690:AAG:
NM_001042492.3(NF1):c.2252-33_2252-8del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816746	17	29554202 - 29554227	17	31227184 - 31227209	816746	804943	rs1597713206	NC_000017.11:31227183:TGCAGTAACTTGATTTGCTGTTGTATT:T
NM_001042492.3(NF1):c.1722-8_1722-3delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816745	17	29550454 - 29550459	17	31223436 - 31223441	816745	804941	rs1597708581	NC_000017.11:31223435:TACTGC:AAAA
NM_001042492.3(NF1):c.1722-20_1722-17del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816744	17	29550440 - 29550443	17	31223422 - 31223425	816744	804940	rs1597708558	NC_000017.11:31223421:AATGAA:AA
NM_001042492.3(NF1):c.655-12_655-9del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816743	17	29508714 - 29508717	17	31181696 - 31181699	816743	804929	rs1597658505	NC_000017.11:31181695:TTCTTT:TT
NM_001042492.3(NF1):c.587-15_587-14del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816742	17	29508425 - 29508426	17	31181407 - 31181408	816742	804927	rs1597657969	NC_000017.11:31181406:TT:
NM_001042492.2(NF1):c.[6708delT;6710C>G]	NF1	F2215fs, F2236fs, A2216G, A2237G	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000812142	17|17	29665044	17|17	31338026	812142	904244|904246		NC_000017.11:31338025:TTT:TT|NC_000017.11:31338029:C:G
NM_001042492.3(NF1):c.1532del (p.Pro511fs)	NF1	P511fs	not specified	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000811921	17	29546026	17	31219008	811921	800012	rs1597703352	NC_000017.11:31219007:CC:C
NM_001042492.3(NF1):c.7040del (p.Ser2347fs)	NF1	S2326fs, S2347fs	not specified	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000811904	17	29667641	17	31340623	811904	800023	rs1597848220	NC_000017.11:31340622:G:
NM_001042492.3(NF1):c.3217_3218delinsTTCC (p.Met1073fs)	NF1	M1073fs	not specified	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000811815	17	29559110 - 29559111	17	31232092 - 31232093	811815	800014	rs1597718755	NC_000017.11:31232091:AT:TTCC
NM_001042492.3(NF1):c.6246del (p.Arg2083fs)	NF1	R2062fs, R2083fs	not specified	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000811798	17	29663751	17	31336733	811798	800021	rs1597842843	NC_000017.11:31336732:A:
NM_001042492.3(NF1):c.338del (p.Leu113fs)	NF1	L113fs	not specified|not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000811776	17	29490252	17	31163234	811776	800009	rs1597635740	NC_000017.11:31163233:TT:T
NM_001042492.3(NF1):c.4015_4028del (p.Asn1338_Leu1339insTer)	NF1		not specified	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000811453	17	29576040 - 29576053	17	31249022 - 31249035	811453	800017	rs1597735056	NC_000017.11:31249021:ACCTCCTTCAGATGAC:AC
NM_001042492.3(NF1):c.5404del (p.Thr1802fs)	NF1	T1781fs, T1802fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000805931	17	29654651	17	31327633	805931	794261	rs1597832056	NC_000017.11:31327632:AA:A
NM_001042492.3(NF1):c.7923del (p.Glu2641fs)	NF1	E2641fs, E2620fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803378	17	29684339	17	31357321	803378	791731	rs1597866921	NC_000017.11:31357320:AA:A
NM_001042492.3(NF1):c.7458-2_7459del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803376	17	29679273 - 29679276	17	31352255 - 31352258	803376	791729	rs1597862010	NC_000017.11:31352254:AGGA:
NM_001042492.3(NF1):c.5847del (p.Met1949fs)	NF1	M1949fs, M1928fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803371	17	29661890	17	31334872	803371	791724	rs1597840055	NC_000017.11:31334871:G:
NM_001042492.3(NF1):c.5079del (p.His1693fs)	NF1	H1672fs, H1693fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803366	17	29653081	17	31326063	803366	791719	rs1597829969	NC_000017.11:31326062:T:
NM_001042492.3(NF1):c.5045_5046del (p.Asn1681_Cys1682insTer)	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803364	17	29653046 - 29653047	17	31326028 - 31326029	803364	791717	rs1597829906	NC_000017.11:31326027:TGT:T
NM_001042492.3(NF1):c.4463del (p.Thr1488fs)	NF1	T1488fs, T1467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803360	17	29587419	17	31260401	803360	791713	rs1597746962	NC_000017.11:31260400:C:
NM_001042492.3(NF1):c.3381_3382del (p.Gly1128fs)	NF1	G1128fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803353	17	29559784 - 29559785	17	31232766 - 31232767	803353	791706	rs1597719504	NC_000017.11:31232765:AG:
NM_001042492.3(NF1):c.3198-6_3198-1del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803350	17	29559085 - 29559090	17	31232067 - 31232072	803350	791703	rs1597718651	NC_000017.11:31232066:TTTCAG:
NM_001042492.3(NF1):c.1989del (p.Asn664fs)	NF1	N664fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803345	17	29552254	17	31225236	803345	791698	rs1202226733	NC_000017.11:31225235:GGG:GG
NM_001042492.3(NF1):c.1950del (p.Leu650fs)	NF1	L650fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803344	17	29552217	17	31225199	803344	791697	rs1597710658	NC_000017.11:31225198:A:
NM_001042492.3(NF1):c.1854del (p.Asp618fs)	NF1	D618fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803343	17	29552121	17	31225103	803343	791696	rs1597710342	NC_000017.11:31225102:T:
NM_001042492.3(NF1):c.1188_1189del (p.Ile396fs)	NF1	I396fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803342	17	29528430 - 29528431	17	31201412 - 31201413	803342	791695	rs1597682729	NC_000017.11:31201411:TCT:T
NM_001042492.3(NF1):c.333del (p.Lys111fs)	NF1	K111fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803338	17	29490246	17	31163228	803338	791691	rs1597635722	NC_000017.11:31163227:AAA:AA
NM_001042492.3(NF1):c.2998_2999del (p.Arg1000fs)	NF1	R1000fs	Neurofibromatosis, type 1	Likely pathogenic	criteria provided, single submitter	VCV000800769	17	29557285 - 29557286	17	31230267 - 31230268	800769	788908	rs1597716817	NC_000017.11:31230266:CG:
NM_001042492.3(NF1):c.979_997del (p.Leu327fs)	NF1	L327fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000800651	17	29527530 - 29527548	17	31200512 - 31200530	800651	789249	rs1597680978	NC_000017.11:31200511:CTGTGTAAAGCAAGTACTT:
NM_001042492.3(NF1):c.7851_7852delinsCT (p.Ala2617_Leu2618=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000798781	17	29684090 - 29684091	17	31357072 - 31357073	798781	785531	rs1597866565	NC_000017.11:31357071:GC:CT
NM_001042492.3(NF1):c.6148-5del	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000794289	17	29663646	17	31336628	794289	788138	rs1597842669	NC_000017.11:31336627:TTT:TT
NM_001042492.3(NF1):c.7063-4_7063-2del	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2018)	criteria provided, conflicting interpretations	VCV000761296	17	29670021 - 29670023	17	31343003 - 31343005	761296	776295	rs1597851237	NC_000017.11:31343002:TAATA:TA
NM_001042492.3(NF1):c.7738+8del	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV000743779	17	29683606	17	31356588	743779	760540	rs1597865876	NC_000017.11:31356587:AAA:AA
NM_001042492.3(NF1):c.3197+7_3197+9del	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000741211	17	29557946 - 29557948	17	31230928 - 31230930	741211	760548	rs755212937	NC_000017.11:31230927:AAAAAAA:AAAA
NM_001042492.3(NF1):c.2033_2034delinsTA (p.Pro678Leu)	NF1	P678L	Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000707503	17	29553484 - 29553485	17	31226466 - 31226467	707503	694067	rs1597712334	NC_000017.11:31226465:CG:TA
NM_001042492.3(NF1):c.2524_2531delinsAGCTTCCA (p.Gly842_Leu844delinsSerPheHis)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694606	17	29556157 - 29556164	17	31229139 - 31229146	694606	682678	rs1597715286	NC_000017.11:31229138:GGCTTCCT:AGCTTCCA
NM_001042492.3(NF1):c.4981_4984del (p.Lys1661fs)	NF1	K1640fs, K1661fs	Neurofibromatosis, type 1	Pathogenic	criteria provided, single submitter	VCV000694511	17	29652982 - 29652985	17	31325964 - 31325967	694511	682498		NC_000017.11:31325963:TAAGT:T
NM_001042492.3(NF1):c.2086_2088del (p.Trp696del)	NF1	W696del	Neurofibromatosis, type 1	Pathogenic	criteria provided, single submitter	VCV000694507	17	29553536 - 29553538	17	31226518 - 31226520	694507	682494		NC_000017.11:31226517:GTGG:G
NM_001042492.3(NF1):c.5118del (p.Val1707fs)	NF1	V1686fs, V1707fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000691988	17	29653119	17	31326101	691988	679797	rs1597830046	NC_000017.11:31326100:TT:T
NM_001042492.3(NF1):c.1839_1844del (p.Asn614_Lys615del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV000666067	17	29550576 - 29550581	17	31223558 - 31223563	666067	645518	rs1597708816	NC_000017.11:31223557:TAAAAATAA:TAA
NM_001042492.3(NF1):c.4581del (p.His1528fs)	NF1	H1528fs, H1507fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000665381	17	29588732	17	31261714	665381	645638	rs1597748682	NC_000017.11:31261713:T:
NM_001042492.3(NF1):c.1066del (p.Leu356fs)	NF1	L356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000664219	17	29528057	17	31201039	664219	645489	rs1597681864	NC_000017.11:31201038:CC:C
NM_001042492.3(NF1):c.3732_3742del (p.Thr1245fs)	NF1	T1245fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000664141	17	29562652 - 29562662	17	31235634 - 31235644	664141	645603	rs1597722429	NC_000017.11:31235633:TACTCTGTTTG:
NM_001042492.3(NF1):c.7415del (p.Pro2472fs)	NF1	P2451fs, P2472fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000663189	17	29677293	17	31350275	663189	645749	rs1597859768	NC_000017.11:31350274:CC:C
NM_001042492.3(NF1):c.964del (p.Ile322fs)	NF1	I322fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000663019	17	29527514	17	31200496	663019	645483	rs1597680909	NC_000017.11:31200495:AA:A
NM_001042492.3(NF1):c.2970_2971del (p.Met991fs)	NF1	M991fs	Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Cafe-au-lait spot|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000663010	17	29556972 - 29556973	17	31229954 - 31229955	663010	645561	rs1597716432	NC_000017.11:31229953:AA:
NM_001042492.3(NF1):c.243_254delinsTGAGAGAGA (p.Ser82_Ile85delinsGluArgAsp)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 9, 2018)	criteria provided, single submitter	VCV000663004	17	29486066 - 29486077	17	31159048 - 31159059	663004	645445	rs1597629809	NC_000017.11:31159047:CTCTCAGTTGAT:TGAGAGAGA
NM_001042492.3(NF1):c.204+4del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000662071	17	29483148	17	31156130	662071	652906	rs1597626163	NC_000017.11:31156129:A:
NM_001042492.3(NF1):c.129_131del (p.Ile44del)	NF1	I44del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 12, 2018)	criteria provided, single submitter	VCV000661709	17	29483068 - 29483070	17	31156050 - 31156052	661709	645440	rs1597625973	NC_000017.11:31156049:TAAT:T
NM_001042492.3(NF1):c.4068_4069del (p.Glu1356fs)	NF1	E1356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000661607	17	29576095 - 29576096	17	31249077 - 31249078	661607	645616	rs1597735186	NC_000017.11:31249076:AT:
NM_001042492.3(NF1):c.1895del (p.Cys632fs)	NF1	C632fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000660981	17	29552162	17	31225144	660981	645524	rs1597710497	NC_000017.11:31225143:G:
NM_001042492.3(NF1):c.1095_1096del (p.Gly367fs)	NF1	G367fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000660347	17	29528087 - 29528088	17	31201069 - 31201070	660347	645491	rs1597681960	NC_000017.11:31201068:AA:
NM_001042492.3(NF1):c.8205_8214del (p.Asp2736fs)	NF1	D2715fs, D2736fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000660162	17	29687549 - 29687558	17	31360531 - 31360540	660162	645784	rs1597870141	NC_000017.11:31360530:TGATGCCTTG:
NM_001042492.3(NF1):c.6540del (p.Ser2181fs)	NF1	S2160fs, S2181fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000659910	17	29664497	17	31337479	659910	645710	rs1597843853	NC_000017.11:31337478:CC:C
NM_001042492.3(NF1):c.2293del (p.Arg765fs)	NF1	R765fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000659735	17	29554277	17	31227259	659735	645539	rs1597713360	NC_000017.11:31227258:C:
NM_001042492.3(NF1):c.4631del (p.Ala1544fs)	NF1	A1544fs, A1523fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000659661	17	29588782	17	31261764	659661	645640	rs1597748782	NC_000017.11:31261763:C:
NM_001042492.3(NF1):c.8084_8089delinsA (p.Pro2695fs)	NF1	P2674fs, P2695fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000659275	17	29685611 - 29685616	17	31358593 - 31358598	659275	645780	rs1597868244	NC_000017.11:31358592:CACCAC:A
NM_001042492.3(NF1):c.4062del (p.Ser1355fs)	NF1	S1355fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000658776	17	29576088	17	31249070	658776	645615	rs1597735166	NC_000017.11:31249069:CC:C
NM_001042492.3(NF1):c.2947_2948del (p.Leu983fs)	NF1	L983fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000658369	17	29556948 - 29556949	17	31229930 - 31229931	658369	645560	rs1597716378	NC_000017.11:31229929:TCT:T
NM_001042492.3(NF1):c.4495delinsTG (p.Ile1499fs)	NF1	I1478fs, I1499fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000658301	17	29587451	17	31260433	658301	645636	rs1597747012	NC_000017.11:31260432:A:TG
NM_001042492.3(NF1):c.3212del (p.Ala1071fs)	NF1	A1071fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000657966	17	29559105	17	31232087	657966	645580	rs1597718735	NC_000017.11:31232086:C:
NM_001042492.3(NF1):c.4108del (p.Gln1370fs)	NF1	Q1370fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000657584	17	29576134	17	31249116	657584	645618	rs1597735273	NC_000017.11:31249115:CC:C
NC_000017.11:g.(?_31200422)_(31265339_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000657376	17	29527440 - 29592357	17	31200422 - 31265339	657376	652627		
NM_000267.3(NF1):c.7128delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000657065	17	29676137	17	31349119	657065	652773	rs1597858338	NC_000017.11:31349118:GGG:GG
NC_000017.11:g.(?_31229825)_(31265349_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000655758	17	29556843 - 29592367	17	31229825 - 31265349	655758	652798		
NM_001042492.3(NF1):c.7393del (p.Asp2465fs)	NF1	D2465fs, D2444fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000655473	17	29677272	17	31350254	655473	645748	rs1597859719	NC_000017.11:31350253:G:
NC_000017.11:g.(?_31325810)_(31374165_?)del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000655234	17	29652828 - 29701183	17	31325810 - 31374165	655234	653098		
NM_001042492.3(NF1):c.5669_5690del (p.Gly1890fs)	NF1	G1869fs, G1890fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654611	17	29657370 - 29657391	17	31330352 - 31330373	654611	645682	rs1597834703	NC_000017.11:31330351:AGGGCCAGTTACTAGAGACATCAGG:AGG
NM_001042492.3(NF1):c.4404del (p.Ser1470fs)	NF1	S1470fs, S1449fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000654170	17	29586121	17	31259103	654170	645629	rs1597745728	NC_000017.11:31259102:G:
NM_001042492.3(NF1):c.370del (p.Cys124fs)	NF1	C124fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000653825	17	29490285	17	31163267	653825	645453	rs1597635825	NC_000017.11:31163266:T:
NM_001042492.3(NF1):c.653del (p.Lys218fs)	NF1	K218fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000653602	17	29508503	17	31181485	653602	645466	rs1131691094	NC_000017.11:31181484:AAAA:AAA
NM_001042492.3(NF1):c.4738_4745delinsAAAAAGG (p.Glu1580fs)	NF1	E1580fs, E1559fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000653392	17	29592260 - 29592267	17	31265242 - 31265249	653392	645643	rs1597753176	NC_000017.11:31265241:GAAAAAGA:AAAAAGG
NM_001042492.3(NF1):c.7784_7785del (p.Lys2595fs)	NF1	K2595fs, K2574fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000652439	17	29684022 - 29684023	17	31357004 - 31357005	652439	645760	rs1597866414	NC_000017.11:31357003:AAA:A
NM_001042492.3(NF1):c.403_405del (p.Arg135del)	NF1	R135del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000652355	17	29490318 - 29490320	17	31163300 - 31163302	652355	645455	rs1597635919	NC_000017.11:31163299:CGG:
NM_001042492.3(NF1):c.4849_4853delinsATATCAG (p.Gln1617fs)	NF1	Q1596fs, Q1617fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000651932	17	29652851 - 29652855	17	31325833 - 31325837	651932	645648	rs1597829519	NC_000017.11:31325832:CAAAT:ATATCAG
NM_001042492.3(NF1):c.4618del (p.Ala1540fs)	NF1	A1519fs, A1540fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000651837	17	29588768	17	31261750	651837	645639	rs1597748742	NC_000017.11:31261749:GG:G
NM_001042492.3(NF1):c.6704+1del	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000651367	17	29664898	17	31337880	651367	653264	rs1597844692	NC_000017.11:31337879:GG:G
NM_001042492.3(NF1):c.7959del (p.Pro2655fs)	NF1	P2634fs, P2655fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000651321	17	29684376	17	31357358	651321	645773	rs1597866998	NC_000017.11:31357357:C:
NM_001042492.3(NF1):c.7158del (p.Phe2386fs)	NF1	F2365fs, F2386fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000650764	17	29670120	17	31343102	650764	645733	rs1597851420	NC_000017.11:31343101:TTT:TT
NM_001042492.3(NF1):c.6341_6342del (p.Gly2114fs)	NF1	G2114fs, G2093fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000649391	17	29663846 - 29663847	17	31336828 - 31336829	649391	645703	rs1597843052	NC_000017.11:31336827:GT:
NM_001042492.3(NF1):c.2525del (p.Gly842fs)	NF1	G842fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000649295	17	29556157	17	31229139	649295	645547	rs1597715284	NC_000017.11:31229138:GG:G
NM_001042492.3(NF1):c.6538del (p.Ser2180fs)	NF1	S2159fs, S2180fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000649128	17	29664495	17	31337477	649128	645709	rs1597843836	NC_000017.11:31337476:TT:T
NM_001042492.3(NF1):c.4832_4834delinsAC (p.Arg1611fs)	NF1	R1611fs, R1590fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000649126	17	29592354 - 29592356	17	31265336 - 31265338	649126	645646	rs1597753353	NC_000017.11:31265335:GGA:AC
NM_001042492.3(NF1):c.3759_3767del (p.Tyr1254_Leu1256del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000648655	17	29562676 - 29562684	17	31235658 - 31235666	648655	645605	rs1597722477	NC_000017.11:31235657:ACTCTACCAACT:ACT
NM_000267.3(NF1):c.480delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000648269	17	29496908	17	31169890	648269	652908	rs1597643722	NC_000017.11:31169889:GG:G
NM_001042492.3(NF1):c.7131del (p.Phe2377fs)	NF1	F2377fs, F2356fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000648010	17	29670092	17	31343074	648010	645730	rs1597851351	NC_000017.11:31343073:TTTT:TTT
NC_000017.11:g.(?_31232063)_(31249129_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000647943	17	29559081 - 29576147	17	31232063 - 31249129	647943	653089		
NM_001042492.3(NF1):c.6642+6del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 13, 2019)	criteria provided, single submitter	VCV000647927	17	29664606	17	31337588	647927	653249	rs1597844152	NC_000017.11:31337587:G:
NM_000267.3(NF1):c.2252-1delG	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000647570	17	29554235	17	31227217	647570	653233	rs1597713259	NC_000017.11:31227216:GG:G
NM_001042492.3(NF1):c.3245_3247del (p.Gly1082_Leu1083delinsVal)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000646920	17	29559138 - 29559140	17	31232120 - 31232122	646920	645583	rs1597718783	NC_000017.11:31232119:GTC:
NM_001042492.3(NF1):c.4957_4964del (p.Arg1653fs)	NF1	R1632fs, R1653fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000646596	17	29652959 - 29652966	17	31325941 - 31325948	646596	645654	rs1597829749	NC_000017.11:31325940:CGCTTTAA:
NM_001042492.3(NF1):c.2458del (p.His819_Val820insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000646475	17	29556091	17	31229073	646475	645545	rs1597715179	NC_000017.11:31229072:G:
NM_001042492.3(NF1):c.790del (p.Ala264fs)	NF1	A264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000646450	17	29509585	17	31182567	646450	645475	rs1597659893	NC_000017.11:31182566:G:
NM_001042492.3(NF1):c.2122del (p.Ser708fs)	NF1	S708fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000646410	17	29553573	17	31226555	646410	645530	rs1597712535	NC_000017.11:31226554:T:
NM_001042492.3(NF1):c.1861del (p.Ser621fs)	NF1	S621fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000645426	17	29552127	17	31225109	645426	645520	rs1597710358	NC_000017.11:31225108:TT:T
NM_001042492.3(NF1):c.5494del (p.Glu1832fs)	NF1	E1811fs, E1832fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000645159	17	29654740	17	31327722	645159	645673	rs1597832223	NC_000017.11:31327721:GGG:GG
NM_001042492.3(NF1):c.7037_7040del (p.Asp2346fs)	NF1	D2325fs, D2346fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000644855	17	29667635 - 29667638	17	31340617 - 31340620	644855	645727	rs1597848201	NC_000017.11:31340616:TAGATAG:TAG
NM_001042492.3(NF1):c.5802del (p.Phe1934fs)	NF1	F1934fs, F1913fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000643961	17	29657504	17	31330486	643961	645688	rs1597834952	NC_000017.11:31330485:TTT:TT
NM_001042492.3(NF1):c.5971_5978del (p.Ile1992fs)	NF1	I1992fs, I1971fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000643803	17	29662012 - 29662019	17	31334994 - 31335001	643803	645694	rs1597840273	NC_000017.11:31334993:CATCTATTCA:CA
NM_001042492.3(NF1):c.3197+2del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000643763	17	29557945	17	31230927	643763	653239	rs1597717694	NC_000017.11:31230926:T:
NM_001042492.3(NF1):c.5286_5289del (p.Val1762_Gln1763insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000643507	17	29654534 - 29654537	17	31327516 - 31327519	643507	645664	rs1597831854	NC_000017.11:31327515:CCAA:
NM_001042492.3(NF1):c.7955_7956del (p.Lys2652fs)	NF1	K2631fs, K2652fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000642977	17	29684371 - 29684372	17	31357353 - 31357354	642977	645772	rs1555536765	NC_000017.11:31357352:AAA:A
NC_000017.11:g.(?_31200402)_(31265359_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000642049	17	29527420 - 29592377	17	31200402 - 31265359	642049	653088		
NM_001042492.3(NF1):c.7612del (p.Gly2539fs)	NF1	G2539fs, G2518fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000640820	17	29679429	17	31352411	640820	645755	rs1597862293	NC_000017.11:31352410:C:
NM_001042492.3(NF1):c.4481del (p.His1494fs)	NF1	H1473fs, H1494fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000640494	17	29587437	17	31260419	640494	645634	rs1597746982	NC_000017.11:31260418:A:
NM_001042492.3(NF1):c.6794del (p.Lys2265fs)	NF1	K2244fs, K2265fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000638554	17	29665130	17	31338112	638554	626344	rs1597845155	NC_000017.11:31338111:AAA:AA
NM_001042492.3(NF1):c.5516del (p.Ile1839fs)	NF1	I1839fs, I1818fs	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636803	17	29654764	17	31327746	636803	624625	rs1597832304	NC_000017.11:31327745:T:
NM_001042492.3(NF1):c.2010del (p.Ala671fs)	NF1	A671fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 16, 2018)	no assertion criteria provided	VCV000635451	17	29553461	17	31226443	635451	623343	rs1597712251	NC_000017.11:31226442:A:
NM_001042492.3(NF1):c.799_802del (p.Trp267fs)	NF1	W267fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000632276	17	29509594 - 29509597	17	31182576 - 31182579	632276	620580	rs1567826683	NC_000017.11:31182575:TGGC:
NM_001042492.3(NF1):c.1672del (p.Ile558fs)	NF1	I558fs	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000618759	17	29548898	17	31221880	618759	610073	rs1567845057	NC_000017.11:31221879:A:
NM_001042492.3(NF1):c.7964del (p.Pro2655fs)	NF1	P2634fs, P2655fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618756	17	29684380	17	31357362	618756	610081	rs1567627268	NC_000017.11:31357361:CC:C
NM_001042492.3(NF1):c.4332+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000599036	17	29585520	17	31258502	599036	590165	rs1567862095	NC_000017.11:31258501:GG:G
NM_001042492.3(NF1):c.2455del (p.His819fs)	NF1	H819fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584470	17	29556086	17	31229068	584470	575604	rs1567848761	NC_000017.11:31229067:CCC:CC
NC_000017.11:g.(?_31325800)_(31374175_?)del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000584292	17	29652818 - 29701193	17	31325800 - 31374175	584292	570775		
NC_000017.11:g.(?_31334559)_(31359035_?)del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000584219	17	29661577 - 29686053	17	31334559 - 31359035	584219	574254		
NC_000017.11:g.(?_31325800)_(31360723_?)del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000584146	17	29652818 - 29687741	17	31325800 - 31360723	584146	570774		
NC_000017.11:g.(?_31200412)_(31265349_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000584096	17	29527430 - 29592367	17	31200412 - 31265349	584096	570772		
NC_000017.11:g.(?_31095300)_(31095379_?)del	NF1|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000583860	17	29422318 - 29422397	17	31095300 - 31095379	583860	574249		
NC_000017.11:g.(?_31325814)_(31374161_?)del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000583680	17	29652832 - 29701179	17	31325814 - 31374161	583680	568578		
NC_000017.11:g.(?_31155977)_(31163382_?)del	NF1|LOC108281170|LOC108281180		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000583632	17	29482995 - 29490400	17	31155977 - 31163382	583632	570664		
NC_000017.11:g.(?_31334828)_(31335041_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000583626	17	29661846 - 29662059	17	31334828 - 31335041	583626	568579		
NC_000017.11:g.(?_31200412)_(31206381_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000583529	17	29527430 - 29533399	17	31200412 - 31206381	583529	570758		
NM_001042492.3(NF1):c.1857_1863del (p.Arg619fs)	NF1	R619fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000582772	17	29552124 - 29552130	17	31225106 - 31225112	582772	571000	rs1567846634	NC_000017.11:31225105:AAGTTCC:
NM_001042492.3(NF1):c.2322_2323del (p.Glu775fs)	NF1	E775fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000582698	17	29554306 - 29554307	17	31227288 - 31227289	582698	568844	rs1567847962	NC_000017.11:31227287:TG:
NM_001042492.3(NF1):c.1680del (p.Leu560fs)	NF1	L560fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000582154	17	29548906	17	31221888	582154	570966	rs1567845069	NC_000017.11:31221887:G:
NM_001042492.3(NF1):c.889-2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000581747	17	29527438	17	31200420	581747	570959	rs1567834983	NC_000017.11:31200419:A:
NM_001042492.3(NF1):c.607del (p.Ala203fs)	NF1	A203fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000581692	17	29508460	17	31181442	581692	570942	rs1567825887	NC_000017.11:31181441:G:
NM_000267.3(NF1):c.3497delG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000581647	17	29560019	17	31233001	581647	570956	rs1567851231	NC_000017.11:31233000:GG:G
NM_001042492.3(NF1):c.1815del (p.Cys606fs)	NF1	C606fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000581113	17	29550555	17	31223537	581113	574379	rs1567845935	NC_000017.11:31223536:C:
NM_001042492.3(NF1):c.882_885del (p.Met294fs)	NF1	M294fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000581086	17	29509675 - 29509678	17	31182657 - 31182660	581086	574360	rs1567826819	NC_000017.11:31182656:ATGAAT:AT
NM_001042492.3(NF1):c.2424del (p.His809fs)	NF1	H809fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000580980	17	29556056	17	31229038	580980	574389	rs1567848731	NC_000017.11:31229037:TT:T
NM_001042492.3(NF1):c.4456del (p.Cys1486fs)	NF1	C1465fs, C1486fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000580782	17	29587411	17	31260393	580782	571112	rs1567862860	NC_000017.11:31260392:TT:T
NM_001042492.3(NF1):c.7188del (p.Tyr2398fs)	NF1	Y2398fs, Y2377fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000580631	17	29670149	17	31343131	580631	571052	rs777872719	NC_000017.11:31343130:AAAA:AAA
NM_001042492.3(NF1):c.4516_4517delinsTT (p.Ala1506Phe)	NF1	A1506F, A1485F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000580544	17	29587472 - 29587473	17	31260454 - 31260455	580544	574409	rs1567862930	NC_000017.11:31260453:GC:TT
NM_001042492.3(NF1):c.1525del (p.Cys509fs)	NF1	C509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000579706	17	29541599	17	31214581	579706	570880	rs1135402813	NC_000017.11:31214580:TTT:TT
NM_001042492.3(NF1):c.4044del (p.His1348fs)	NF1	H1348fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000579586	17	29576071	17	31249053	579586	570973	rs1567858344	NC_000017.11:31249052:T:
NM_001042492.3(NF1):c.204+3_204+6del	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000578995	17	29483145 - 29483148	17	31156127 - 31156130	578995	574346	rs1567814632	NC_000017.11:31156126:GTGAGT:GT
NM_001042492.3(NF1):c.3197+491_3384del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000577962	17	29558432 - 29559785	17	31231414 - 31232767	577962	568862		
NM_001042492.3(NF1):c.4020del (p.Gln1341fs)	NF1	Q1341fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000577224	17	29576046	17	31249028	577224	574405	rs1567858318	NC_000017.11:31249027:TT:T
NM_001042492.3(NF1):c.298del (p.Asp100fs)	NF1	D100fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000576707	17	29490212	17	31163194	576707	568763	rs1567817841	NC_000017.11:31163193:GG:G
NM_001042492.3(NF1):c.2148_2159delinsTGAAGTGTCT (p.Glu716fs)	NF1	E716fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000575987	17	29553599 - 29553610	17	31226581 - 31226592	575987	568833	rs1567847538	NC_000017.11:31226580:AGCAGATATCCG:TGAAGTGTCT
NM_001042492.3(NF1):c.3384del (p.Gly1129fs)	NF1	G1129fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000575579	17	29559787	17	31232769	575579	571069	rs1567851054	NC_000017.11:31232768:T:
NM_001042492.3(NF1):c.4949_4954del (p.Pro1650_Asn1652delinsHis)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000575520	17	29652951 - 29652956	17	31325933 - 31325938	575520	571132	rs1567611339	NC_000017.11:31325932:CTAGCA:
NM_001042492.3(NF1):c.7662_7664delinsAG (p.Lys2555fs)	NF1	K2555fs, K2534fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000575440	17	29683524 - 29683526	17	31356506 - 31356508	575440	571228	rs1567626632	NC_000017.11:31356505:TAA:AG
NM_001042492.3(NF1):c.2434del (p.Ile812fs)	NF1	I812fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000574941	17	29556067	17	31229049	574941	570925	rs1567848739	NC_000017.11:31229048:A:
NM_001042492.3(NF1):c.2034del (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000574937	17	29553485	17	31226467	574937	570903	rs1567847384	NC_000017.11:31226466:G:
NM_001042492.3(NF1):c.3695del (p.Pro1232fs)	NF1	P1232fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000574642	17	29560217	17	31233199	574642	570962	rs1567851532	NC_000017.11:31233198:CC:C
NM_001042492.3(NF1):c.2041del (p.Arg681fs)	NF1	R681fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000574512	17	29553491	17	31226473	574512	570906	rs1567847398	NC_000017.11:31226472:CC:C
NM_001042492.3(NF1):c.449del (p.Phe150fs)	NF1	F150fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000574327	17	29490363	17	31163345	574327	570855	rs1567817974	NC_000017.11:31163344:TT:T
NM_001042492.3(NF1):c.8033del (p.Leu2677_Leu2678insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000574267	17	29685559	17	31358541	574267	571247	rs1567627755	NC_000017.11:31358540:TT:T
NM_001042492.3(NF1):c.586+5del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000573461	17	29497020	17	31170002	573461	574352	rs1567820838	NC_000017.11:31170001:G:
NM_001042492.3(NF1):c.4663del (p.Ala1555fs)	NF1	A1534fs, A1555fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000573251	17	29588813	17	31261795	573251	568913	rs1567863614	NC_000017.11:31261794:GG:G
NM_001042492.3(NF1):c.997del (p.Tyr333fs)	NF1	Y333fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000572921	17	29527547	17	31200529	572921	568794	rs1567835183	NC_000017.11:31200528:TT:T
NM_001042492.3(NF1):c.5723_5742del (p.Ile1908fs)	NF1	I1908fs, I1887fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000572845	17	29657426 - 29657445	17	31330408 - 31330427	572845	574419	rs1567613682	NC_000017.11:31330407:ATTGTCTCTATTAGTAAGACA:A
NM_001042492.3(NF1):c.2380del (p.Tyr794fs)	NF1	Y794fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000572818	17	29554595	17	31227577	572818	570921	rs1567848178	NC_000017.11:31227576:T:
NM_001042492.3(NF1):c.7062+1_7062+5del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000572463	17	29667661 - 29667665	17	31340643 - 31340647	572463	571216	rs1567619134	NC_000017.11:31340642:AAGGTAAG:AAG
NM_001042492.3(NF1):c.328del (p.Val110fs)	NF1	V110fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000571592	17	29490242	17	31163224	571592	568765	rs1567817865	NC_000017.11:31163223:GG:G
NM_001042492.3(NF1):c.988_995del (p.Ala330fs)	NF1	A330fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV000571225	17	29527539 - 29527546	17	31200521 - 31200528	571225	568790	rs1567835161	NC_000017.11:31200520:GCAAGTAC:
NM_001042492.3(NF1):c.4262del (p.Pro1421fs)	NF1	P1400fs, P1421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000571036	17	29585449	17	31258431	571036	568901	rs1567861977	NC_000017.11:31258430:CC:C
NM_001042492.3(NF1):c.5347del (p.Tyr1783fs)	NF1	Y1783fs, Y1762fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000570774	17	29654593	17	31327575	570774	571011	rs1567612415	NC_000017.11:31327574:TTT:TT
NM_001042492.3(NF1):c.592del (p.Ala198fs)	NF1	A198fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000570686	17	29508445	17	31181427	570686	570938	rs1567825858	NC_000017.11:31181426:G:
NM_001042492.3(NF1):c.1370_1372del (p.His457del)	NF1	H457del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000569917	17	29533366 - 29533368	17	31206348 - 31206350	569917	570879	rs1567838357	NC_000017.11:31206347:CACC:C
NM_001042492.3(NF1):c.4989del (p.Phe1663fs)	NF1	F1642fs, F1663fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000569882	17	29652989	17	31325971	569882	571005	rs1567611380	NC_000017.11:31325970:TTT:TT
NM_001042492.3(NF1):c.2167del (p.Val723fs)	NF1	V723fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000569878	17	29553615	17	31226597	569878	570917	rs1567847571	NC_000017.11:31226596:GGGG:GGG
NM_001042492.3(NF1):c.4749del (p.Glu1583fs)	NF1	E1562fs, E1583fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000569717	17	29592270	17	31265252	569717	574411	rs1567864983	NC_000017.11:31265251:AA:A
NM_001042492.3(NF1):c.2622_2629del (p.Lys874fs)	NF1	K874fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000569716	17	29556254 - 29556261	17	31229236 - 31229243	569716	574391	rs1567848976	NC_000017.11:31229235:AGGGTTCTA:A
NM_001042492.3(NF1):c.5461del (p.Val1821fs)	NF1	V1821fs, V1800fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000569647	17	29654709	17	31327691	569647	574415	rs1567612531	NC_000017.11:31327690:G:
NM_001042492.3(NF1):c.7232_7258del (p.Arg2411_Val2420delinsIle)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000569304	17	29676180 - 29676206	17	31349162 - 31349188	569304	568991	rs1567623439	NC_000017.11:31349161:GAATTTTACATACACTACTAACTCTGG:
NM_001042492.3(NF1):c.1331del (p.Gly444fs)	NF1	G444fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000569133	17	29533327	17	31206309	569133	574370	rs1567838293	NC_000017.11:31206308:GG:G
NM_001042492.3(NF1):c.4526del (p.Arg1509fs)	NF1	R1488fs, R1509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000568205	17	29587482	17	31260464	568205	570988	rs1567862956	NC_000017.11:31260463:G:
NM_001042492.3(NF1):c.750del (p.Phe250fs)	NF1	F250fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000567780	17	29509543	17	31182525	567780	568786	rs1567826633	NC_000017.11:31182524:TTT:TT
NM_001042492.3(NF1):c.5039_5041delinsT (p.Tyr1680fs)	NF1	Y1680fs, Y1659fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000567655	17	29653041 - 29653043	17	31326023 - 31326025	567655	568927	rs1567611457	NC_000017.11:31326022:ATA:T
NM_001042492.3(NF1):c.1619del (p.Glu540fs)	NF1	E540fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000567071	17	29546114	17	31219096	567071	570963	rs1567843934	NC_000017.11:31219095:A:
NM_001042492.3(NF1):c.4966del (p.Thr1656fs)	NF1	T1656fs, T1635fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000566482	17	29652965	17	31325947	566482	571002	rs1567611351	NC_000017.11:31325946:AAAA:AAA
NM_001042492.3(NF1):c.7921del (p.Glu2641fs)	NF1	E2641fs, E2620fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000565583	17	29684338	17	31357320	565583	571241	rs1567627210	NC_000017.11:31357319:G:
NM_001042492.3(NF1):c.5943del (p.Met1981fs)	NF1	M1981fs, M1960fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000565500	17	29661986	17	31334968	565500	571145	rs1567615872	NC_000017.11:31334967:G:
NM_001042492.3(NF1):c.6174del (p.Ile2058fs)	NF1	I2058fs, I2037fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000565403	17	29663678	17	31336660	565403	568948	rs1567616894	NC_000017.11:31336659:TT:T
NM_001042492.3(NF1):c.5535del (p.Arg1846fs)	NF1	R1825fs, R1846fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000565311	17	29654782	17	31327764	565311	574417	rs1567612647	NC_000017.11:31327763:TT:T
NM_001042492.3(NF1):c.2800_2802del (p.Phe934del)	NF1	F934del	Neurofibromatosis type 6	Uncertain significance	no assertion criteria provided	VCV000560364	17	29556433 - 29556435	17	31229415 - 31229417	560364	551418	rs1567849174	NC_000017.11:31229414:TTT:
NM_001042492.3(NF1):c.8159del (p.Lys2720fs)	NF1	K2699fs, K2720fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547700	17	29686030	17	31359012	547700	538237	rs1555537029	NC_000017.11:31359011:AAA:AA
NM_001042492.3(NF1):c.7753del (p.Ser2585fs)	NF1	S2564fs, S2585fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547696	17	29683990	17	31356972	547696	538233	rs1555536685	NC_000017.11:31356971:TTT:TT
NM_001042492.3(NF1):c.7169_7178delinsCAGC (p.Leu2390_His2393delinsSerAla)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547693	17	29670133 - 29670142	17	31343115 - 31343124	547693	538230	rs1555535448	NC_000017.11:31343114:TGGTTGGACA:CAGC
NM_001042492.3(NF1):c.6952_6955del (p.Val2318fs)	NF1	V2297fs, V2318fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547688	17	29667552 - 29667555	17	31340534 - 31340537	547688	538225	rs1555535163	NC_000017.11:31340533:GGTAG:G
NM_001042492.3(NF1):c.6780_6791delinsATGAGAC (p.His2261_Ile2264delinsTer)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547682	17	29665118 - 29665129	17	31338100 - 31338111	547682	538219	rs1555534952	NC_000017.11:31338099:TCATGGGCAGAT:ATGAGAC
NM_001042492.3(NF1):c.6671del (p.Lys2224fs)	NF1	K2203fs, K2224fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547679	17	29664864	17	31337846	547679	538216	rs1555534919	NC_000017.11:31337845:AA:A
NM_001042492.3(NF1):c.6645del (p.Cys2216fs)	NF1	C2195fs, C2216fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547677	17	29664839	17	31337821	547677	538214	rs1555534913	NC_000017.11:31337820:A:
NM_001042492.3(NF1):c.5560_5562delinsT (p.Leu1854fs)	NF1	L1833fs, L1854fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547662	17	29654808 - 29654810	17	31327790 - 31327792	547662	538199	rs1555533641	NC_000017.11:31327789:CTG:T
NM_001042492.3(NF1):c.5548_5549del (p.Val1850fs)	NF1	V1829fs, V1850fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547661	17	29654795 - 29654796	17	31327777 - 31327778	547661	538198	rs1555533636	NC_000017.11:31327776:TGT:T
NM_001042492.3(NF1):c.5072_5073delinsCCC (p.Lys1691fs)	NF1	K1691fs, K1670fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547655	17	29653074 - 29653075	17	31326056 - 31326057	547655	538192	rs1555533363	NC_000017.11:31326055:AG:CCC
NM_001042492.3(NF1):c.4783del (p.Gln1595fs)	NF1	Q1574fs, Q1595fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547650	17	29592304	17	31265286	547650	538187	rs1555619404	NC_000017.11:31265285:CC:C
NM_001042492.3(NF1):c.4744_4745del (p.Glu1582fs)	NF1	E1561fs, E1582fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547649	17	29592265 - 29592266	17	31265247 - 31265248	547649	538186	rs1555619395	NC_000017.11:31265246:AGA:A
NM_001042492.3(NF1):c.4658del (p.Pro1553fs)	NF1	P1532fs, P1553fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547648	17	29588808	17	31261790	547648	538185	rs1555619029	NC_000017.11:31261789:CC:C
NM_001042492.3(NF1):c.4369_4371del (p.Lys1457del)	NF1	K1436del, K1457del	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2020)	criteria provided, conflicting interpretations	VCV000547644	17	29586085 - 29586087	17	31259067 - 31259069	547644	538181	rs1555618653	NC_000017.11:31259066:AAAA:A
NM_001042492.3(NF1):c.3911del (p.Leu1304fs)	NF1	L1304fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547639	17	29562974	17	31235956	547639	538176	rs1555615549	NC_000017.11:31235955:TTT:TT
NM_001042492.3(NF1):c.3791_3801del (p.Glu1264fs)	NF1	E1264fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547637	17	29562710 - 29562720	17	31235692 - 31235702	547637	538174	rs1555615469	NC_000017.11:31235691:GAAGTAGAATTG:G
NM_001042492.3(NF1):c.3686del (p.Asn1229fs)	NF1	N1229fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547633	17	29560208	17	31233190	547633	538170	rs1555615103	NC_000017.11:31233189:AA:A
NM_001042492.3(NF1):c.3656_3658del (p.Gly1219del)	NF1	G1219del	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547632	17	29560177 - 29560179	17	31233159 - 31233161	547632	538169	rs1555615077	NC_000017.11:31233158:AGGAG:AG
NM_001042492.3(NF1):c.3357del (p.Val1120fs)	NF1	V1120fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547628	17	29559759	17	31232741	547628	538165	rs1555614934	NC_000017.11:31232740:AA:A
NM_001042492.3(NF1):c.3324_3325del (p.Leu1109fs)	NF1	L1109fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547627	17	29559727 - 29559728	17	31232709 - 31232710	547627	538164	rs1555614918	NC_000017.11:31232708:AT:
NM_001042492.3(NF1):c.3124del (p.Met1041_Val1042insTer)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547622	17	29557869	17	31230851	547622	538159	rs1555614624	NC_000017.11:31230850:GG:G
NM_001042492.3(NF1):c.2873_2877delinsTGG (p.Thr958fs)	NF1	T958fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547618	17	29556875 - 29556879	17	31229857 - 31229861	547618	538155	rs1555614426	NC_000017.11:31229856:CTCAA:TGG
NM_001042492.3(NF1):c.2552del (p.Cys851fs)	NF1	C851fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547611	17	29556185	17	31229167	547611	538148	rs1555614260	NC_000017.11:31229166:G:
NM_001042492.3(NF1):c.1490del (p.Val497fs)	NF1	V497fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547591	17	29541566	17	31214548	547591	538128	rs1555612286	NC_000017.11:31214547:T:
NM_001042492.3(NF1):c.1413_1414delinsT (p.Lys471fs)	NF1	K471fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547590	17	29541489 - 29541490	17	31214471 - 31214472	547590	538127	rs1555612273	NC_000017.11:31214470:AG:T
NM_001042492.3(NF1):c.1245del (p.Arg416fs)	NF1	R416fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547585	17	29528488	17	31201470	547585	538122	rs1555611098	NC_000017.11:31201469:T:
NM_001042492.3(NF1):c.1104_1107del (p.Gln369fs)	NF1	Q369fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547583	17	29528093 - 29528096	17	31201075 - 31201078	547583	538120	rs1555610984	NC_000017.11:31201074:CAGTCAG:CAG
NM_001042492.3(NF1):c.1077del (p.Pro360fs)	NF1	P360fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547582	17	29528069	17	31201051	547582	538119	rs1555610972	NC_000017.11:31201050:T:
NM_001042492.3(NF1):c.988del (p.Ala330fs)	NF1	A330fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547577	17	29527539	17	31200521	547577	538114	rs1555610896	NC_000017.11:31200520:G:
NM_001042492.3(NF1):c.817del (p.Leu273fs)	NF1	L273fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547572	17	29509612	17	31182594	547572	538109	rs1555608972	NC_000017.11:31182593:C:
NM_001042492.3(NF1):c.654+4del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547568	17	29508510	17	31181492	547568	538105	rs1555608683	NC_000017.11:31181491:AA:A
NM_001042492.3(NF1):c.188del (p.Lys63fs)	NF1	K63fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547563	17	29483126	17	31156108	547563	538100	rs1555604939	NC_000017.11:31156107:AAA:AA
NM_001042492.3(NF1):c.1801_1803del (p.Arg601del)	NF1	R601del	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000546244	17	29550540 - 29550542	17	31223522 - 31223524	546244	536932	rs1555613421	NC_000017.11:31223521:GCGG:G
NM_001042492.3(NF1):c.233del (p.Asn78fs)	NF1	N78fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000545744	17	29486050	17	31159032	545744	536486	rs1438566555	NC_000017.11:31159031:AAAAAAA:AAAAAA
NM_001042492.3(NF1):c.5157del (p.Ile1719fs)	NF1	I1698fs, I1719fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000545724	17	29653159	17	31326141	545724	536216	rs1555533382	NC_000017.11:31326140:A:
NC_000017.11:g.(?_31200416)_(31206377_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000527686	17	29527434 - 29533395	17	31200416 - 31206377	527686	531005		
NC_000017.11:g.(?_31334832)_(31335037_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000527681	17	29661850 - 29662055	17	31334832 - 31335037	527681	531012		
NM_001042492.3(NF1):c.586+10_586+15del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000527652	17	29497023 - 29497028	17	31170005 - 31170010	527652	530847	rs1555607130	NC_000017.11:31170004:TAAATGTA:TA
NM_001042492.3(NF1):c.909_910delinsTT (p.Arg304Ter)	NF1	R304*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000527594	17	29527460 - 29527461	17	31200442 - 31200443	527594	530942	rs1555610854	NC_000017.11:31200441:AC:TT
NM_001042492.3(NF1):c.5561del (p.Leu1854fs)	NF1	L1833fs, L1854fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527589	17	29654809	17	31327791	527589	531008	rs1555533644	NC_000017.11:31327790:T:
NM_001042492.3(NF1):c.4770_4777del (p.Leu1590fs)	NF1	L1590fs, L1569fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000527574	17	29592290 - 29592297	17	31265272 - 31265279	527574	531302	rs1555619402	NC_000017.11:31265271:TTAAGTATTT:TT
NM_001042492.3(NF1):c.594del (p.Phe199fs)	NF1	F199fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527567	17	29508447	17	31181429	527567	530673	rs1555608647	NC_000017.11:31181428:A:
NM_001042492.3(NF1):c.920_921delinsA (p.Leu307fs)	NF1	L307fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527551	17	29527471 - 29527472	17	31200453 - 31200454	527551	530873	rs1555610860	NC_000017.11:31200452:TT:A
NM_001042492.3(NF1):c.3043del (p.Leu1015fs)	NF1	L1015fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000527530	17	29557330	17	31230312	527530	531235	rs1555614514	NC_000017.11:31230311:C:
NM_001042492.3(NF1):c.4571_4572delinsAA (p.Ser1524Lys)	NF1	S1503K, S1524K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527528	17	29587527 - 29587528	17	31260509 - 31260510	527528	530852	rs1555618860	NC_000017.11:31260508:GC:AA
NM_001042492.3(NF1):c.2870del (p.Asn957fs)	NF1	N957fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000527526	17	29556871	17	31229853	527526	530761	rs1555614423	NC_000017.11:31229852:AA:A
NM_001042492.3(NF1):c.311_312del (p.Arg103_Leu104insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000527507	17	29490226 - 29490227	17	31163208 - 31163209	527507	530917	rs1555606053	NC_000017.11:31163207:TA:
NM_001042492.3(NF1):c.6275del (p.Asn2092fs)	NF1	N2092fs, N2071fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000527500	17	29663779	17	31336761	527500	531356	rs1555534697	NC_000017.11:31336760:AA:A
NM_001042492.3(NF1):c.4983_4985delinsCTTA (p.Lys1661fs)	NF1	K1661fs, K1640fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000527499	17	29652985 - 29652987	17	31325967 - 31325969	527499	530867	rs1555533326	NC_000017.11:31325966:GTG:CTTA
NM_001042492.3(NF1):c.624_632del (p.Gln209_Ala211del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000527497	17	29508475 - 29508483	17	31181457 - 31181465	527497	531189	rs1555608666	NC_000017.11:31181456:GCGCAGTTAGC:GC
NM_001042492.3(NF1):c.4070del (p.Phe1357fs)	NF1	F1357fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000527483	17	29576096	17	31249078	527483	530818	rs1555617354	NC_000017.11:31249077:TT:T
NM_001042492.3(NF1):c.5786del (p.Glu1929fs)	NF1	E1908fs, E1929fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527475	17	29657490	17	31330472	527475	531344	rs1555533883	NC_000017.11:31330471:A:
NM_001042492.3(NF1):c.5812+3_5812+4del	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000527469	17	29657519 - 29657520	17	31330501 - 31330502	527469	531348	rs1555533888	NC_000017.11:31330500:AA:
NM_001042492.3(NF1):c.4529_4543del (p.Leu1510_Asn1514del)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000527466	17	29587483 - 29587497	17	31260465 - 31260479	527466	531065	rs1555618846	NC_000017.11:31260464:TCTACTCTGGAACAATC:TC
NM_001042492.3(NF1):c.2668_2677del (p.Pro890fs)	NF1	P890fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000527452	17	29556299 - 29556308	17	31229281 - 31229290	527452	531232	rs1555614293	NC_000017.11:31229280:CACCTGTCAGCA:CA
NM_001042492.3(NF1):c.569del (p.Lys189_Leu190insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000527450	17	29496997	17	31169979	527450	530671	rs1555607110	NC_000017.11:31169978:TT:T
NM_001042492.3(NF1):c.4438del (p.Asp1481fs)	NF1	D1460fs, D1481fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527443	17	29587393	17	31260375	527443	531289	rs1555618806	NC_000017.11:31260374:CC:C
NM_001042492.3(NF1):c.8112_8113del (p.Ser2705fs)	NF1	S2684fs, S2705fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527440	17	29685638 - 29685639	17	31358620 - 31358621	527440	530934	rs1555536947	NC_000017.11:31358619:AAA:A
NM_001042492.3(NF1):c.693_694delinsCT (p.Thr232Ser)	NF1	T232S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000527424	17	29508766 - 29508767	17	31181748 - 31181749	527424	530682	rs1555608748	NC_000017.11:31181747:TA:CT
NM_001042492.3(NF1):c.6704+2del	NF1		Neurofibromatosis type 6|Neurofibroma|Axillary freckling|Inguinal freckling	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523350	17	29664900	17	31337882	523350	514081	rs1555534929	NC_000017.11:31337881:T:
NM_001042492.3(NF1):c.4998del (p.Pro1667fs)	NF1	P1646fs, P1667fs	Neurofibromatosis, type 1|Cafe-au-lait spot|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523347	17	29652996	17	31325978	523347	514078	rs1135402867	NC_000017.11:31325977:TTTTT:TTTT
NM_001042492.3(NF1):c.7076_7102del (p.Val2359_Leu2367del)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000522586	17	29670039 - 29670065	17	31343021 - 31343047	522586	513200	rs1555535403	NC_000017.11:31343020:GTATTTATGGCAATCCGGAATCCTCTGG:G
NM_001042492.3(NF1):c.7505del (p.Gly2502fs)	NF1	G2502fs, G2481fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522466	17	29679321	17	31352303	522466	513135	rs1555536358	NC_000017.11:31352302:GG:G
NM_001042492.3(NF1):c.3060del (p.Glu1020_Val1021insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000517397	17	29557346	17	31230328	517397	497565	rs1555614521	NC_000017.11:31230327:AA:A
NM_001042492.3(NF1):c.7274del (p.Asn2425fs)	NF1	N2425fs, N2404fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504241	17	29676220	17	31349202	504241	495684	rs1555536030	NC_000017.11:31349201:AAA:AA
NM_001042492.3(NF1):c.4684del (p.Asn1563fs)	NF1	N1563fs, N1542fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504235	17	29588834	17	31261816	504235	495668	rs1555619041	NC_000017.11:31261815:CC:C
NM_000267.3(NF1):c.5206delG	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503953	17	29654516	17	31327498	503953	495413	rs1555533549	NC_000017.11:31327497:GG:G
NM_001042492.3(NF1):c.8084del (p.Pro2695fs)	NF1	P2695fs, P2674fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 16, 2015)	no assertion criteria provided	VCV000492890	17	29685608	17	31358590	492890	485782	rs1555536928	NC_000017.11:31358589:CCCC:CCC
NM_001042492.3(NF1):c.7811del (p.Leu2604fs)	NF1	L2583fs, L2604fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2016)	no assertion criteria provided	VCV000492889	17	29684050	17	31357032	492889	485781	rs1555536701	NC_000017.11:31357031:T:
NM_001042492.3(NF1):c.5830del (p.Leu1944fs)	NF1	L1944fs, L1923fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000492886	17	29661872	17	31334854	492886	485778	rs1555534378	NC_000017.11:31334853:CC:C
NM_001042492.3(NF1):c.5295_5296del (p.Ala1767fs)	NF1	A1767fs, A1746fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000492884	17	29654543 - 29654544	17	31327525 - 31327526	492884	485776	rs1555533552	NC_000017.11:31327524:TT:
NM_001042492.3(NF1):c.1400_1415del (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2015)	no assertion criteria provided	VCV000492876	17	29541476 - 29541491	17	31214458 - 31214473	492876	485769	rs1555612270	NC_000017.11:31214457:CATTTAAAGAAAAAGT:
NM_001042492.3(NF1):c.282del (p.Ala95fs)	NF1	A95fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2015)	no assertion criteria provided	VCV000492873	17	29486104	17	31159086	492873	485765	rs1555605404	NC_000017.11:31159085:TT:T
NM_001042492.3(NF1):c.4818_4822del (p.Phe1606fs)	NF1	F1585fs, F1606fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000488562	17	29592338 - 29592342	17	31265320 - 31265324	488562	481430	rs1555619413	NC_000017.11:31265319:TTTTATT:TT
NM_001042492.3(NF1):c.5087del (p.Leu1696fs)	NF1	L1696fs, L1675fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000488453	17	29653089	17	31326071	488453	481323	rs1555533368	NC_000017.11:31326070:T:
NM_001042492.3(NF1):c.3161_3165del (p.Asn1054fs)	NF1	N1054fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485960	17	29557904 - 29557908	17	31230886 - 31230890	485960	478117	rs1555614642	NC_000017.11:31230885:CAAACCAA:CAA
NM_001042492.3(NF1):c.6006+5_6006+25del	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481949	17	29662051 - 29662071	17	31335033 - 31335053	481949	478954	rs1555534435	NC_000017.11:31335032:TATTGAGTTTGCTCAAATATTTAT:TAT
NM_001042492.3(NF1):c.2674del (p.Ser892fs)	NF1	S892fs	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|not specified	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481923	17	29556307	17	31229289	481923	478216	rs1555614296	NC_000017.11:31229288:A:
NM_001042492.3(NF1):c.1255del (p.Thr419fs)	NF1	T419fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000481904	17	29528498	17	31201480	481904	478707	rs1555611105	NC_000017.11:31201479:A:
NM_001042492.3(NF1):c.7496del (p.Gly2499fs)	NF1	G2478fs, G2499fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480793	17	29679312	17	31352294	480793	478346	rs1555536352	NC_000017.11:31352293:GG:G
NM_001042492.3(NF1):c.8389_8391del (p.Glu2797del)	NF1	E2797del, E2776del	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480208	17	29701040 - 29701042	17	31374022 - 31374024	480208	478572	rs1555538511	NC_000017.11:31374021:AGGAG:AG
NM_001042492.3(NF1):c.560del (p.Cys187fs)	NF1	C187fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 28, 2016)	criteria provided, single submitter	VCV000480102	17	29496989	17	31169971	480102	477928	rs1555607107	NC_000017.11:31169970:G:
NM_001042492.3(NF1):c.996_999del (p.Tyr333fs)	NF1	Y333fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457882	17	29527544 - 29527547	17	31200526 - 31200529	457882	467543	rs1555610900	NC_000017.11:31200525:TACTTAC:TAC
NM_001042492.3(NF1):c.952del (p.Glu318fs)	NF1	E318fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000457877	17	29527503	17	31200485	457877	467412	rs1555610881	NC_000017.11:31200484:G:
NM_001042492.3(NF1):c.908del (p.Leu303fs)	NF1	L303fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000457876	17	29527459	17	31200441	457876	466417	rs1555610848	NC_000017.11:31200440:T:
NM_001042492.3(NF1):c.8066del (p.Val2689fs)	NF1	V2668fs, V2689fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2017)	criteria provided, single submitter	VCV000457864	17	29685593	17	31358575	457864	467786	rs1555536923	NC_000017.11:31358574:T:
NM_001042492.3(NF1):c.7458-7_7459delinsT	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000457847	17	29679268 - 29679276	17	31352250 - 31352258	457847	466713	rs1555536334	NC_000017.11:31352249:CTTTCAGGA:T
NM_001042492.3(NF1):c.7063-6del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000457818	17	29670019	17	31343001	457818	467528	rs756593267	NC_000017.11:31343000:TTT:TT
NM_001042492.3(NF1):c.7034_7041del (p.Leu2345fs)	NF1	L2324fs, L2345fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000457815	17	29667634 - 29667641	17	31340616 - 31340623	457815	467733	rs1555535192	NC_000017.11:31340615:TTAGATAGT:T
NM_001042492.3(NF1):c.6855del (p.Thr2284_Tyr2285insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2017)	criteria provided, single submitter	VCV000457810	17	29665757	17	31338739	457810	467726	rs1555535042	NC_000017.11:31338738:C:
NM_001042492.3(NF1):c.6667del (p.Cys2223fs)	NF1	C2223fs, C2202fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000457800	17	29664861	17	31337843	457800	467521	rs1555534917	NC_000017.11:31337842:T:
NM_001042492.3(NF1):c.5833del (p.Cys1945fs)	NF1	C1945fs, C1924fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457765	17	29661874	17	31334856	457765	467670	rs1555534379	NC_000017.11:31334855:TTT:TT
NM_001042492.3(NF1):c.5586del (p.Gly1863fs)	NF1	G1842fs, G1863fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000457754	17	29654834	17	31327816	457754	467627	rs1555533648	NC_000017.11:31327815:A:
NM_001042492.3(NF1):c.5269-41_5291del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000457747	17	29654473 - 29654536	17	31327455 - 31327518	457747	466649	rs1555533543	
NM_001042492.3(NF1):c.5178del (p.Pro1727fs)	NF1	P1706fs, P1727fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000457741	17	29653180	17	31326162	457741	467828	rs1555533393	NC_000017.11:31326161:A:
NM_001042492.3(NF1):c.4967_4968del (p.Thr1656fs)	NF1	T1635fs, T1656fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000457728	17	29652968 - 29652969	17	31325950 - 31325951	457728	467480	rs1555533323	NC_000017.11:31325949:ACA:A
NM_001042492.3(NF1):c.4892del (p.Thr1630_Leu1631insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000457725	17	29652892	17	31325874	457725	467589	rs1555533290	NC_000017.11:31325873:TTT:TT
NM_001042492.3(NF1):c.4703del (p.Lys1568fs)	NF1	K1568fs, K1547fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000457711	17	29588852	17	31261834	457711	467791	rs1555619052	NC_000017.11:31261833:AAA:AA
NM_001042492.3(NF1):c.4482_4483del (p.His1494fs)	NF1	H1494fs, H1473fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000457702	17	29587437 - 29587438	17	31260419 - 31260420	457702	467779	rs1555618821	NC_000017.11:31260418:ATA:A
NM_001042492.3(NF1):c.4229del (p.Phe1410fs)	NF1	F1410fs, F1389fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000457685	17	29585416	17	31258398	457685	467763	rs1555618511	NC_000017.11:31258397:TT:T
NM_001042492.3(NF1):c.4074_4075delinsAA (p.Pro1359Thr)	NF1	P1359T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457678	17	29576101 - 29576102	17	31249083 - 31249084	457678	467757	rs1555617362	NC_000017.11:31249082:CC:AA
NM_001042492.3(NF1):c.3075del (p.Arg1026fs)	NF1	R1026fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000457620	17	29557361	17	31230343	457620	467683	rs1555614526	NC_000017.11:31230342:GG:G
NM_001042492.3(NF1):c.2802del (p.Phe934fs)	NF1	F934fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457601	17	29556433	17	31229415	457601	467646	rs1555614343	NC_000017.11:31229414:TTT:TT
NM_001042492.3(NF1):c.2411del (p.Ala804fs)	NF1	A804fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000457584	17	29556044	17	31229026	457584	467462	rs1555614180	NC_000017.11:31229025:C:
NM_001042492.3(NF1):c.232_234del (p.Asn78del)	NF1	N78del	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457577	17	29486055 - 29486057	17	31159037 - 31159039	457577	467227	rs1555605367	NC_000017.11:31159036:AAT:
NM_001042492.3(NF1):c.1527+4_1527+7del	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457536	17	29541604 - 29541607	17	31214586 - 31214589	457536	466451	rs1555612294	NC_000017.11:31214585:GTAAGTA:GTA
NM_001042492.3(NF1):c.1514del (p.Lys505fs)	NF1	K505fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000457535	17	29541588	17	31214570	457535	467281	rs1555612289	NC_000017.11:31214569:AAA:AA
NM_001042492.3(NF1):c.1183_1185+2del	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457519	17	29528174 - 29528178	17	31201156 - 31201160	457519	466426	rs1555611039	NC_000017.11:31201155:TAAGGT:T
NC_000017.11:g.(?_31325814)_(31338145_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000457508	17	29652832 - 29665163	17	31325814 - 31338145	457508	467089		
NC_000017.10:g.(?_29508434)_(29509689_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000457506	17	29508434 - 29509689			457506	467016		
NC_000017.10:g.(?_29486022)_(29533395_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000457503	17	29486022 - 29533395			457503	467009		
NC_000017.11:g.(?_31095304)_(31156132_?)del	NF1|LOC108281169|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000457497	17	29422322 - 29483150	17	31095304 - 31156132	457497	466208		
NM_001042492.3(NF1):c.2890del (p.Thr964fs)	NF1	T964fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451156	17	29556890	17	31229872	451156	445737	rs1555614437	NC_000017.11:31229871:AAA:AA
NM_001042492.3(NF1):c.1541del (p.Gln514fs)	NF1	Q514fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449422	17	29546036	17	31219018	449422	445732	rs1555612815	NC_000017.11:31219017:A:
NM_001042492.3(NF1):c.7782del (p.Val2596fs)	NF1	V2596fs, V2575fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431694	17	29684021	17	31357003	431694	425199	rs1135402908	NC_000017.11:31357002:T:
NM_001042492.3(NF1):c.7383del (p.Leu2462fs)	NF1	L2441fs, L2462fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431691	17	29677261	17	31350243	431691	425196	rs1135402905	NC_000017.11:31350242:TT:T
NM_001042492.3(NF1):c.7337_7338del (p.Val2445_Ser2446insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431690	17	29677215 - 29677216	17	31350197 - 31350198	431690	425195	rs1135402904	NC_000017.11:31350196:TCT:T
NM_001042492.3(NF1):c.7287del (p.Phe2429fs)	NF1	F2429fs, F2408fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000431688	17	29676233	17	31349215	431688	425193	rs1135402902	NC_000017.11:31349214:TTT:TT
NM_001042492.3(NF1):c.7030del (p.Thr2344fs)	NF1	T2323fs, T2344fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431683	17	29667631	17	31340613	431683	425188	rs1135402897	NC_000017.11:31340612:A:
NM_001042492.3(NF1):c.6878del (p.Ala2293fs)	NF1	A2293fs, A2272fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431681	17	29665780	17	31338762	431681	425186	rs1135402895	NC_000017.11:31338761:C:
NM_001042492.3(NF1):c.6810del (p.Ser2272fs)	NF1	S2251fs, S2272fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431678	17	29665147	17	31338129	431678	425183	rs1135402893	NC_000017.11:31338128:TT:T
NM_001042492.3(NF1):c.6600del (p.Ser2201fs)	NF1	S2180fs, S2201fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431677	17	29664558	17	31337540	431677	425182	rs1135402892	NC_000017.11:31337539:A:
NM_001042492.3(NF1):c.6546_6550del (p.Tyr2182_Asp2184delinsTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431675	17	29664504 - 29664508	17	31337486 - 31337490	431675	425180	rs1135402890	NC_000017.11:31337485:CCGGG:
NM_001042492.3(NF1):c.6545del (p.Tyr2182fs)	NF1	Y2161fs, Y2182fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431674	17	29664503	17	31337485	431674	425179	rs1135402889	NC_000017.11:31337484:A:
NM_001042492.3(NF1):c.6452_6456delinsA (p.Leu2151fs)	NF1	L2130fs, L2151fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431672	17	29664410 - 29664414	17	31337392 - 31337396	431672	425177	rs1135402887	NC_000017.11:31337391:TCAGT:A
NM_001042492.3(NF1):c.6326del (p.Phe2109fs)	NF1	F2109fs, F2088fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431669	17	29663829	17	31336811	431669	425174	rs1135402885	NC_000017.11:31336810:TTT:TT
NM_001042492.3(NF1):c.6197del (p.Thr2066fs)	NF1	T2045fs, T2066fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431667	17	29663702	17	31336684	431667	425172	rs1135402883	NC_000017.11:31336683:C:
NM_001042492.3(NF1):c.5780del (p.Leu1927fs)	NF1	L1906fs, L1927fs	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000431664	17	29657480	17	31330462	431664	425169	rs1135402880	NC_000017.11:31330461:TTTTT:TTTT
NM_001042492.3(NF1):c.5637del (p.Ala1879_Leu1880insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431661	17	29657340	17	31330322	431661	425166	rs1135402877	NC_000017.11:31330321:CC:C
NM_001042492.3(NF1):c.5571_5572delinsT (p.Ala1858fs)	NF1	A1837fs, A1858fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431659	17	29654819 - 29654820	17	31327801 - 31327802	431659	425163	rs1135402875	NC_000017.11:31327800:CG:T
NM_001042492.3(NF1):c.5571del (p.Ile1857fs)	NF1	I1857fs, I1836fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431658	17	29654819	17	31327801	431658	425164	rs1135402874	NC_000017.11:31327800:C:
NM_001042492.3(NF1):c.5546_5553del (p.Asp1849fs)	NF1	D1828fs, D1849fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431657	17	29654794 - 29654801	17	31327776 - 31327783	431657	425162	rs1135402873	NC_000017.11:31327775:ATGTCCCT:
NM_001042492.3(NF1):c.4819del (p.Tyr1607fs)	NF1	Y1607fs, Y1586fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000431648	17	29592336	17	31265318	431648	425153	rs876658492	NC_000017.11:31265317:TTTTTT:TTTTT
NM_001042492.3(NF1):c.4460del (p.Pro1487fs)	NF1	P1487fs, P1466fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000431643	17	29587415	17	31260397	431643	425148	rs1135402861	NC_000017.11:31260396:CC:C
NM_001042492.3(NF1):c.4324del (p.Met1442fs)	NF1	M1421fs, M1442fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431636	17	29585511	17	31258493	431636	425141	rs1135402856	NC_000017.11:31258492:AA:A
NM_001042492.3(NF1):c.4254del (p.Ile1418fs)	NF1	I1397fs, I1418fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431635	17	29585441	17	31258423	431635	425140	rs1135402855	NC_000017.11:31258422:TT:T
NM_001042492.3(NF1):c.4076del (p.Pro1359fs)	NF1	P1359fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431632	17	29576098	17	31249080	431632	425137	rs1135402852	NC_000017.11:31249079:CCCCCC:CCCCC
NM_001042492.3(NF1):c.4000del (p.Glu1334fs)	NF1	E1334fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431631	17	29576026	17	31249008	431631	425136	rs1135402851	NC_000017.11:31249007:GG:G
NM_001042492.3(NF1):c.3692_3708del (p.Val1231fs)	NF1	V1231fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431628	17	29560211 - 29560227	17	31233193 - 31233209	431628	425133	rs1135402848	NC_000017.11:31233192:GTGGTTCCTTGTTCTCAGTGG:GTGG
NM_001042492.3(NF1):c.3665del (p.Pro1222fs)	NF1	P1222fs	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431627	17	29560186	17	31233168	431627	425132	rs867391752	NC_000017.11:31233167:CCC:CC
NM_001042492.3(NF1):c.3037del (p.Thr1013fs)	NF1	T1013fs	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431615	17	29557320	17	31230302	431615	425120	rs1135402838	NC_000017.11:31230301:AAAAA:AAAA
NM_001042492.3(NF1):c.3027del (p.Gln1010fs)	NF1	Q1010fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431614	17	29557313	17	31230295	431614	425119	rs1135402837	NC_000017.11:31230294:TT:T
NM_001042492.3(NF1):c.2886_2897del (p.Glu962_Ala966delinsAsp)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431612	17	29556888 - 29556899	17	31229870 - 31229881	431612	425117	rs1135402835	NC_000017.11:31229869:ACAAACCATAGC:
NM_001042492.3(NF1):c.2848del (p.Gln950fs)	NF1	Q950fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431610	17	29556481	17	31229463	431610	425115	rs1135402833	NC_000017.11:31229462:C:
NM_001042492.3(NF1):c.2349del (p.Lys783fs)	NF1	K783fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431606	17	29554561	17	31227543	431606	425111	rs1135402829	NC_000017.11:31227542:AAAA:AAA
NM_001042492.3(NF1):c.2338_2343del (p.Thr780_His781del)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431605	17	29554551 - 29554556	17	31227533 - 31227538	431605	425110	rs1135402828	NC_000017.11:31227532:ATACACAT:AT
NM_001042492.3(NF1):c.1883_1885delinsCC (p.Tyr628fs)	NF1	Y628fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431600	17	29552150 - 29552152	17	31225132 - 31225134	431600	425105	rs1135402823	NC_000017.11:31225131:ACG:CC
NM_001042492.3(NF1):c.1845+1_1845+5del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000431598	17	29550582 - 29550586	17	31223564 - 31223568	431598	425103	rs1135402822	NC_000017.11:31223563:TAAGGTAAG:TAAG
NM_001042492.3(NF1):c.1714_1721+5del	NF1	E572fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431597	17	29548940 - 29548952	17	31221922 - 31221934	431597	425102	rs1135402821	NC_000017.11:31221921:GAGATTAGGTATA:
NM_001042492.3(NF1):c.1667_1670del (p.Asp556fs)	NF1	D556fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431595	17	29548890 - 29548893	17	31221872 - 31221875	431595	425100	rs1135402819	NC_000017.11:31221871:TAGATAG:TAG
NM_001042492.3(NF1):c.1641+2del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431594	17	29546138	17	31219120	431594	425099	rs1135402818	NC_000017.11:31219119:T:
NM_001042492.3(NF1):c.1613del (p.Met538fs)	NF1	M538fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431593	17	29546108	17	31219090	431593	425098	rs1135402817	NC_000017.11:31219089:T:
NM_001042492.3(NF1):c.1561del (p.Ser521fs)	NF1	S521fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431590	17	29546056	17	31219038	431590	425095	rs1135402814	NC_000017.11:31219037:A:
NM_001042492.3(NF1):c.1469_1472del (p.Lys490fs)	NF1	K490fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431586	17	29541543 - 29541546	17	31214525 - 31214528	431586	425091	rs1135402811	NC_000017.11:31214524:TAAGTA:TA
NM_001042492.3(NF1):c.1462del (p.Ser488fs)	NF1	S488fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431585	17	29541537	17	31214519	431585	425090	rs1135402810	NC_000017.11:31214518:AA:A
NM_001042492.3(NF1):c.1400del (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431583	17	29541476	17	31214458	431583	425088	rs1135402808	NC_000017.11:31214457:C:
NM_001042492.3(NF1):c.1280_1292del (p.Pro427fs)	NF1	P427fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431579	17	29533275 - 29533287	17	31206257 - 31206269	431579	425084	rs1135402804	NC_000017.11:31206256:GCCTAAGATTGATGC:GC
NM_001042492.3(NF1):c.1152del (p.Arg385fs)	NF1	R385fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431578	17	29528142	17	31201124	431578	425083	rs1135402803	NC_000017.11:31201123:TTT:TT
NM_001042492.3(NF1):c.1144del (p.Ser382fs)	NF1	S382fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431577	17	29528134	17	31201116	431577	425082	rs1135402802	NC_000017.11:31201115:TTT:TT
NM_001042492.3(NF1):c.1041_1045del (p.Gln347fs)	NF1	Q347fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431575	17	29527590 - 29527594	17	31200572 - 31200576	431575	425080	rs1135402800	NC_000017.11:31200571:CAGTCCA:CA
NM_001042492.3(NF1):c.862del (p.Val288fs)	NF1	V288fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431571	17	29509657	17	31182639	431571	425076	rs1135402797	NC_000017.11:31182638:G:
NM_001042492.3(NF1):c.792del (p.Ala265fs)	NF1	A265fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431570	17	29509587	17	31182569	431570	425075	rs1135402796	NC_000017.11:31182568:A:
NM_001042492.3(NF1):c.789del (p.Ala264fs)	NF1	A264fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431569	17	29509582	17	31182564	431569	425074	rs1135402795	NC_000017.11:31182563:AAA:AA
NM_001042492.3(NF1):c.603del (p.Phe201fs)	NF1	F201fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431566	17	29508454	17	31181436	431566	425071	rs1135402792	NC_000017.11:31181435:TTT:TT
NM_001042492.3(NF1):c.541_542del (p.Gln181fs)	NF1	Q181fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431564	17	29496969 - 29496970	17	31169951 - 31169952	431564	425069	rs1135402790	NC_000017.11:31169950:ACA:A
NM_001042492.3(NF1):c.538_541del (p.Leu180fs)	NF1	L180fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431563	17	29496967 - 29496970	17	31169949 - 31169952	431563	425068	rs1135402789	NC_000017.11:31169948:TTAC:
NM_001042492.3(NF1):c.496_497del (p.Val166fs)	NF1	V166fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431562	17	29496924 - 29496925	17	31169906 - 31169907	431562	425067	rs1135402788	NC_000017.11:31169905:TGT:T
NM_001042492.3(NF1):c.332_335del (p.Lys111fs)	NF1	K111fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431561	17	29490245 - 29490248	17	31163227 - 31163230	431561	425066	rs1135402787	NC_000017.11:31163226:CAAACA:CA
NM_001042492.3(NF1):c.2033del (p.Pro678fs)	NF1	P678fs	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428991	17	29553478	17	31226460	428991	420780	rs587781807	NC_000017.11:31226459:CCCCCCC:CCCCCC
NM_001042492.3(NF1):c.1218del (p.His407fs)	NF1	H407fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428985	17	29528459	17	31201441	428985	420769	rs1131691106	NC_000017.11:31201440:TTT:TT
NM_001042492.3(NF1):c.60+2del	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428980	17	29422389	17	31095371	428980	420759	rs1131691101	NC_000017.11:31095370:T:
NM_001042492.3(NF1):c.3525_3526del (p.Arg1176fs)	NF1	R1176fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428971	17	29560048 - 29560049	17	31233030 - 31233031	428971	420797	rs1131691092	NC_000017.11:31233029:AA:
NM_001042492.3(NF1):c.7317AGC[1] (p.Ala2441del)	NF1	A2420del, A2441del	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426216	17	29676265 - 29676267	17	31349247 - 31349249	426216	415550	rs1085307506	NC_000017.11:31349246:AGCAG:AG
NM_001042492.3(NF1):c.2034delinsCA (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 9, 2021)	criteria provided, single submitter	VCV000423262	17	29553485	17	31226467	423262	409865	rs1064796331	NC_000017.11:31226466:G:CA
NM_001042492.3(NF1):c.6006_6006+1delinsAA	NF1		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000422898	17	29662049 - 29662050	17	31335031 - 31335032	422898	409878	rs1064796077	NC_000017.11:31335030:GG:AA
NM_001042492.3(NF1):c.7971-8del	NF1		not specified|Neurofibromatosis, type 1|not provided	Benign/Likely benign(Last reviewed: Jun 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000422659	17	29685482	17	31358464	422659	409888	rs564545012	NC_000017.11:31358463:TTTTTTTTT:TTTTTTTT
NM_001042492.3(NF1):c.7970+4_7970+7del	NF1		Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420082	17	29684388 - 29684391	17	31357370 - 31357373	420082	409887	rs1064794279	NC_000017.11:31357369:GTAAGTA:GTA
NM_001042492.3(NF1):c.3739_3742del (p.Phe1247fs)	NF1	F1247fs	Inborn genetic diseases|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420078	17	29562657 - 29562660	17	31235639 - 31235642	420078	409871	rs1064794276	NC_000017.11:31235638:TGTTTG:TG
NC_000017.11:g.(?_31163186)_(31169997_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000417339	17	29490204 - 29497015	17	31163186 - 31169997	417339	401506		
NC_000017.11:g.(?_31343009)_(31343135_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000417337	17	29670027 - 29670153	17	31343009 - 31343135	417337	401483		
NC_000017.11:g.(?_31094927)_(31182665_?)del	NF1|LOC108281169|LOC108281170|LOC108281180|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000417336	17	29421945 - 29509683	17	31094927 - 31182665	417336	401966		
NC_000017.11:g.(?_31327499)_(31327839_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2016)	criteria provided, single submitter	VCV000417335	17	29654517 - 29654857	17	31327499 - 31327839	417335	402236		
NC_000017.11:g.(?_31163186)_(31163376_?)del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000417334	17	29490204 - 29490394	17	31163186 - 31163376	417334	401502		
NC_000017.11:g.(?_31094927)_(31095369_?)del	NF1|LOC111811965		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000417332	17	29421945 - 29422387	17	31094927 - 31095369	417332	401475		
NM_001042492.3(NF1):c.4577+9del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000412971	17	29587540	17	31260522	412971	401758	rs772339679	NC_000017.11:31260521:TTT:TT
NM_001042492.3(NF1):c.288+1del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404591	17	29486109	17	31159091	404591	401612	rs1057519370	NC_000017.11:31159090:GGGG:GGG
NM_001042492.3(NF1):c.2071del (p.Leu691fs)	NF1	L691fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000404582	17	29553520	17	31226502	404582	402173	rs1060500364	NC_000017.11:31226501:CCC:CC
NM_001042492.3(NF1):c.5699del (p.Ile1900fs)	NF1	I1900fs, I1879fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000404568	17	29657403	17	31330385	404568	401812	rs1060500353	NC_000017.11:31330384:T:
NM_001042492.3(NF1):c.5925del (p.Asp1976fs)	NF1	D1976fs, D1955fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000404562	17	29661967	17	31334949	404562	401833	rs1060500349	NC_000017.11:31334948:TT:T
NM_001042492.3(NF1):c.1392+1del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 28, 2016)	criteria provided, single submitter	VCV000404560	17	29533389	17	31206371	404560	402357	rs1060500347	NC_000017.11:31206370:GG:G
NM_001042492.3(NF1):c.6487_6488del (p.Leu2163fs)	NF1	L2142fs, L2163fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2016)	criteria provided, single submitter	VCV000404549	17	29664445 - 29664446	17	31337427 - 31337428	404549	402343	rs1060500338	NC_000017.11:31337426:TT:
NM_001042492.3(NF1):c.7373del (p.Arg2458fs)	NF1	R2458fs, R2437fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000404546	17	29677252	17	31350234	404546	401907	rs1060500335	NC_000017.11:31350233:G:
NM_001042492.3(NF1):c.7607del (p.Lys2536fs)	NF1	K2515fs, K2536fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000404533	17	29679423	17	31352405	404533	402384	rs1060500327	NC_000017.11:31352404:AA:A
NM_001042492.3(NF1):c.99del (p.Val34fs)	NF1	V34fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000404524	17	29483037	17	31156019	404524	401600	rs1060500320	NC_000017.11:31156018:AAA:AA
NM_001042492.3(NF1):c.4622_4636del (p.Thr1541_Leu1546delinsMet)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000404519	17	29588773 - 29588787	17	31261755 - 31261769	404519	402283	rs1064792912	NC_000017.11:31261754:CACTTCTTGCATACC:
NM_001042492.3(NF1):c.924_927del (p.Gly309fs)	NF1	G309fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000404496	17	29527473 - 29527476	17	31200455 - 31200458	404496	402117	rs1060500301	NC_000017.11:31200454:GCTGGC:GC
NM_001042492.3(NF1):c.7320del (p.Ala2441fs)	NF1	A2420fs, A2441fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 27, 2016)	criteria provided, single submitter	VCV000404495	17	29676268	17	31349250	404495	401835	rs1060500300	NC_000017.11:31349249:A:
NM_001042492.3(NF1):c.7701del (p.Lys2568_Met2569insTer)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404488	17	29683558	17	31356540	404488	402387	rs1060500295	NC_000017.11:31356539:CCCCCC:CCCCC
NM_001042492.3(NF1):c.4598del (p.Arg1533fs)	NF1	R1533fs, R1512fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2016)	criteria provided, single submitter	VCV000404484	17	29588749	17	31261731	404484	402468	rs1060500292	NC_000017.11:31261730:G:
NM_001042492.3(NF1):c.3639_3641del (p.Met1215del)	NF1	M1215del	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404465	17	29560162 - 29560164	17	31233144 - 31233146	404465	401752	rs1060500276	NC_000017.11:31233143:AAT:
NM_001042492.3(NF1):c.3567del (p.Gly1190fs)	NF1	G1190fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000404456	17	29560089	17	31233071	404456	402231	rs1060500271	NC_000017.11:31233070:AA:A
NM_001042492.3(NF1):c.6699del (p.Gln2234fs)	NF1	Q2213fs, Q2234fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 7, 2016)	criteria provided, single submitter	VCV000404452	17	29664893	17	31337875	404452	401863	rs1060500268	NC_000017.11:31337874:T:
NM_001042492.3(NF1):c.68del (p.Ile23fs)	NF1	I23fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000374082	17	29483008	17	31155990	374082	361008	rs1057518884	NC_000017.11:31155989:T:
NM_001042492.3(NF1):c.*2638_*2646delinsTTATG	NF1		Neurofibromatosis, familial spinal|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322601	17	29703811 - 29703819	17	31376793 - 31376801	322601	327988	rs886052813	NC_000017.11:31376792:GATAATCTA:TTATG
NM_001042492.3(NF1):c.*2215_*2219del	NF1		Neurofibromatosis, familial spinal|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322598	17	29703386 - 29703390	17	31376368 - 31376372	322598	345471	rs201032889	NC_000017.11:31376367:GTGTAGT:GT
NM_001042492.3(NF1):c.*871del	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322584	17	29702044	17	31375026	322584	345445	rs759306393	NC_000017.11:31375025:A:
NM_001042492.3(NF1):c.*125del	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322578	17	29701297	17	31374279	322578	327979	rs397754615	NC_000017.11:31374278:CC:C
NM_001042492.3(NF1):c.61-4del	NF1		not specified|Neurofibromatosis-Noonan syndrome|not provided|Neurofibromatosis, type 1|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Benign/Likely benign(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000322566	17	29482989	17	31155971	322566	337802	rs551568608	NC_000017.11:31155970:TTTTTTTTT:TTTTTTTT
NG_009018.1(NF1):g.[134769_136954del2186;136931_139830del2900]	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2013)	no assertion criteria provided	VCV000267490	17|17	29553925 - 29556824	17|17	31226905 - 31229804	267490	262763|262762		
NM_001042492.3(NF1):c.7581del (p.Gln2528fs)	NF1	Q2507fs, Q2528fs	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237598	17	29679395	17	31352377	237598	242710	rs878853917	NC_000017.11:31352376:GGGG:GGG
NM_001042492.3(NF1):c.397del (p.Glu133fs)	NF1	E133fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000237559	17	29490312	17	31163294	237559	242621	rs878853891	NC_000017.11:31163293:G:
NM_001042492.3(NF1):c.3897del (p.Lys1299fs)	NF1	K1299fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000237558	17	29562958	17	31235940	237558	242677	rs878853890	NC_000017.11:31235939:AAAAA:AAAA
NM_001042492.3(NF1):c.3064del (p.Val1021_Met1022insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000237545	17	29557350	17	31230332	237545	242665	rs878853881	NC_000017.11:31230331:AA:A
NM_001042492.3(NF1):c.2409+2del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000237536	17	29554626	17	31227608	237536	242656	rs878853875	NC_000017.11:31227607:T:
NM_001042492.3(NF1):c.2002-4_2010del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000237529	17	29553449 - 29553461	17	31226431 - 31226443	237529	242649	rs878853871	NC_000017.11:31226430:TCAGGATAGTGCA:
NM_001042492.3(NF1):c.2851-3del	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000233398	17	29556848	17	31229830	233398	235616	rs876660379	NC_000017.11:31229829:TTT:TT
NM_001042492.3(NF1):c.1714del (p.Glu572fs)	NF1	E572fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233017	17	29548938	17	31221920	233017	235561	rs876660135	NC_000017.11:31221919:GGG:GG
NM_001042492.3(NF1):c.7190-5del	NF1		Neurofibromatosis, type 1|not provided|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230047	17	29676128	17	31349110	230047	235806	rs769290414	NC_000017.11:31349109:TTTTTT:TTTTT
NM_000267.3(NF1):c.4368-?_5943+?del	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, single submitter	VCV000224941					224941	226809		
NM_001042492.3(NF1):c.4174-8_4174-6del	NF1		Neurofibromatosis, type 1|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000221137	17	29585352 - 29585354	17	31258334 - 31258336	221137	222599	rs751729752	NC_000017.11:31258333:TTGTT:TT
NM_001042492.3(NF1):c.7063-7_7063-6delinsC	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000221040	17	29670020 - 29670021	17	31343002 - 31343003	221040	222629	rs864622725	NC_000017.11:31343001:TT:C
NM_001042492.3(NF1):c.3198-5_3198-4del	NF1		not provided|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220515	17	29559062 - 29559063	17	31232044 - 31232045	220515	222590	rs371047262	NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.889-6del	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000220058	17	29527434	17	31200416	220058	222569	rs864622362	NC_000017.11:31200415:C:
NM_000267.3(NF1):c.5944-?_6858+?del	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000219404					219404	222545		
NM_000267.3(NF1):c.[4110+1791_7394+859dup;4110+1798del]	NF1|EVI2A|OMG|EVI2B		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217112	17|17	29577935	17|17	31250917	217112	213715|213714	rs863224944	NC_000017.11:31250916:AAAAA:AAAA
NM_000267.3(NF1):c.7884_8315-5528del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217104	17	29684364 - 29695503	17	31357346 - 31368485	217104	213736		
NM_001042492.3(NF1):c.7321+383_7925del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217101	17	29676650 - 29684340	17	31349632 - 31357322	217101	213734		
NM_000267.3(NF1):c.7000-499_7908-479del	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217100	17	29669528 - 29685019	17	31342510 - 31358001	217100	213733		
NM_000267.3(NF1):c.5943+448_7127-414del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217099	17	29662497 - 29675724	17	31335479 - 31348706	217099	213732		
NM_000267.3(NF1):c.5943+265_7000-999delins15	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217098	17	29662314 - 29669028	17	31335296 - 31342010	217098	213731		
NM_000267.3(NF1):c.5749+189_6999+1035del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217097	17	29657705 - 29668698	17	31330687 - 31341680	217097	213725		
NM_000267.3(NF1):c.5749+6_6858+633delins130	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217096	17	29657522 - 29666456	17	31330504 - 31339438	217096	213724		
NM_001042492.3(NF1):c.5813-1748_6247delinsCTA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217095	17	29660108 - 29663752	17	31333090 - 31336734	217095	213727		
NM_001042492.3(NF1):c.5813-374_6007-176del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217094	17	29661481 - 29663174	17	31334463 - 31336156	217094	213730		
NM_001042492.3(NF1):c.5813-1086_6006+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217093	17	29660768 - 29662291	17	31333750 - 31335273	217093	213728		
NM_001042492.3(NF1):c.5812+750_6006+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217092	17	29658266 - 29662293	17	31331248 - 31335275	217092	213726		
NM_001042492.3(NF1):c.5813-460_6006+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217091	17	29661395 - 29662292	17	31334377 - 31335274	217091	213729	rs1555534307	
NM_000267.3:c.5547-961+5943+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217090					217090	213757		
NM_001042492.3(NF1):c.5609+336_6006+244del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217089	17	29655193 - 29662293	17	31328175 - 31335275	217089	213723		
NM_000267.3(NF1):c.4773-23713_7907+14del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217088					217088	213756		
NM_000267.3(NF1):c.4941_7127-2901del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217087	17	29653006 - 29673237	17	31325988 - 31346219	217087	213722		
NM_000267.3(NF1):c.4773-2116_7127-1817delinsAGTTACC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217086	17	29650722 - 29674321	17	31323704 - 31347303	217086	213720		
NM_000267.3(NF1):c.4515-343_8314+3380del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217084					217084	213755		
NM_000267.3(NF1):c.4661+1660_4773-8837del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217083					217083	213754		
NM_000267.3(NF1):c.4662-1076_4772+1300delins260	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217081	17	29591171 - 29593657	17	31264153 - 31266639	217081	213717		
NM_000267.3(NF1):c.4368-391_4515-122delins105	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217080	17	29586996 - 29588607	17	31259978 - 31261589	217080	213716		
NM_000267.3:c.3975-364_4515-510indel810	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217079					217079	213753		
NM_001042492.3(NF1):c.3975-1922_4174-2448delinsTTTACTTAGGT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217078	17	29574080 - 29582914	17	31247062 - 31255896	217078	213713		
NM_000267.3(NF1):c.3709-266_7259-397delinsCAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217076					217076	213751		
NM_000267.3(NF1):c.3708+598_4772+16224del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217075	17	29560829 - 29608581	17	31233811 - 31281563	217075	213711		
NM_001042492.3(NF1):c.3709-941_3974+2711del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217074	17	29561647 - 29565709	17	31234629 - 31238691	217074	213712		
NM_001042492.3(NF1):c.2410-110_2850+65delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217073	17	29555933 - 29556548	17	31228915 - 31229530	217073	213708	rs1555614169	
NM_000267.3(NF1):c.2048_5041del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217072					217072	213750		
NM_000267.3(NF1):c.1846-613_4773-1009delinsTTAGGTTTAT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217071					217071	213749		
NM_000267.3(NF1):c.1845+537_4661+331del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217070	17	29551122 - 29589206	17	31224104 - 31262188	217070	213704		
NM_001042492.3(NF1):c.1988_2410-218delinsTGTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217069	17	29552255 - 29555825	17	31225237 - 31228807	217069	213706		
NM_001042492.3(NF1):c.1846-496_2410-645delinsTAGC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217068	17	29551617 - 29555398	17	31224599 - 31228380	217068	213705		
NM_000267.3(NF1):c.1641+156_3975-2222del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217067	17	29546292 - 29573780	17	31219274 - 31246762	217067	213703		
NM_001042492.3(NF1):c.1528-960_1761del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217066	17	29545061 - 29550499	17	31218043 - 31223481	217066	213702		
NM_001042492.3(NF1):c.1527+1509_1641+1137del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217065	17	29543111 - 29547272	17	31216093 - 31220254	217065	213701		
NM_000267.3(NF1):c.1393-3329_3975-6377del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217064	17	29538140 - 29569625	17	31211122 - 31242607	217064	213696		
NM_001042492.3(NF1):c.1393-2488_1642-648delinsAATAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217063	17	29538981 - 29548220	17	31211963 - 31221202	217063	213698		
NM_001042492.3(NF1):c.1393-2652_1528-892del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217062	17	29538815 - 29545129	17	31211797 - 31218111	217062	213697		
NM_000267.3(NF1):c.1260+220_7553-1095del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217061					217061	213748		
NM_000267.3(NF1):c.889-1633_7395-667del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217060					217060	213747		
NM_000267.3(NF1):c.889-8381_6757-5del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217059					217059	213746		
NM_000267.3(NF1):c.888+3798_5750-2053del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217058					217058	213745		
NM_000267.3(NF1):c.888+8334_1721+34delinsTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217057	17	29518017 - 29548981	17	31190999 - 31221963	217057	213692		
NM_001042492.3(NF1):c.889-894_1261-284del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217056	17	29526546 - 29532974	17	31199528 - 31205956	217056	213694		
NM_000267.3(NF1):c.889-8107_1261-278del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217055	17	29519333 - 29532980	17	31192315 - 31205962	217055	213693		
NM_000267.3(NF1):c.888+5515_1261-1635del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217054	17	29515198 - 29531623	17	31188180 - 31204605	217054	213691		
NM_001042492.3(NF1):c.889-453_908del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217053	17	29526983 - 29527455	17	31199965 - 31200437	217053	213695	rs1555610774	
NM_000267.3(NF1):c.731-302_8314+3681del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217052					217052	213744		
NM_000267.3(NF1):c.655-60_888+5621delins135	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217051	17	29508668 - 29515304	17	31181650 - 31188286	217051	213690		
NM_000267.3(NF1):c.587-282_8315-3687del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217050					217050	213743		
NM_000267.3(NF1):c.586+1209_1845+35del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217049					217049	213742		
NM_000267.3(NF1):c.586+3099_1261-1045del	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217048	17	29500114 - 29532213	17	31173096 - 31205195	217048	213688		
NM_000267.3(NF1):c.586+2095_1261-2276delinsGTGG	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217047	17	29499110 - 29530982	17	31172092 - 31203964	217047	213687		
NM_001042492.3(NF1):c.587-1766_888+1856del	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217046	17	29506671 - 29511536	17	31179653 - 31184518	217046	213689		
NM_000267.3(NF1):c.480-134_8315-6206del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217045					217045	213741		
NM_000267.3(NF1):c.480-2832_888+5938delinsTTGAA	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217044	17	29494077 - 29515621	17	31167059 - 31188603	217044	213686		
NM_001042492.3(NF1):c.480-2989_586+3445del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217043	17	29493920 - 29500460	17	31166902 - 31173442	217043	213685		
NM_000267.3(NF1):c.289-1237_586+3325del	NF1|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217042	17	29488967 - 29500340	17	31161949 - 31173322	217042	213681		
NM_000267.3(NF1):c.289-950_586+3043del	NF1|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217041	17	29489254 - 29500058	17	31162236 - 31173040	217041	213684		
NM_000267.3(NF1):c.289-956_586+4999del	NF1|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217040	17	29489248 - 29502014	17	31162230 - 31174996	217040	213683		
NM_000267.3(NF1):c.288+230_480-1812delins323	NF1|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217039	17	29486341 - 29495097	17	31159323 - 31168079	217039	213680		
NM_000267.3(NF1):c.204+155_2990+53del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217038					217038	213740		
NM_001042492.3(NF1):c.205-1284_289-944del	NF1|LOC108281170|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217037	17	29484707 - 29489223	17	31157689 - 31162205	217037	213679		
NM_000267.3(NF1):c.60+3120_3975-326del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217036					217036	213739		
NM_000267.3(NF1):c.60+24136_587-5022del	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217035					217035	213738		
NM_000267.3(NF1):c.61-16315_479+99del	NF1|LOC108281169|LOC108281170|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217034	17	29466686 - 29490493	17	31139668 - 31163475	217034	213675		
NM_000267.3(NF1):c.61-12088_204+933del	NF1|LOC108281169|LOC108281170		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217033	17	29470913 - 29484077	17	31143895 - 31157059	217033	213676		
NM_001042492.3(NF1):c.6852_6855del (p.Tyr2285fs)	NF1	Y2285fs	not specified|Ganglioglioma|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216866	17	29665752 - 29665755	17	31338734 - 31338737	216866	213290	rs1555535032	NC_000017.11:31338733:ACTTAC:AC
NM_001042492.3(NF1):c.5907_5908del (p.Arg1970fs)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216865	17	29661949 - 29661950	17	31334931 - 31334932	216865	213287	rs863224835	NC_000017.11:31334930:AAA:A
NM_001042492.3(NF1):c.3139_3140del (p.Asp1047fs)	NF1	D1047fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2015)	criteria provided, single submitter	VCV000216063	17	29557884 - 29557885	17	31230866 - 31230867	216063	213265	rs863224490	NC_000017.11:31230865:AGA:A
NM_001042492.3(NF1):c.1059del (p.Lys354fs)	NF1	K354fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2015)	criteria provided, single submitter	VCV000216060	17	29527609	17	31200591	216060	213248	rs863224488	NC_000017.11:31200590:TT:T
NM_001042492.3(NF1):c.2298_2304del (p.Glu767fs)	NF1	E767fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	VCV000188217	17	29554278 - 29554284	17	31227260 - 31227266	188217	186248	rs786204154	NC_000017.11:31227259:GCATTGAGCAT:GCAT
NM_001042492.3(NF1):c.1783_1784del (p.Glu595fs)	NF1	E595fs	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188086	17	29550522 - 29550523	17	31223504 - 31223505	188086	186246	rs786204059	NC_000017.11:31223503:AGA:A
NM_001042492.3(NF1):c.7057_7059del (p.Asp2353del)	NF1	D2332del, D2353del	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187215	17	29667658 - 29667660	17	31340640 - 31340642	187215	184740	rs786203558	NC_000017.11:31340639:GAC:
NM_001042492.3(NF1):c.1756_1759del (p.Thr586fs)	NF1		Neurofibroma|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186215	17	29550494 - 29550497	17	31223476 - 31223479	186215	184559	rs786202782	NC_000017.11:31223475:TAACTA:TA
NM_001042492.3(NF1):c.3457_3460del (p.Leu1153fs)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185963	17	29559859 - 29559862	17	31232841 - 31232844	185963	184625	rs1321848637	NC_000017.11:31232840:ACTCA:A
NM_001042492.3(NF1):c.7392del (p.Asp2465fs)	NF1	D2444fs, D2465fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000185448	17	29677271	17	31350253	185448	184751	rs786202180	NC_000017.11:31350252:T:
NM_001042492.3(NF1):c.1392+5_1392+6delinsTT	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2021)	criteria provided, conflicting interpretations	VCV000142958	17	29533394 - 29533395	17	31206376 - 31206377	142958	152672	rs587782851	NC_000017.11:31206375:GA:TT
NF1, 1-BP DEL, 4071C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000000370					370	15409		
NM_001042492.3(NF1):c.3784del (p.Ser1262fs)	NF1	S1262fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000000367	17	29562701	17	31235683	367	15406	rs1567852567	NC_000017.11:31235682:TTTT:TTT
NM_001042492.3(NF1):c.945_946delinsAA (p.Leu316Met)	NF1	L316M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000000366	17	29527496 - 29527497	17	31200478 - 31200479	366	15405	rs267606609	NC_000017.11:31200477:GC:AA
NM_001042492.3(NF1):c.2970_2972del (p.Met992del)	NF1	M992del	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis-Noonan syndrome|Caf√©-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000363	17	29556972 - 29556974	17	31229954 - 31229956	363	15402	rs267606606	NC_000017.11:31229953:AAT:
NF1, DEL	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000000360					360	15399		
NM_000267.3(NF1):c.1541_1542del (p.Gln514fs)	NF1	Q514fs	not provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000346	17	29546036 - 29546037	17	31219018 - 31219019	346	15385	rs267606600	NC_000017.11:31219017:AG:
NF1, 5-BP DEL	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000333					333	15372		
NM_000268.4(NF2):c.770_784del (p.Pro257_Ile261del)	NF2		Neurofibromatosis, type 2	Pathogenic	no assertion criteria provided	VCV001299301	22	30057285 - 30057299	22	29661296 - 29661310	1299301	1163368		NC_000022.11:29661295:TCCCGTGGAATGAAATCC:TCC
NM_000268.4(NF2):c.1341-5del	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV001090880	22	30070819	22	29674830	1090880	1085934		NC_000022.11:29674829:TT:T
NM_000268.4(NF2):c.886-9del	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001080489	22	30064313	22	29668324	1080489	1085927		NC_000022.11:29668323:T:
NC_000022.10:g.(?_30051485_30051628del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV001072529					1072529	1058144		
NC_000022.10:g.(?_29999988)_(30077600_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001070380	22	29999988 - 30077600			1070380	1058142		
NC_000022.10:g.(?_29999988)_(30090791_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001070379	22	29999988 - 30090791			1070379	1058143		
NC_000022.10:g.(?_29999982)_(30090797_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV001070378	22	29999982 - 30090797			1070378	1058141		
NM_000268.4(NF2):c.375_376del (p.Gln125fs)	NF2	Q125fs, Q42fs, Q83fs, Q84fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV001069587	22	30038201 - 30038202	22	29642212 - 29642213	1069587	1065009		NC_000022.11:29642211:AGA:A
NM_000268.4(NF2):c.675+1del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001067241	22	30054252	22	29658263	1067241	1056675		NC_000022.11:29658262:GGG:GG
NC_000022.10:g.(?_30064316)_(30067943_?)del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV001066695	22	30064316 - 30067943			1066695	1054678		
NC_000022.10:g.(?_30035073)_(30035207_?)del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV001066694	22	30035073 - 30035207			1066694	1054677		
NM_000268.4(NF2):c.1493_1494delinsCT (p.Phe498Ser)	NF2	F415S, F456S, F457S, F498S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001061051	22	30074231 - 30074232	22	29678242 - 29678243	1061051	1052071		NC_000022.11:29678241:TC:CT
NM_000268.4(NF2):c.115-8101del	NF2		Neurofibromatosis, type 2	Uncertain significance	no assertion criteria provided	VCV001050057	22	30024617	22	29628628	1050057	1038823		NC_000022.11:29628627:TTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTT
NC_000022.10:g.(?_30050636)_(30050946_?)del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001041202	22	30050636 - 30050946			1041202	1022427		
NM_000268.4(NF2):c.1395_1396delinsAT (p.Arg466Ter)	NF2	R383*, R424*, R425*, R466*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000998281	22	30070879 - 30070880	22	29674890 - 29674891	998281	986118		NC_000022.11:29674889:GC:AT
NM_000268.4(NF2):c.432del (p.Ser143_Tyr144insTer)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 9, 2020)	no assertion criteria provided	VCV000992435	22	30038259	22	29642270	992435	980396		NC_000022.11:29642269:C:
NM_000268.4(NF2):c.319_325delinsTAGGATA (p.Glu107_Leu109delinsTer)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000970254	22	30035157 - 30035163	22	29639168 - 29639174	970254	959061		NC_000022.11:29639167:GAGGAGC:TAGGATA
NM_000268.4(NF2):c.447+1del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000969640	22	30038274	22	29642285	969640	959062		NC_000022.11:29642284:GG:G
NC_000022.11:g.29600322_29604002del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000967709	22	29996311 - 29999991	22	29600322 - 29604002	967709	960965		
NM_000268.4(NF2):c.10del (p.Ala4fs)	NF2	A4fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000962511	22	29999994	22	29604005	962511	951407		NC_000022.11:29604004:GGGG:GGG
NM_000268.4(NF2):c.322del (p.Glu108fs)	NF2	E108fs, E66fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000955527	22	30035159	22	29639170	955527	951409		NC_000022.11:29639169:GG:G
NM_000268.4(NF2):c.1162del (p.Ala388fs)	NF2	A347fs, A388fs, A305fs, A346fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000941030	22	30069296	22	29673307	941030	939260		NC_000022.11:29673306:GG:G
NM_000268.4(NF2):c.1413_1428del (p.Leu472fs)	NF2	L430fs, L431fs, L472fs, L389fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000936088	22	30070897 - 30070912	22	29674908 - 29674923	936088	939264		NC_000022.11:29674907:GCTCCTGGAGATTGCC:
NC_000022.11:g.(?_29603989)_(29636886_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000833432	22	29999978 - 30032875			833432	821438		
NC_000022.11:g.(?_29603999)_(29642295_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000832466	22	29999988 - 30038284			832466	821444		
NC_000022.11:g.(?_29671816)_(29671958_?)del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000832037	22	30067805 - 30067947			832037	821448		
NC_000022.11:g.(?_29671816)_(29678333_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831227	22	30067805 - 30074322			831227	821449		
NC_000022.11:g.(?_29603999)_(29604122_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000831122	22	29999988 - 30000111			831122	821442		
NC_000022.11:g.(?_29658157)_(29661364_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000830877	22	30054146 - 30057353			830877	821447		
NM_000268.4(NF2):c.1229del (p.Gln410fs)	NF2	Q369fs, Q368fs, Q327fs, Q410fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803674	22	30069364	22	29673375	803674	792049	rs1601648452	NC_000022.11:29673374:A:
NM_000268.4(NF2):c.1060del (p.Asp354fs)	NF2	D354fs, D312fs, D313fs, D271fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803673	22	30067873	22	29671884	803673	792048	rs1601644146	NC_000022.11:29671883:GGG:GG
NM_000268.4(NF2):c.933del (p.Ala313fs)	NF2	A272fs, A313fs, A271fs, A230fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803671	22	30064368	22	29668379	803671	792046	rs1601636894	NC_000022.11:29668378:GG:G
NM_000268.4(NF2):c.745_752del (p.Arg249fs)	NF2	R207fs, R249fs, R166fs, R208fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803669	22	30057261 - 30057268	22	29661272 - 29661279	803669	792044	rs1601624078	NC_000022.11:29661271:ACAGACTGAC:AC
NM_000268.4(NF2):c.223_240+8del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803664	22	30032848 - 30032873	22	29636859 - 29636884	803664	792039	rs1601579295	NC_000022.11:29636858:CTCAAAATGGACAAGAAGGTTGGGCT:
NM_000268.4(NF2):c.179_185del (p.Trp60fs)	NF2	W60fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803663	22	30032803 - 30032809	22	29636814 - 29636820	803663	792038	rs1601579095	NC_000022.11:29636813:TGGTTCTT:T
NM_000268.4(NF2):c.810+23_810+25del	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000681582	22	30057350 - 30057352	22	29661361 - 29661363	681582	670594	rs765519341	NC_000022.11:29661360:GATG:G
NC_000022.11:g.(?_29636741)_(29639222_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000665033	22	30032730 - 30035211	22	29636741 - 29639222	665033	653205		
NC_000022.11:g.(?_29603989)_(29604122_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000661747	22	29999978 - 30000111	22	29603989 - 29604122	661747	653285		
NM_000268.4(NF2):c.517-92_568del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000654267	22	30051485 - 30051628	22	29655496 - 29655639	654267	653616	rs1601613230	
NC_000022.11:g.(?_29673259)_(29673496_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000652949	22	30069248 - 30069485	22	29673259 - 29673496	652949	653697		
NM_000268.4(NF2):c.1702_1703del (p.Arg568fs)	NF2	R527fs, R568fs, R485fs, R526fs	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000652858	22	30077555 - 30077556	22	29681566 - 29681567	652858	649366	rs755032702	NC_000022.11:29681565:AG:
NC_000022.11:g.(?_29603989)_(29681611_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000640993	22	29999978 - 30077600	22	29603989 - 29681611	640993	653696		
NM_000268.4(NF2):c.-142del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584996	22	29999843	22	29603854	584996	576052	rs1569259403	NC_000022.11:29603853:GGGG:GGG
NC_000022.11:g.(?_29642196)_(29642291_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000583855	22	30038185 - 30038280	22	29642196 - 29642291	583855	573218		
NC_000022.11:g.(?_29636741)_(29661349_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000583523	22	30032730 - 30057338	22	29636741 - 29661349	583523	573936		
NM_000268.4(NF2):c.810+8_810+9del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000578502	22	30057336 - 30057337	22	29661347 - 29661348	578502	575246	rs760095910	NC_000022.11:29661346:AT:
NM_000268.4(NF2):c.3_14del (p.Met1_Ala4del)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000566704	22	29999985 - 29999996	22	29603996 - 29604007	566704	571857	rs1351718417	NC_000022.11:29603995:GCCATGGCCGGGGCCAT:GCCAT
NM_000268.4(NF2):c.1447-2del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547707	22	30074183	22	29678194	547707	538257	rs1556002457	NC_000022.11:29678193:A:
NM_000268.4(NF2):c.465del (p.Ser156fs)	NF2	S73fs, S114fs, S115fs, S156fs	Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547705	22	30050660	22	29654671	547705	538255	rs1555992948	NC_000022.11:29654670:CCCC:CCC
NM_000268.4(NF2):c.58_61delinsGT (p.Lys20fs)	NF2	K20fs	Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547703	22	30000045 - 30000048	22	29604056 - 29604059	547703	538253	rs1555978369	NC_000022.11:29604055:AAGA:GT
NC_000022.11:g.(?_29654651)_(29654731_?)del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000527728	22	30050640 - 30050720	22	29654651 - 29654731	527728	534010		
NC_000022.11:g.(?_29668327)_(29678329_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527725	22	30064316 - 30074318	22	29668327 - 29678329	527725	534011		
NM_000268.4(NF2):c.563_564del (p.Ile188fs)	NF2	I105fs, I146fs, I147fs, I188fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000527703	22	30051629 - 30051630	22	29655640 - 29655641	527703	534709	rs1555993313	NC_000022.11:29655639:TT:
NM_000268.4(NF2):c.970del (p.Gln324fs)	NF2	Q324fs, Q241fs, Q282fs, Q283fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527702	22	30064404	22	29668415	527702	534186	rs1555998851	NC_000022.11:29668414:CCC:CC
NM_000268.4(NF2):c.243_248del (p.Leu82_Asp83del)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527697	22	30035081 - 30035086	22	29639092 - 29639097	527697	534151	rs777858863	NC_000022.11:29639091:ACTGGA:
NM_000268.4(NF2):c.273del (p.Val92fs)	NF2	V50fs, V92fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000457911	22	30035111	22	29639122	457911	471883	rs1555987647	NC_000022.11:29639121:A:
NM_000268.4(NF2):c.1738-4_1741delinsG	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000457909	22	30090737 - 30090744	22	29694748 - 29694755	457909	471495	rs1556008383	NC_000022.11:29694747:ACAGCTCA:G
NM_000268.4(NF2):c.1346_1347del (p.Lys449fs)	NF2	K366fs, K408fs, K407fs, K449fs	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000453214	22	30070829 - 30070830	22	29674840 - 29674841	453214	446398	rs1556001351	NC_000022.11:29674839:AAA:A
NC_000022.11:g.(?_29668333)_(29671948_?)del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000417575	22	30064322 - 30067937	22	29668333 - 29671948	417575	403757		
NC_000022.11:g.(?_29639090)_(29639212_?)del	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000417574	22	30035079 - 30035201	22	29639090 - 29639212	417574	403750		
NM_000268.3(NF2):c.1739_1747delTCACCTTGC	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412216	22	30090740 - 30090748	22	29694751 - 29694759	412216	404394	rs1060503674	NC_000022.11:29694750:GCTCACCTTGC:GC
NM_000268.4(NF2):c.*3613_*3618del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341174	22	30094401 - 30094406	22	29698412 - 29698417	341174	351344	rs755969033	NC_000022.11:29698411:GCCCAAGCC:GCC
NM_000268.4(NF2):c.*3319del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341169	22	30094109	22	29698120	341169	337799	rs372162228	NC_000022.11:29698119:GG:G
NM_000268.4(NF2):c.*2007del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341126	22	30092785	22	29696796	341126	351319	rs886057365	NC_000022.11:29696795:TTTTTTTTTTTTTT:TTTTTTTTTTTTT
NM_000268.4(NF2):c.*1320_*1325del	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341109	22	30092108 - 30092113	22	29696119 - 29696124	341109	351304	rs148703036	NC_000022.11:29696118:GTGGGAGTG:GTG
NM_000268.4(NF2):c.*1264del	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341103	22	30092055	22	29696066	341103	351299	rs886057353	NC_000022.11:29696065:C:
NM_000268.4(NF2):c.*704del	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341093	22	30091495	22	29695506	341093	351294	rs567370520	NC_000022.11:29695505:A:
NC_000022.10:g.[30057723_30063344del;30063345_30067790del]	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 21, 2014)	no assertion criteria provided	VCV000267491	22|22	30063345 - 30067790	22|22	29667356 - 29671801	267491	262765|262764		
NM_000268.3(NF2):c.-443-?_*3798+?del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000237611					237611	243642		
NC_000017.10:g.(?_29422322)_(29664606_?)del	OMG|EVI2A|EVI2B|NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV001072078	17	29422322 - 29664606			1072078	1057873		
PHOX2B, 1-BP DEL, 676G	PHOX2B		Neuroblastoma with Hirschsprung disease	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000006013					6013	21052		
NM_000535.7(PMS2):c.2117del (p.Lys706fs)	PMS2	K519fs, K603fs, K515fs, K571fs, K600fs, K654fs, K706fs, K395fs	Lynch syndrome|Hereditary cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary nonpolyposis colorectal cancer type 4|Endometrial carcinoma|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142765	7	6022512	7	5982881	142765	152479	rs587782704	NC_000007.14:5982880:TT:T
NC_000015.9:g.(?_38591568)_(38643870_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV001073448	15	38591568 - 38643870			1073448	1057679		
NC_000015.9:g.(?_38545367)_(38545438_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV001073447	15	38545367 - 38545438			1073447	1057677		
NC_000015.9:g.(?_38591554)_(38591768_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001073310	15	38591554 - 38591768			1073310	1057678		
NM_152594.3(SPRED1):c.1232_1241del (p.Ser411fs)	SPRED1	S411fs	Legius syndrome	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001068652	15	38643758 - 38643767	15	38351557 - 38351566	1068652	1063235		NC_000015.10:38351556:TTGTCTTTCATTGT:TTGT
NC_000015.10:g.(?_38253186)_(38253227_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832303	15	38545387 - 38545428			832303	820688		
NC_000015.10:g.(?_38299363)_(38324819_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000831554	15	38591564 - 38617020			831554	820689		
NM_152594.3(SPRED1):c.903_906del (p.Leu302fs)	SPRED1	L302fs	Legius syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817884	15	38643432 - 38643435	15	38351231 - 38351234	817884	805820	rs1595763662	NC_000015.10:38351230:AGTTA:A
NM_152594.3(SPRED1):c.1149_1152del (p.Gly385fs)	SPRED1	G385fs	Legius syndrome|not provided	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000646826	15	38643679 - 38643682	15	38351478 - 38351481	646826	643124	rs1595763925	NC_000015.10:38351477:AGAG:
NM_152594.3(SPRED1):c.1151del (p.Glu384fs)	SPRED1	E384fs	Legius syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000642469	15	38643681	15	38351480	642469	643125	rs1595763928	NC_000015.10:38351479:A:
NC_000015.10:g.(?_38253180)_(38351670_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000584323	15	38545381 - 38643871	15	38253180 - 38351670	584323	568569		
NM_152594.3(SPRED1):c.1053del (p.Lys351fs)	SPRED1	K351fs	Legius syndrome	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000581681	15	38643580	15	38351379	581681	569323	rs1566876954	NC_000015.10:38351378:AAAA:AAA
NM_152594.3(SPRED1):c.301_307del (p.Leu101fs)	SPRED1	L101fs	Legius syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000578285	15	38614533 - 38614539	15	38322332 - 38322338	578285	566981	rs1566867246	NC_000015.10:38322331:GTCTTACGT:GT
NM_152594.3(SPRED1):c.1044_1046delinsC (p.Arg349fs)	SPRED1	R349fs	Legius syndrome	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000565472	15	38643574 - 38643576	15	38351373 - 38351375	565472	573221	rs1566876929	NC_000015.10:38351372:TAG:C
NM_152594.3(SPRED1):c.1225_1226delinsTT (p.Ala409Phe)	SPRED1	A409F	not specified|Legius syndrome|not provided|Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000561784	15	38643755 - 38643756	15	38351554 - 38351555	561784	552852	rs1566877075	NC_000015.10:38351553:GC:TT
NM_152594.3(SPRED1):c.24del (p.Asp9fs)	SPRED1	D9fs	Legius syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547790	15	38545410	15	38253209	547790	538026	rs1555386654	NC_000015.10:38253208:T:
NM_152594.3(SPRED1):c.7_20del (p.Glu3fs)	SPRED1	E3fs	Legius syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547789	15	38545392 - 38545405	15	38253191 - 38253204	547789	538025	rs1555386651	NC_000015.10:38253190:CGAGGAGACGGCGAC:C
NM_152594.3(SPRED1):c.1_2del (p.Met1fs)	SPRED1	M1fs	Legius syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547788	15	38545387 - 38545388	15	38253186 - 38253187	547788	538024	rs1555386649	NC_000015.10:38253185:AT:
NM_152594.3(SPRED1):c.290_291delinsGA (p.Lys97Arg)	SPRED1	K97R	Legius syndrome	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000536697	15	38614524 - 38614525	15	38322323 - 38322324	536697	529110	rs1555391042	NC_000015.10:38322322:AG:GA
NC_000015.10:g.(?_38299373)_(38357249_?)del	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000417474	15	38591574 - 38649450	15	38299373 - 38357249	417474	400528		
NM_152594.3(SPRED1):c.*2506_*2513del	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315760	15	38646367 - 38646374	15	38354166 - 38354173	315760	322364	rs770258605	NC_000015.10:38354165:TGAGTAAATGAG:TGAG
NM_152594.3(SPRED1):c.*2414del	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315759	15	38646277	15	38354076	315759	331674	rs532033889	NC_000015.10:38354075:TTT:TT
NM_152594.3(SPRED1):c.*1659_*1662del	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315753	15	38645522 - 38645525	15	38353321 - 38353324	315753	331665	rs57589132	NC_000015.10:38353320:CTATCT:CT
NM_152594.3(SPRED1):c.-156del	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315729	15	38545225	15	38253024	315729	322333	rs531519324	NC_000015.10:38253023:GGGGGGG:GGGGGG
NM_152594.3(SPRED1):c.796_797del (p.Met266fs)	SPRED1	M266fs	Legius syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220172	15	38643326 - 38643327	15	38351125 - 38351126	220172	222418	rs864622410	NC_000015.10:38351124:AT:
NM_152594.3(SPRED1):c.1045_1046del (p.Arg349fs)	SPRED1	R349fs	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030784	15	38643575 - 38643576	15	38351374 - 38351375	30784	39741	rs1566876941	NC_000015.10:38351373:AG:
GRCh37/hg19 2q37.1(chr2:234639310-234662263)x1	UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A3|DNAJB3		not provided	Benign(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000604325	2	234639310 - 234662263			604325	595661		
GRCh37/hg19 17q11.2(chr17:28941066-30326958)x1	UTP6|ADAP2|ATAD5|COPRS|CRLF3|EVI2A|EVI2B|MIR193A|NF1|OMG|RAB11FIP4|RNF135|SUZ12|TEFM		Chromosome 17q11.2 deletion syndrome, 1.4 MB	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000666441	17	28941066 - 30326958			666441	654000		
